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ABSTRACT 
The mechanism of local metabolic regulation of coronary blood flow is still 
unclear. It is still unknown which control system- an "open-loop feedback control" 
or a "close-loop control" - operates in the coronary circulation and whether common 
mechanisms exist in this control. To separate the putative chemicals proposed to be 
physiological regulators in the coronary bed, the time courses of coronary resistance 
change in response to either increased cardiac work or hypoxia have been examined, 
before and after a, ~ and adenosine inhibition. 
An acute open-chest sheep model was used for this investigation. The sheep 
were anaesthetised with sodium pentobarbitone and instrumented for circumflex 
coronary artery and pulmonary artery flows, left ventricular, proximal aortic and 
coronary sinus pressure. Continuous coronary sinus oxygen saturation was measured 
by a fibre optic technique. Blood samples from coronary sinus and proximal aorta 
were analysed for blood gases, Na+ and K+. An occluding band was.placed around 
the proximal aorta to produce variable increments of aortic pressure for variable 
periods. Low oxygen gases (5%02, ·5%C02 and 90%N2) were used to produce 
systemic hypoxia. Phentolamine, propranalol and 8-phenyltheophylline were used as 
a, ~ and adenosine blockers respectively, and nonadrenaline and isoprenaline 
(injected into left vel1:tricle) and intra-coronary injection of adenosine were used to test 
the efficacy of the blockers. Continuous coronary resistance was calculated 
throughout each intervention. 
The recovery of coronary resistance to normal after the change of the afterload 
of the left ventricle had a constant half life of 4.7±0.2 seconds. The half life was not 
related to either the degree or the duration of increased work. a, ~ and adenosine 
inhibitors did not alter the half life, but produced more profound changes in coronary 
m 
resistance due to increased cardiac work. The half life of exogenous adenosine was 
about 26 seconds. 
During the increase of aortic pressure the coronary sinus oxygen saturation 
varied significantly both above and below the steady state unpredictably, but with 
systemic hypoxia there was vasodilation during which the oxygen level in the 
coronary sinus was closely linked to coronary resistance with a small "hysteresis" 
when the hypoxia was reversed .. After adenosine blockade, the coronary resistance 
and oxygen supply were more closer linked. 
The results suggest an open loop control system with a short acting mediator 
whose half life is the same for varying periods and degrees of increased work, but 
very much shorter than that of adenosine. The metabolic control of coronary flow is 
not dependent on the oxygen requirements of the muscle. Multiple factors may 
involved in the local coronary vasoregulation. Current data do not support adenosine 
as the common factor in metabolic vasodilation. 
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CHAPTER 1 
INTRODUCTION 
1 
1.1 INTRODUCTION 
Cardiovascular deseases remain one of the major causes of morbidity and 
mortality in modern society. The scientific community has paid increasing attention to 
the role of vasoactivity of blood vessels which_ may affect or accompany such 
diseases. To understand the pathophysiological mechanisms that are responsible for 
the clinical manifestations of various cardiac states, it is necessary to gain a thorough 
understanding of the physiological mechanisms that operate in the healthy individual. 
The circulation system has the principal function of transport, to deliver the 
oxygen and nutrients necessary for tissue metabolism and to remove the waste 
products and heat resulting from the metabolic processes. Each organ will place 
different demands on the circulation to function effectively. In numerous examples the 
system has shown how effectively the function of the system is altered to meet the 
demand and to function smoothly. The feedback loops involved in regulatory 
activities may comprise local mechanisms of humoral or metabolic origin contained 
within the organ itself, and neural mechanisms mediated at the spinal cord level or by 
the higher centres in the brain. 
It has been observed that during exercise there is a 15- to 20-fold increase in 
blood flow to skeletal muscles, and a 3- to 4-fold increase to the myocardium, but a 
decrease in blood flow to the kidney, splanchnic area and nonexercising muscle. With 
changes in emotional state such as quiet, stress and sleep, there would be a different 
supply of blood to different organs, mainly dependent on the demand of each organ. 
For the exercising situation, with a rapid increase in energy requirements, relatively 
rapid circulatory adjustments are essential in order to meet the increased need for 0 2 
and nutrients by the exercising muscle. Also important is the need to remove the end 
products of metabolism such as C02 and lactic acid and to dissipate the excess heat 
2 
produced by the reactions. How the circulatory system meets these increased 
demands is still an enigma. 
Although the mechanisms of vasoregulation may be similar throughout the 
body, the tissues served by the vasculature are heterogeneous and provide very 
specific functions. Different organs will need different systems of both systemic 
regulation and local regulation. In this thesis, only the local control of blood flow in 
coronary circulation will be discussed. The term "local control of blood flow" means 
the blood flow to certain organ can be regulated smoothly and effectively within organ 
I 
itself to supply the demand of the organ without evoking the autonomic system. 
Investigators have tried to explain this phenomenon in many ways. However, none of 
the explanations satisfy all of the observed phenomena. Researchers in this area used 
one term " autoregulation " to describe these phenomenon. In order to specify the 
auto-regulation due to different causes, most recent researchers use "autoregulation" 
only for the flow re-adjustment due to the change of driving pressure of blood flow 
and use another term "metabolic vasodilation" for the flow re-adjustment due to the 
change of the metabolic state when these is no alteration of perfusion pressure. 
The phenomenon of "flow re-adjustments" of the coronary system shows that 
the coronary circulation can always supply enough blood to meet the demands of the 
heart within a certain range without requiring the central nervous control. According 
to a general feedback control model, there are two control systems. As the heart 
metabolic status changes, there are two ways for the coronary circulation to be 
adjusted in order to meet' the demands of the heart under the new metabolic situation. 
One is that the muscle may adjust the release of some substances, with the property of 
' ' 
coronary vasodilation into the interstitium of the tissue to increase the coronary blood 
flow (CBF). This system can be called "open-loop feedback control". In this case 
very often the system will overshoot, which means that coronary circulation may 
supply more blood flow than it actually needs for any particular situation. The 
3 
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alternative is that a change of heart work induces a different metabolic status which is 
detected by the system which then releases some vasoactive substances into the 
interstitium to regulate CBF to keep the metabolic status constant. This can be called 
"close-loop feedback controlling-system". Which system actually controls coronary 
circulation is unclear, but most researchers favour the close-loop feedback controlling 
system. 
In addition to not knowing which controlling system operates in the coronary 
circulation , we also do not know the exact metabolite or even whether a single 
metabolite or several metabolites are involved. Reports in the literature are conflicting. 
Several compounds such as adenosine, some of the prostaglandins and endothelial 
dependent relaxing factor (EDRF) have a temporal relationship to vasodilation. 
This thesis sets out to further examine whether common mechanisms exist in 
local control of CBF and to collect further data to separate the putative chemicals 
proposed to be physiological regulators in coronary vasoregulation. To do so, I will 
emphasize vasoregulation related to increased cardiac effort and decreased oxygen 
supply. 
The hypotheses for this work are: 
• There are common mechanisms in the local regulation of CBF after the 
changes of cardiac work and hypoxia. 
• The control of CBF due to the changes of metabolic states of the heart 
is independent of the autonomic nervous system. 
• Oxygen is an end control/actor in the regulation ofCBF. 
• Adenosine is not the end control factor in the regulation ofCBF. 
4 
The general aims are: 
• to determine the time course of changes in coronary resistance in 
response to increased cardiac work, both before and after a, /3 and 
adenosine inhibition; 
• to elucidate whether common mechanisms exist in the local regulation 
of coronary circulation and to examine which control system, "an open-
loop feedback control" or "a close-loop control" operates in coronary 
circulation and 
• to assess the relationship of work done and severity of hypoxia and 
metabolic state. 
1. 2 ORGANISATION OF THESIS 
This thesis is divided into 9 chapters, a bibliography and four appendices. 
Chapter 1 contains this introduction. In chapter 2, I examine how the various theories 
were postulated historically and how they were tested in different regional circulations 
throughout the body. Chapter 2 also outlines the development of studies of 
mechanisms in the local control of circulation. Chapter 3 systematically reviews the 
roles of oxygen and adenosine in the local control of coronary circulation from 
published work. In chapter 4, the methods and materials used for this work are 
discussed. In chapters 5, 6, 7 and 8, I present, discuss and analyze each study 
separately and compare my results with those of others. Chapter 9 synthesizes my 
findings, extends understanding in this field, gives conclusions, and postulates future 
work. 
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CHAPTER 2 
HISTORICAL REVIEW 
6 
2 .1 INTRODUCTION 
Autore~ulation of blood flow, in the broad sense, can be defined as the 
capability of an organ to regulate its blood supply in accordance with its metabolic 
need. But the usual, more exact definition of autoregulation is the intrinsic ability of 
the organ to maintain its blood flow relatively constant despite the changes in 
perfusion pressure [Johnson, 1964; Feigl, 1983; and Dole, 1987]. Metabolic 
regulation refers to the vasoregulation due to the changes of the metabolic need within 
the organ itself. 
The earliest observation of this phenomenon was by Jone in 1852, who 
discovered that rhythmical vasoconstrictions in the bat wing veins are dependent on 
the internal pressure. He was also the first to describe myogenic activity of blood 
vessels. In 1902, Bayliss observed that as the arterial pressure rises, the hindlimb 
arteries are distended passively and when the blood pressure ~alls again, they constrict 
much below their previous level and only gradually return to that state. He also found 
that as the arterial pressure diminishes, the limb arteries relax. Those reactions are 
independenr of the central nervous system and can be obtained both in nornial 
condition and excited conditions in arteries. Thus he postulated that the blood flow 
regulation described by Jone as myogenic in nature is present in arterial vessels as well 
[Bayliss, 1902]. To this day, some researc.hers still call this the Bayliss phenomenon. 
After the first description of autoregulation on dog's kidneys by Rein [1931], 
research in this area was quiet for nearly twenty years, with only a few reports · 
appearing to support Bayliss' hypothesis. Forbes and co-workers [1937] showed the 
s pial arterioles constricted in response to an elevation of arterial pressure and dilated 
following a reduction. Selkurt [1946] noted that, at an arterial pressure above 
80mmHg, local arterial pressure changes had little effect on flow. Folkow [1949] 
reported that an elevation of the arterial perfusion pressure caused an initial increase in 
7 
flow followed by a return toward control levels. Although later workers were able to 
explain this result by either the myogenic or the metabolic theories, Folkow favoured 
the myogenic theory. Folkow's study was important because: 
• he demonstrated that denervated organs possess vascular tone; 
• his studies examined the origin of the vascular tone in a quantitative 
manner; and 
• the experiments were designed to overcome the objections that ha.4;,been 
raised by earlier critics of Bayliss [Johnson, 1977]. 
As the techniques used for circulation research developed in the 1950's, 
autoregulation and metabolic regulation became the object of serious research as part 
of an intensified interest in the local mechanism of blood flow regulation. 
I 
Investigators proposed many explanations for their experimental results with much 
controversy and few uricontested conclusions. In 1963, a symposium on this topic 
provided a detailed view of the field at that time, and recognized four important 
mechanisms of autoregulation. They are myogenic, metabolic, tissue pressure and 
tubulo-glomerular feedback [Johnson, 1964]. 
Briefly, the myogenic theory is that the stretch due to an increased arterial 
pressure causes the arteriolar smooth muscle to constrict in order to keep blood flow 
relatively constant at the microvascular level. Most research on the myogenic response 
has been performed on isolated vessels from skeletal muscle. In this area, many 
experiments have been done using rabbit ear arteries by Speden and his coll~agues in 
the Department of Physiology of the University of Tasmania. They observed that 
isolated segments of active ear arteries from rabbits reacted to distension by pressure 
jumps from 60mmHg to lOOmmHg with a counteracting constriction which took 
1-2mins to achieve near-completion and was not dependent upon a functional 
sympathetic innervation [Speden, 1984; 1986]. In later experiments, they showed that 
active ear arteries possessed myogenic mechanisms which had the capacity to 
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minimize distension of active ear arteries against pulsatile pressures of physiological 
frequency, mean pressure and pulse amplitude [Speden, 1987]. They also measured 
the ear artery myogenic response to rapid and gradually induced pressure jumps in 
either the presence or the absence of the endothelium. The results were not 
significantly different, leading to the conclusion that the myogenic response is 
independent of the endothelium in active isolated pressurized rabbit ear arteries 
[McLeod, 1989]. A few studies have used cerebral and renal vessels. One study has 
shown that diastolic pressure increase resulted in a brief and small coronary 
vasoconstriction response in the awake dogs [Sadick, 1987]. After excluding the 
involvement of a neurogenic mechanism and an increase in CBF which might increase 
the washout or vasodilating metabolitesl, the authors attributed the response to the 
myogenic mechanism. 
The metabolic hypothesis proposes that flow is relatively constant because in 
vascular smooth muscle either constriction or dilation is controlled by metabolic 
substances which are regulated by organ demand. In this area research has been done 
in many organs including brain, heart, kidney, and skeletal muscle. Through those 
experiments; a number of putative metabolic substances have been conjectured: 
oxygen, carbon dioxide, hydrogen, potassium, adenosine, adenine nucleotides, 
magnesium, osmotic, prostaglandins, free radical and endothelial substances [Johnson 
1964; 1986; Berne 1979; Feigl 1983; Dole 1987]. Many investigators have set up a 
series of studies to examine each candidate carefully. Unfortunately none of the 
proposed metabolites can explain all the phenomena. It has been ~ifficult to separate 
myogenic and metabolic mechanisms of autoregulation in the heart because changes in 
perfusion pressure (myogenic stimulus) very often result in increased work which is 
also associated with changes in blood flow (metabolic stimulus). 
1This increase of the washout of vasodilating metabolites may be responsible for the vasoconstriction 
following the increase of perfusion pressure (metabolic instead of myogenic theory). 
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The tissue pressure hypothesis is based on the obseivation that an increase in 
perfusion pressure induced an increase in the permeability of vessel walls, thus 
increasing ultrafiltration, resulting in an increase in tissue pressure. This hypothesis 
may be important for those vessels in organs which have a stiff capsule such as renal 
arterioles, because the increase of tissue pressure, that is interstitial pressure, would 
tend to collapse small veins and some arterioles if the organs were encapsulated 
[Johnson, 1986]. 
The tubulo-glomerular feedback theory suggests that an increase in arterial 
pressure leads first to increased glomerular filtration, secondly to increased solute and 
concentration of electrolytes such as Na+ in the tubular fluid. It is suggested that this 
acts on the macula densa which are considered to sense changes in the tubular fluid 
and may release a constrictor, which restores glomerular filtration to close to the 
original level by decreasing flow [Johnson, 1986]. 
2.2 LOCAL V ASOREGULATION IN REGIONAL CIRCULATION 
2. 2 .1 Cerebral Circulation 
Cerebral autoregulation refers to a cerebral blood flow that remains relatively 
constant in response to the change of cerebral perfusion pressure. Cerebral blood 
flow is maintained relatively constant down to an arterial pressure of 60-70mmHg 
[MacKenzie, 1979; Hernandez, 1978; Fitch, 1975]. As blood pressure was lowered 
further, below the so-called lower limit of autoregulation, cerebral blood flow 
decreased despite continued vasodilation of the cerebral resistance vessels [Reistad, 
1983]. When the arterial blood pressure is at 40mmHg, maximum vasodilation is 
reached [Kontos, 1978a; MacKenzie, 1979], suggesting that 40mmHg more 
accurately represents the lower limit of autoregulation in cerebral circulation. In the 
brain, because of its heavy dependence on aerobic metabolism and its high resting 
oxygen consumption [Eklof, 1973], many investigators have proposed the hypothesis 
10 
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that oxygen levels in tissue are directly and inversely active on the arterial supply. ie a 
low tissue p02 causes direct vasodilation. Kontos and co-workers [1978b] 
demonstrated arterial hypoxia produced marked cerebral arterial vasodilation, which 
was partially reversed by perfusi~g the space under the cranial window with artificial 
cerebrospinal fluid containing 94% oxygen. He suggests two possible mechanisms 
for this oxygen hypothesis. First, it may be a kind of local reflex. The cerebral 
vessels have nerves attached to them originating in the brain itself [Falck, 1965; 
Swanson, 1975]. However it remained controversial because Edvinson and his 
colleagues [1975] failed to confirm the existence of these nerves. Secondly, cell 
hypoxia induces the release of vasodilator metabolites which are responsible for 
vascular smooth muscle relaxation of the pial arterioles by diffusion. Rubio's 
experiment [1975] failed to support oxygen as a mediator of cerebral autoregulation. 
However, this conclusion was based on the assumption I that adenosine is responsible 
for the cerebral autoregulation. The results: a) hypoxia caused by ventilating low 
oxygen gas induced the brain adenosine levels to increase significantly; b) increase in 
p02 from 21 to 29.7mmHg did not produce changes in adenosine levels, leading them 
to conclude that oxygen is not a direct mediator in cerebral vasoregulation due to the 
alteration of perfusion pressure. 
Winn [1980a; 1980b; 1981] suggested adenosine is a mediator of cerebral 
vasoregulation. To assess the role of adenosine in the autoregulation of cerebral blood 
flow, Van Wylen et al [1988] measured dialysate adenosine and cerebral blood flow 
over a range of arterial pressures from 80mmHg to 30mmHg, by using the brain 
dialysis technique, the hydrogen-clearance technique and an adenosine antagonist. 
Their results showed that autoregulation existed in all circumstances. Adenosine did 
not increase until hemorrhaging caused arterial pressure to dr9p to 50mmHg. With a 
1 Although an impressive body of experimental data supports this theory, the result is still not conclusive. 
Thus, I still refer to it as an assumption. 
11 
similar reduction in cerebral blood flow, the dialysate adenosine concentration was 
greater on the side of locally infused theophylline. Thus, they suggest that adenosine 
is not responsible for cerebral autoregulation at blood pressure > 50mmHg, but may 
contribute to the decrease in cerebral vascular resistance observed at arterial pressures 
below the autoregulation range. Wahl et al [1979] were unable to detect changes in 
perivascular H+ or K+ over the pressure range of 60-200mmHg despite observing 
changes in vessel diameter. They pointed out that this can not support the hypothesis 
that hydrogen or potassium is a mediator of autoregulation under these circumstances. 
Other researchers found marked vasodilation with very severe increases in arterial 
perfusing pressure [Kontos, 1978a; MacKenzie, 1976] which seems to contradict the 
autoregulation hypothesis. 
It is well accepted that metabolic and myogenic mechanisms are involved in 
vasoregulation of cerebral blood flow [Johnson, 1986; Reistad, 1983]. Distinction 
between these two factors has become very difficult since they often act together. 
Wagner et al [1983] suggested that the dominant mechanism of cerebral autoregulation 
is metabolic, not myogenic, based on the finding that regional and global cerebral 
vascular resistance decreased in response to the elevation of cerebral venous pressure. 
Wei and his colleagues [1984] confirmed Wagner's finding. They observed that 
myogenic vasoconstriction is not abolished during increases of venous pressure when 
the metabolic mechanism (dominant mechanism) is eliminated by increased local 
supply of oxygen. It is still possible that cerebral autoregulation is mediated solely by 
a myogenic mechanism and that metabolic factors come into play only when the 
oxygen supply-to-demand ratio is greatly reduced. The predominance of one over the 
other depends on the initiating stimulus [Van Wylen, 1988]. To date, the precise 
- -
mechanism of local cerebral vasoregulation is not clear. 
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2. 2. 2 Skeletal Circulation 
In skeletal muscle, two mechanisms responsible for local vasoregulation have 
been proposed: the myogenic hypothesis [Folkow, 1964; Johnson, 1986] and the 
metabolic hypothesis [Berne, 1964; Haddy, 1975; 1978]. Arterial pulsatile pressure 
induces constriction in skeletal muscle vessels [Rovick, 1964]. Transient stretch 
caused by the artenal pulse pressure induces an especially pronounced response in the 
distal arteriole and may be an important determinant in the ba~al vascular tone 
[Grande, 1977]. In the isolated rabbit ear resistance arteriole, considerable evidence 
was obtained that stretch-dependent tone may be similar to basal vascular tone which 
responds to the change in the level of transmural pressure [Hwa, 1986]. Some 
researchers have presented evidence which indicates that oxygen plays a role in the 
blood flow control in skeletal muscle [Granger, 1973; Prewitt, 1976]. Granger 
[1973] developed a mathematical model which showed the correlation between degree 
of autoregulation and venous oxygen concentration. The major point of discussion 
between them is the question; by what mechanism does -oxygen affect vascular 
resistance. Two feedback mechanisms have been proposed as follows: 
• The vasodilator theory [Imai, 1964; Rubio, 1969; Pittman, 1973; 
Gorczynski, 1978] 
The change of oxygen state causes the release of some metabolites. Most 
' investigators who are in favour of this theory believe the metabolite is 
adenosine,from parenchymal cells which moves into the interstitial spaces 
at a rate which is inversely proportional to the 02 supply : demand ratio. 
• The direct effect theory [Detar, 1968; Carrier, 1964] 
The intrinsic vasoregulation is mediated through the direct effect of 
changes in interstitial p02 on vascular smooth muscle. 
Both hypotheses have an equally.impressive body of experimental results in 
support. In the cremaster muscle of the rats, Prewitt and co-workers [1976] examined 
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the effect of 0 2 on microcirculatory flow and capillary density over a wide range of 
bath p02. The change of p02 caused inverse changes in red cell velocity and capillary 
density. A particularly interesting result was that the flow is also regulated when 
tissue p02 is above the critical level (p02 = 5mmHg) at which level it was believed it 
could not influence metabolism in vitro [Jobsis, 1972]. By studing individual 
arterioles autoregulatory responses to alterations in arterial or venous perfusion 
pressure within the rat cremaster muscle at different bath p02 value, more pronounced 
vasodilation due to the change of infusion pressure was found when p02 'was low. It 
was concluded that autoregulation dilation of arterioles was reduced but not abolished 
by elevated tissue oxygen [Morff, 1982]. Stowe et al [1975] indicated that tissue 
C02 tension and/or pH are also involved in the autoregulation along with oxygen 
tension in dog gracilis muscle perfused at constant flow. Davis [1988] further 
concluded that both oxygen and carbon dioxide tension are key variables in the local 
controi of muscle blood flow and they might account for nearly all of the blood flow 
response to steady-state exercise in bat wings. However, some other studies could 
not confirm that muscle blood flow is consistently related to venous oxygen tension 
[Duling, 1975; Granger, 1976; Sparks, 1980]. It has _been suggested that both 
mechanisms are simultaneously contributing to the local vascular region although 
Morff [1982] observed vasoconstriction in response to increased venous pressure in 
the artery of the rat cremaster muscle and suggested that the predominant mechanism 
was myogenic, but that metabolic mechanisms were also operative in skeletal muscle. 
2.2.3 Mesenteric Circulation 
In the mesenteric system, the dilation of individual arteries following reduction 
in arterial pressure could also be interpreted by either the myogenic or metabolic 
hypotheses [Burrows, 1981]. Elevation of venous pressure could differentiate 
between these two mechanisms [Johnson, 1964]. Burrows and Johnson [1981] 
designed an experiment to test the effect of venous pressure elevation on the arterial 
14 
bed by calculating circumferential wan· tension as an index of a tension-sensitive 
myogenic mechanism and arteriolar volume flow as an index of metabolic mechanism 
in the isolated autoperfused cat mesentery. These results demonstrated that although 
both mechanisms contribute to local blood flow control with increase of intravascular 
pressure, it seems that the myogenic mechanism is dominant. However Shepherd and 
co-workers [1977] found that a reduction of blood flow by 35% abolished the 
constrictor response to increased venous pressure in the intestine. The response is 
different from that in skeletal muscle in that non-pulsatile perfusion of the intestine 
decreased both the occurrence and magnitude of the constrictor response [Shepherd, 
1977]. In an isolated rat portal vein, the myogenic response to stretching of the 
vascular wall depended on muscle length and was strongly influenced by variations in 
the rate of change in length. The dynamic component appeared much more prominent 
than the static component [Johnson, 1976]. 
2 • 2 • 4 Renal Circulation 
It has been observed that Glomemlar Filtration Rate remains almost unchanged 
over a range_ of mean arterial blood pressures between 80 to 180mmHg [Conrad, 
1984]. The exact value of the lower limits of the renal autoregulatory range are 
somewhat variable according to the preparation under study. Renal Blood Flow is 
also maintained nearly constant over a wide range of arterial blood pressures in the rat, 
man, dog and rabbit [Forster, 1947; Shipley, 1951; Arendshorst, 1975]. The intrinsic 
renal sensing mechanism that controls the vasoregulatory response is not known but 
there are three major hypotheses: 
• The renal vessels respond to some index of transmural pressure, ie an 
increase in transmural pressure due to increasing arterial blood pressure 
will cause a myogenic reflex vasoconstriction, thus reducing blood flow. 
This is the myogenic theory. 
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• Changes in renal perfusion pressure produce parallel alterations in 
interstitial hydraulic pressure and post glomerular vascular resistance 
[Hinshaw, 1959; 1964]. A rise in perfusion pressure is thought to lead to 
an increase in interstitial pressure, compression of the peritubular 
cdpillaries and intrarenal veins, and a rise in total renal vascular resistance. 
This is the tissue pressure theory. 
• It has been suggested that some signal created by a change in blood 
pr_essure is sensed by a tubuloglomerular feedback system which controls 
the level of angiotensin II by modulating renin release by the 
juxtaglomerular apparatus [Knox, 1974; Navar, 1978]. This is the 
tubulo-glomerular feedback theory. 
Due to technical problems in measuring 'renal tissue pressure' either by a 
needle inserted into the renal parenchyma or by renal venous wedge pressure, it is still 
very difficult to actually determine the true interstitial pressure. This makes a 
quantitative evaluation of the tissue pressure theory difficult. Ott et al [1971] invented 
a new method to measure tissue pressure by implanting a rigid-walled, multi.perforated 
capsule into the substance of the renal cortex. It was believed that interstitial fluid 
would accumulate and equilibrium in this capsule and hydraulic pressure in this space 
could be used as an index of interstitial fluid pressure. Stromberg [-1970] observed 
that the pressure measured with this type of capsule was related to the development of 
a membrane of hyaluronate and collagen which fills the pores and surrounds the 
capsule soon after implantation. Thus, the capsule performed as an oncometer and 
' 
probably does not reflect interstitial fluid hydraulic pressure alone. 
2.3 CONCLUSION 
It has been recognized for many years that vasoregulation is involved in the 
local control of many organs. There are many theories to interpret this phenomenon, 
but none .of them explains it completely. Due to methodological problems little work 
has been done in defining myogenic mechanisms. In metabolic dilation more than one 
chemical acts on the vascular smooth muscle and different organs such as the 
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hindlimb, kidney, heart, and skeletal muscle have different dominant chemicals. 
These differences may reflect intrinsic difference in behaviour in organs. 
In this chapter, I emphasize the local control of blood flow in non-coronary 
vessels. Like other organs, the coronary circulation exhibits the local vasoregulatory 
phenomenon. The first preliminary description of coronary vasoregulation was by 
Eckel and co-workers [1949]. Now it is well established that coronary blood flow is 
regulated according to the heart's demand. Detailed discussion of coronary 
vasoregulation, especially metabolic vasoregulation, follows in the next chapter. 
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CHAPTER 3 
LITERATURE REVIEW 
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3 .1 INTRODUCTION 
Coronary flow is regulated so that coronary supply meets demand. The 
metabolic hypothesis is widely believed to be dominant amongst three hypothetic 
mechanisms - metabolic, myogenic and tissue pressure - for vasoregulation in local 
control of coronary blood flow (CBF). 
Metabolic regulation of CBF refers to the vasoregulation secondary to the 
changes of myocardial work or oxygen usage, regardless of perfusion pressure. 
Many' metabolites have been proposed as physiological regulators of coronary flow. 
There is evidence that oxygen, carbon dioxide and adenosine are vasoactive. in the 
coronary circulation. Other chemicals such as prostaglandins, endothelium-derived 
relaxing factor (EDRF), potassium and hydrogen ions are also related to local control 
of CBF at one time or another. Unfortunately each of the metabolites satisfies the 
requirements ln some respects and not in others. Thus, almost all the investigators 
agree that CBF is determined by several factors rather than by a single factor [Belloni, 
1979; Feigl, 1983; Berne, 1979]. 
The term "metabolism" in the local control of blood flow might encompass the 
metabolic changes taking place in the tissues which lead to the vasoregll;lation. The 
term could refer to the formation or breakdown of the vasoactive substance itself or 
even to the metabolic changes occurring within the vascular smooth muscle cell 
leading ultimately to contraction or relaxation [Gregg, 1963]. There are three 
metabolic hypotheses [Berne, 1979; Feigl, 1983; Johnson, 1986]: 
• any change in the coronary inflow causing a change of metabolic status, 
such as p02, pC02, pH, which might affect vascular smooth muscle cells 
directly, in turn causes contraction or dilation in order to recover metabolic 
status; 
• any reduction or increase of coronary inflow induces an increase or 
decrease of vasodilator metabolites which are also responsible for basal 
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vessel tone in the tissue, causing vasodilation or vasoconstriction in order 
to keep the balance between blood need and blood supply; and 
• any change in the coronary inflow may induce a build-up of vasoactive 
metabolites causing vasorelaxation or vasoconstrictionfor blood supply 
and demand balance. 
The important question arises as to whether these three theories can be used for 
all physiological conditions or whether each theory only explains one particular 
condition. Whether those putative vasoregulators act together or separately in 
coronary circulation remains to be determined. 
In this chapter, I will review metabolic control of coronary circulation, 
especially the oxygen and adenosine hypotheses. Other chemicals will also be 
discussed briefly. 
3.2 OXYGEN 
3 . 2 .1 Oxygen Hypothesis 
There is little oxygen reserve remaining in coronary venous blood because the 
myocardium efficiently extracts oxygen from the coronary supply under normal 
conditions. If the heart requires more oxygen in special circumstances, eg exercise, 
this extra demand from the coronary artery will be supplied by the augmentation of 
CBF. The hypothesis that the oxygen deficit is strongly related to CBF or is the 
determinant of CBF is more than half a century old [Gremels, 1926; Hilton, 1925]. 
Working with a Starling heart-lung preparation, Hilton [1924] concluded that 
"the coronary vessels are extremely susceptible to change in the 02 tension of blood". 
In the following year, they performed a series of experiments to demonstrate that 
reduced arterial oxygen tension of coronary blood elicited an increase of CBF, 
probably due to a direct relaxation of the vessel wall [Hilton, 1925]. However, they 
did not eliminate other metabolites produced by hypoxia because although they found 
20 
that perfusion with fresh deoxygenated blood still caused the increase of CBF, this 
could not exclude the release of vasoactive metabolites during that episode [Berne, 
1957]. 
The mechanism responsible for this precise matching between coronary inflow 
and myocardial oxygen requirements appears to be entirely local in nature. 
Pharmacologic autonomic nervous system blockades or dep.ervation of the heart do not 
alter the ability of the coronary blood vessel to regulate [Berne, 1964]. If 02 is 
responsible for coronary vasoregulation, it is expected that hypoxia should increase 
CBF and that hyperoxia should decrease CBF. In isolated rabbit hearts, by changing 
the oxygen content of arterial perfusion by diluting hemoglobin at constant perfusion 
pressure and heart rate, it was found that a decrease in oxyhemoglobin concentration 
results in an increase of CBF, and augmentation of oxyhemoglobin concentration 
induces a diminution of CBF. Unfortunately they were not able to predict the 
magnitude of change in flow [Guz, 1960]. Breathing 100% oxygen resulted in a 
decrease of coronary flow in some experiments [Daniell, 1968; Eckenhoff, 1947; 
Ganz, 1972]. However, interpretations for those experiments were confused by the 
change of CBF accompanying a decrease in heart rate [Ganz,- 1972],- a de-crease in 
myocardial oxygen consumption (MVOi) [Daniell, 1968; Eckenchoff, 1947; Sobol, 
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1962] and an increase in coronary sinus oxygen content [Daniell, 1968; Sobol, 1962]. 
Significant diminution in myocardial blood flow during inhalation of 100% oxygen 
after coronary occlusion was demonstrated by Rivas and co-workers [1980] without 
significant changes of heart rate, mean arterial pressure, and mean left atrial pressure. 
This suggests that arterial hyperoxia has a vasoconstricting effect on coronary 
circulation and the effect is independent of alteration in MV02. 
3. 2. 2 Can Coronary Sinus p02 Reflect Myocardial Tissue p02? 
It is very common to use coronary sinus (CS) oxygen tension to reflect the 
myocardial oxygen tension. The question arises that whether the changes of p(cs)02 
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and p(t)02 are always coincident, and more specifically, under which conditions CS 
oxygen tension can be used as an index of tissue oxygenation. The techniques 
employed to estimate tissue oxygen tension in the past include a carbon monoxide 
binding method [Coburn, 1973] and a polarographic technique [Moss, 1970] in which 
platinum electrodes were inserted into the myocardial wall. 
The rational for CS p02 to represent tissue p02 is based largely on the 
proposal that significant gas exchange occurs across noncapillary vascular walls 
[Duling, 1970; Whalen, 1973]. Schmidt and Niesel [1968] had provided evidence to 
support a close correspondence between tissue and CS p02 because both CS p02 and 
superimposed oxyhaemoglobin saturation remained proportional to each other and is a 
function of the mean saturation of myoglobin in the heart. CS p02 and mean 
polarographically determined myocardial p(t)02 are approximately equal in open-chest 
dogs [LOsse, 1973] and in isolated saline-perfused cat hearts with a perfusion pressure 
of 78mmHg [Schubert, 1978]. Coburn and co-workers [1973] reported that mean 
canine myocardial p(t)02 in equilibrium with myoglobin is only 4-6mmHg by using a 
- -
carpon monoxide binding method. The more interesting result was that they found 
this p(t)02 is ~onstant in spite of large changes in arterial oxygen tension above a 
critical level of 30-35mmHg. Unfortunately, they did not observe the change of CBF 
under these circumstances even though it implied indirectly that coronary circulation 
can maintain a constant mean tissue oxygen tension if arterial oxygen tension is above 
a critical level. 
In addition, p(t)02 is not uniform throughout the myocardium [Whalen, 1973; 
Losse, 1975; Schubert, 1978]. p(t)02 histograms show 60% of the myocardium has 
levels lower than CS p02 [Losse, 1975]. When raising perfusion pressure to 
113mmHg, CS P02 was raised by 20% without significant changes in mean p(t)02 
and CBF in the isolated saline-perfused cat hearts [Schubert, 1978]. Using a 
polarographic technique, 100% oxygen inhalation only caused a 7mmHg increase in 
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intramyocar~al oxygen tension without any increase in coronary venous 02 tension, 
but a five-fold increase in arterial blood 0 2 tension [Moss, 1970]. Thus, sometimes it 
is dangerous to use CS p02 as an indicator of p(t)02. On the other hand, because of 
p(t)02's uniformity across myocardium, it is possible that some region in the 
myocardium beyond the point of measurement of p(t)02 may be anoxic or hypoxic. 
Thus, those hypoxic regions could produce vasoactive metabolites which are 
responsible for regulation of CBF without noticeable changes in CS p02 or measured 
p(t)02 [Belloni, 1979]. It is still unknown whether this uniformity of p(t)02 
throughout the myoca~dium is related to some recent findings by Hoffman's 
laboratory [Austin, 1990], which demonstrated a profound spatial heterogeneity of 
blood flow reserve in all layers of the canine left ventricle at normal perfusion 
pressure. It would be valuable to explore their relationship further to determine the 
role p(t)02 plays in local regulation of CBF. 
3. 2. 3 Oxygen Characteristics 
3.2.3.1 Oxygen Metabolism 
Energy carried mainly in the form of adenosine triphosphate (ATP) is used to 
perform mechanical work in the myocardium. About 90% of ATP is generated by 
oxidative phosphorylation (aerobic) [Kobayashi, 1979]. CS oxygen levels are about 
5ml/100 ml depending on concentration of hemoglobin in the blood [Xhonneux, 
1969], and the coronary artery oxygen tension is reasonably constant with changes.in 
myocardial activity under basal conditions, only very little more oxygen can be 
extrac~ed from arteries when the heart requires more oxygen. In other words, the 
major increase of oxygen requirement can only be met by an augmentation of CBF to 
maintain a nearly constant, very high level of arteriovenous oxygen extraction. One 
direct measurement in the cat heart showed that intracellular p02 ranges between 0 and 
30mmHg in situ [Whalen, 1973]. Moss's [1970] experiment showed that pure 
oxygen inspiration induced a decrease of CBF, moderate increase in tissue oxygen 
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tension, but non-alteration in coronary sinus oxygen tension. This suggested that the 
decreased CBF may elicit more extraction of oxygen in order to supply enough blood 
to the myocardium. 
3. 2. 3. 2 Oxygen Vasoactive Properties 
It is unclear whether oxygen itself has vasoactive properties which are a direct 
interaction between oxygen and vascular smooth muscle or the changes of vascular 
tone due to an imbalance between oxygen supply and demand are dependent on the 
release of some vasoactive substances from the surrounding parenchyma. Gellai 
[1973] showed that, with isolated helical vascular strips, contractile tension to 
acetylcholine was not affected or was only 5-20% affected by lowering the p02 to 
5-lOmmHg. When the p02 nearly reached OmmHg, contractile activity was markedly 
depressed. However, with adenosine in the bath, a decrease in p02 from 100 to 
lOmmHg did influence the effect of adenosine on contractile tension. This suggested 
that local p02 could regulate the vascular changes induced by adenosine and that, the 
equilibrent concentration of release and washout of adenosine in the vicinity of the 
smooth muscle cells of the small coronary vessels would allow oxygen to exert its 
direct regulatory effect under normal condition. 
3.2.3.3 Mechanism of Vasoactive Action 
Basically there are two mechanisms proposed for oxygen vasoaction: 
(a) a direct effect of oxygen on vascular smooth muscle and 
(b) an indirect effect of oxygen on vessels possibly through carbon dioxide, 
adenosine or other metabolites; also possibly related to autonomic nerve 
reflexes. 
Carrier and co-workers [1964] found that the resistance to flow through 
isolated arterial segments decreases as a function of the oxygen tension (below a 
critical value) of the perfusing blood, without a change of blood viscosity. A similar 
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result was demonstrated in isolated strips of rabbit aorta, where the response to 
epinepherine decreases as a function of the oxygen tension of the bathing fluid [Detar, 
1966]. Both authors suggested·that oxygen tension has a direct effect on vascular 
smooth muscle when p02 is below a critical value. An experiment was designed to 
determine contractile responsiveness to hypoxia in isolated aortic and skeletal vessels 
in various sizes from 200µmD to 20µmD. It was found that hypoxia produced greater 
depression of contraction when oxygen demand in vascular segments i_s low than 
when it is high [Chang, 1980]. This result can not be explained by restricted energy 
metabolism. This supports the direct action of oxygen on vascular smooth muscle. 
Numerous studies on strips isolated from vessels have also supported this hypothesis 
[Detar, 1980; Kalsner, 1977]. However, none of these workers was able to offer 
direct evidence for the contention that oxygen produces vasoregulation by direct 
interaction with the smooth muscle cells in the heart. one study [Belloni, 1977] 
demonstrated that CS oxygen content always changed more quickly than did coronary 
vascular resistance after correction for vascular transit effects following a step change 
in heart rate in anaesthetized dogs. They concluded that MV02 changes more rapidly 
than does coronary resistance following 20beats/min changes in heart rate. From this 
it seems logical to think that the delay of coronary resistance variation would allow the 
mediators related to oxidative metabolism to generate and accumulate to the 
concentration which could trigger vasodilation. A few candidates related to oxidative 
metabolism, eg 02, C02, adenosine and prostaglandins, have been postulated to be 
responsible for this vasodilationl. 
To determine whether oxygen can have a direct influence on vascular smooth 
muscle, Pittman [1981] posed three key questions: 
(a) What is the normal p02 physiological range for resistance vessels? 
lThe interaction amongst those candidates will be discussed later. 
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(b) What is the p02 critical value for vascular smooth muscle cells to be 
sensitive to its change? 
(c) What is the mechanism for vascular smooth muscle cells to react to 
changes in their local p02? 
Since mitochondria are the major sink for oxygen in the cells, studying the relationship 
between the function of mitochondria and oxygen tension is very important. It has 
been found that the function of isolated mitochondria is independent of 02 
concentration until very low values are obtained [Sugano, 1974; Oshino, 1974]. The 
critical value is l-5mmHg for isolated cells [Wilson, 1979]. The critical p02 in vitro 
for mitochondria, which is the local p02 below which oxygen becomes unavailable for 
electron transport and oxidative phosphorylation, is nearly zero [Jobsis, 1972]. 
However, Hempel and co-workers [1977] demonstrated that the critical p02 for 
mitochondria in intact tissues could be above zero and may be as high as 50mmHg. 
One study has shown that substantial intracellular oxygen concentration gradients 
established by mitochondrial respiration between the suspending medium and the 
mitochondrial inner membrane occur under hypoxic conditions in isolated cardiac 
myocytes. It was concluded that this intracellular oxygen gradient is an important 
factor in determining the function of isolated mitochondria in cells and may contribute 
to the oxygen dependence of cardiac myocyte function in vivo [Jones, 1986]. 
To study whether the arterial oxygen tension directly controls CBF, Berne et 
al [1957] set up an experiment with special conditions which allowed CS blood rich in 
oxygen not to fall below 5.9vol%, and arterial blood poor in oxygen tension to be as 
low as 11.7vol%, by means of high perfusion pressure in open-chest dogs under 
beating and fibrillating heart conditions. They found that there was no concomitant 
increase in CBF. On the other hand, at normal perfusion pressure, linear correlation 
between CS oxygen tension and CBF was found when hypoxemia reached the point 
at which CS oxygen content was below 5.5 vol% regardless of the arterial oxygen 
tension. As a result, they concluded that the low arterial oxygen tension could not 
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itself increase coronary flow, and that since coronary venous oxygen reflected 
myocardial tissue oxygen content, this latter parameter probably regulates CBF. 
Cytochrome aa3 was proposed as a vascular oxygen receptor, but poisoning the 
enzyme with cyanide did not cause as much dilation as hypoxia [Coburn, 1977]. 
Since the contractile activity of single vascular smooth muscle cells is not effected by 
oxygen until the p02 falls below about 8mmHg [Berne, 1980] which is lower than the 
p02 experienced by resistance vessels in vivo under normal conditions, it is unlikely 
that oxygen will have a direct effect on resistance vessel tone. 
The vascular reaction to imbalance in oxygen supply and demand may be 
attributed to oxygen by way of some other metabolites which are related to oxidative 
metabolism produced by the parenchymal cells. Berne [1963] found the breakdown 
products of adenosine in CS blood during cardiac hypoxia. It was suggested that 
hypoxia has an indirect effect on vascular smooth muscle and adenosine may be 
responsible for triggering the vasodilation due to hypoxia. Considerably evidence has 
been published supporting adenosine as a potent physiological vasodilator in coronary 
circulation1• However, there are no substantial experiments firmly supporting 
oxygen's indirect effect on vascular smooth muscle by releasing adenosine. Thus, we 
know that oxygen is related to the regulation of CBF, but how they relate to each 
other remains to be determined. 
3. 2. 4 Oxygen and Cardiac Activity 
3.2.4.1 Oxygen and Vascular Basal Tone 
The coronary system has higher basal resistance than the brain or kidney. 
Myogenic coronary constriction seems the likeliest and most important factor 
responsible for this. Transmural pressure differential is the major stimulus supporting 
lThis will be discussed in the adenosine hypothesis section. 
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myogenic tone. Electrophysiological studies showed myocyte membrane potential 
was inversely related to the vessel calibre [Harder, 1979]. To develop myocyte 
membrane potential requires energy. There is no doubt that oxygen plays an important 
role in the maintenance of coronary vascular basal tone. 
3.2.4.2 Oxygen and Increased Cardiac Work 
The foundation for the hypothesis that oxygen is responsible for coronary 
regulation during increased cardiac work is the observation that the left CB F 
apparently depends on MV02 [Katz,1958; Khouri, 1965]. This correlation could be 
interpreted in three ways. One is causally related, ie increase of cardiac wo~k causes 
augmentation of oxygen usage which elicits a fall of p(t)02, therefore precapillary 
sphincters are sensitive to this change and induce vasodilation (direct oxygen effect on 
the vascular smooth muscle). Another interpretation is covariant, ie augmentation of 
MV02 (rate of metabolic production) due to increased cardiac work causes release of 
oxygen-dependent vasoactive metabolite(s) into interstitial spaces and evokes 
vasodilation (indirect effect of oxygen on the vascular smooth muscle). In this case, 
the vasoactive metabolite(s) should be proportional to the increased oxygen usage. 
The last interpretation is that the correlation is only coincidental, ie some other 
concomitant change during increased cardiac activity stimulates production of 
vasoactive metabolite(s) which causes vasodilation. 
Can MV02 be the regulating factor for CBF? 
MV02 refers to the volume of oxygen consumed by the heart and is 
determined by the situation and the type of activity the heart is performing. Over the 
years, many indices have been developed and used as reliable predictors of the oxygen 
consumption of the heart. Cardiac oxygen consumption is calculated by the product of 
CBF and artery-venous oxygen content difference under steady-state conditions by 
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· means of the Fick principle. To determine whether MV02 is a regulating factor for 
CBF, there are a few questions that need to be answered. 
a) Does a linear relationship exist between CBF and MV02? 
b) Through what mechanism(s) - direct or indirect- does MV0 2 control 
CBF ?1 in vitro in vitro 
c) No matter how MV0 2 is changed, is it always the same mechanism 
which regulates CBF? 
Most data on the subject show a fairly linear steady-state relationship between flow 
and MV02 [Rubio, 1975]. The correlation coefficients between CBF and MV02 are 
typically 0.8 [Eckenhoff, 1947] to 0.9 [Foltz, 1950; Nelson, 1974] under static and 
dynamic exercise conditions. In such a close relationship, one would expect that the 
changes of flow are always proportional to t~e changes of MV02. The relationship 
between MVO 2 and CBF was modified hy ·changing certain hemodynamic conditions 
such as aortic pressure, cardiac output and heart rate [Braunwald, 1958]. When 
cardiac work and MVO 2 were elevated by increasing aortic pressure, the percentage 
increment in CBF was greater than the percentage increment in MV02. In contrast, 
when work and MVO 2 were increased by augmenting cardiac output, the percentage 
increment in CBF was less than the percentage increment in MV0 2. However, the 
work done by our laboratory demonstrated that both increased aortic pressure and 
elevating stroke volume have an equal effect on the regulation of CBF in terms of the 
same cardiac work [Wright, 1989]. One experiment [Sarnoff, 1963] allowed CBF to 
change without disturbing other hemodynamic conditions in the isolated dog hearts. 
Over a wide range of CBF, MV0 2 did not change if the measures of the cardiac 
activity as aortic pressure, heart rate and stroke volume were held constant. However, 
1This is to determine whether oxygen has a direct or indirect effect on vascular smooth muscle if myocardial 
oxygen consumption controls CBF. This has been discussed in section 3.2.3. 
29 
when CBF were held constant, MV02 varied in the same direction as the amount of 
ventricular myocardial tension. This indicated MV02 could be not changed while the 
coronary artery flow is regulated. The special phenomenon of reactive hyperemia after 
artery occlusion in the ~oronary system was showed to be tightly related to myocardial 
metabolic activity during the inte:wal of arterial occlusion and is not influenced by 
alterations in resting CBF which occur independently of MV02 [Bache, 1973]. 
Thus, MV02 is at least partially responsible for coronary reactive hyperemia. Part of 
the variation of CBF could not be explained by the level of MVO 2• Bache suggested 
that this variation could be due to another mechanism which is not directly related to 
oxidative metabolism. 
If one accepts that MV02 determines CBF, one plausible expectation would 
be that changes in the amount of cardiac work in any condition will result in parallel 
changes of CBF. In cat papillary muscle tension studies, evidence was presented that 
alteration in shortening and external work at a constant intrinsic velocity were 
associated with changes in MV02 [Coleman, 1969]. It has been known for many 
years that exercise is accompanied by a marked increase in CBF [Bassenge, 1973; 
Vatner, 1972; Van Citters, 1969; Restorff, 1975]. One elegant experiment done by 
Khouri and co-workers [1965] showed the effect of graded treadmill exercise on heart 
rate, blood pressure, main left coronary artery flow, stroke coronary flo~, cardiac 
output and stroke volume in intact unanaesthetized dogs. There is close parallelism 
amongst heart rate, coronary flow and cardiac output. In calculating myocardial 
oxygen usage by multiplying the coronary arteriovenous difference by the coronary 
flow, and the left ventricular work by timing the cardiac output with blood pressure, a 
close correlation between cardiac work, oxygen usage, and coronary flow was found. 
It was concluded that cardiac work is an important determinant of myocardial oxygen 
usage and CBF. However, other work produced conflicting results: when the 
frequency of stimulation of the heart and the aortic pressure are kept constant, changes 
of the work performed do not result in change of CBF; also, when the working 
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conditions of the heart are kept constant, changes of CBF do not cause any variation 
of the amount of work performed [Rosenblueth, 1961]. It should be noted that the 
cardiac work was estimated by mechanical measurement in their experiment. The 
important question is whether the work performed by the heart itself determines CBF 
or the change of work results in other changes such as MVO 2 or even other metabolic 
products, the latter having an effect on vascular smooth muscle to elucidate 
vasoregulation. 
3.2.5 Conclusion 
' 
Recent evidence indicates that coronary metabolic vasoregulation is closely 
coupled to oxygen usage by the heart. Hypoxia causes vasodilation and hyperoxia 
results in vasoconstriction. Oxygen could be responsible for the local control of CBF 
during increased cardiac work. This implies that the metabolic vasoregulation is to 
keep oxygen stable. However, the evidence in support of this hypothesis is indirect 
and does not prove myocardial hypoxia is the initiating f actol'.. The mechanism is 
unknown. Oxygen may have a direct or indirect (involving other vasodilator agents)' 
effect on the vascular smooth muscle. There is no data available to directly measure 
vessel wall p02 during vasoregulation and to demonstrate the measured changes 
sufficient to interpret the re-adjustment of coronary resistance. The interpretations of 
experimental results were also clouded by concomitant changes during alteration of 
oxygen content. 
3.3 ADENOSINE 
3. 3 .1 Adenosine Hypothesis 
Observations on the close correlation between CBF and the metabolic activity 
of the myocardium had led Berne to study the products of metabolism under hypoxia 
in 1963. In th~ isolated cat heart, coronary vasodilation and a reduction in the heart 
rat~ were associated with the anoxia-induced appearance of inosine and hypoxanthine 
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[Berne, 1963]. In the intact working heart of open chest dogs [Jacob, 1960], 
concentrations of inosine and hypoxanthine in the CS were found to be from 3 to 27 
times more during myocardial hypoxia than the concentration determined , after 
doubling CBF by infusing adenosine into the left coronary artery. Neither of the 
adenine nucleotide derivatives was present in significant amounts in arterial blood of 
hypoxic dogs or in arterial or cardiac venous blood of the normally ventilated animal, 
indicating that inosine and hypoxanthine came from the myocardium. 
-Berne [1963] assumed that the inosine found in the CS is in some measure 
, 
d~rived directly from adenosine by deamination and not by the dephosphorylation of 
inosinic acid. In other words, the degradation of AMP to inosine and hypoxanthine 
occurs via adenosine rather than via inosine monophosphate (IMP). Based on studies 
by Drury [1929], who demons~ated that adenosine is a potent vasodilator, and by 
Jelliffe [1957], who showed that reoxygenated CS blood collected from hearts 
subjected to hypoxia or ischemia failed to produce changes in vascular resistance when 
infused into the coronary artery, which indicated that if a vasoactive substance is' 
released from the myocardium during hypoxia it is rapidly inactivated and greatly 
diluted by the blood. Berne proposed that adenosine acts as a transmitter signalling 
the oxygen tension at a critical site. in the myocardial cell to the coronary vascular 
smooth muscle cells. 
Berne's adenosine hypothesis for coronary vasoregulation has generated many 
further studies. Generally, these studies have been designed to show that adenosine 
meets the criteria for a compound to be a chemical transmitter responsible for 
vasoregulation. These criteria are [Berne, 1980]: 
a) The compound has to be found in the interstitium under certain 
conditions, and also widely spread throughout the vascular bed. 
b) The compound itself should be a potent vasodilator in the physiological 
quantities found in the interstitium and endogenously infused, and should 
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~ompletely mimic the physiological reaction which has been seen 
endogenously. 
c) The time course of production of the compound should be the same as the 
vasodilation: a precise quantitative cause and effect relationship should be 
established between the interstitial fluid concentration of the compound 
and the diameter of the coronary resistance vessels. 
d) The vario~ inhibitors and blocking agents should have effects consistent 
with the hypothesis whether the compound is released physiologically or 
artificially applied. 
3 .3 .2 Adenosine Characteristics 
3. 3. 2 .1 Adenosine Metabolism 
The processes of adenosine metabolism in the heart are shown in Figure 3.1 
[Berne, 1979; Feigl, 1983; Schrader, 1990; Lloyd, 1988]. Adenosine is formed by 
dephosphorylation of AMP. The enzyme, 5'-nucleotidase which catalyzes this 
reaction, is located in membranes of cardiac cells [Nakatsu, 1972; Rubio, 1973; Nees, 
1980]. It can act both inside and outside cardiac cells to convert A¥P to adenosine 
[Frick, 1976; Schiltz, 1981], and also as a translocase to move adenosine through the 
cell wall. Then adenosine can act on resistance vessels to produce vasodilation 
through either facilitated diffusion into interstitial spaces, or by being formed outside 
the cardiac cell membrane, which permit it to be in contact with extracellular fluid 
[Berne, 1979]. However, there is no substantial evidence to support this. The critical 
, point is that 5'-nucleotidase must have sufficient activity and an appropriate location in 
the myocardium for the formation of adenosine from AMP to prevent cardiac adenylic 
acid deamination of AMP. Recent views on the formation of adenosine have been 
modified by the observation that most of the adenosine in isolated well-oxygenated 
guinea-pig hearts is derived from the transmethylation pathway by hydrolysis of 
S-adenosylhomocystein (SAH) intracellularly [Lloyd, 1988]. 
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Fig. 3.1: :eathways of adenosine formation (see text for detail) 
Two paths for adenosine inactivation are shown in Figure 3.2: either uptake 
by cells followed by rephosphorylation to AMP by adenosine kinase or deamination 
to inosine catalyzed by adenosine deaminase. Adenosine readily enters cells, eg red 
blood cells [Kolassa, 1978; Roos, 1972], myocardial cells [Cobbin, 1974; Olsson, 
1973], leukocytes [Strauss, 1976] and cells in tissue culture [Plagemann, 1974] by 
5'-nucleotidase translocation, simple diffusion and carrier-facilitated diffusion [Berlin, 
1975; Fox, 1978; Paterson, 1981]. On the other hand, adenosine deaminase has 
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simple diffusion 
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or 
or 
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Fig. 3.2: Pathways of adenosine degradation 
Hypoxanthine 
+ 
Ribose-1-P04 
been found to be ubiquitous in the heart [Baer, 1966]. Adenosine deaminase catalyzes 
the rapid degradation of adenosine to inosine and purine nucleoside phosphorylase 
catalyzes the breakdown of inosine to hypoxanthine and ribose-l-P04. Finally 
hypoxanthine forms xanthine under the influence of xanthine oxidase. Apparently this 
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is a major problem for detecting adenosine from heart owing to high intracellular 
activity of adenosine deamiilase. Rubio et al [1972] found that nucleoside 
phosphorylase is restricted to the endothelial cells and the pericytes in the heart. They 
could not detect any nucleoside phosphorylase activity in the cardiac cells by 
histochemical and electron microscopy techniques. This probably explains the 
observation that measurements of adenosine concentrations are higher in the 
myocardium than in the venous effluents of perfused hearts. 
It has been demonstrated that 5'-nucleotidase activity is inhibited by ATP 
[Baer, 1966; Burger, 1967]. Baer and his colleagues postulated that when myocardial 
hypoxia occurs or cardiac performance increases, the reduction of ATP will diminish 
the inhibition of 5'-nucleotidase which will lead to increased formation of adenosine. 
Unfortunately, this attractive hypothesis became invalidated when it was found that 
ADP is a more potent inhibitor of 5'-nucieotidase than ATP [Edward, 1970; 
Sullivan, 1971]. 
3.3.2.2 Adenosine Vasodilating Properties 
Drury [1929] demonstrated that adenosine infused into coronary circulation 
resulted in coronary vasodilation. This has been confirmed in latter studies in dogs 
[Essex, 1940] and rabbits [Wedd, 1931; Wolf, 1956]. These is no doubt that 
exogenous adenosine is a coronary potent vasodilator [Berne, 1979; Feigl, 1983]. 
3.3.2.3 Mechanism of Vasodilating Action 
Although some work has been carried out to detefmine the mechanism(s) of , 
adenosine's vasodilating action and a few theories have been postulated, the results are 
by no means conclusive. Almost all the work has been performed by means of 
exogenous adenosine owing to its very short life and high permeability. Among those 
putative mechanisms, the most attractive is the extracellular adenosine receptor 
hypothesis. 
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In an attempt to determine where adenosine , acts in t4e coronary vessels, a 
synthesized adenosine derivative linked with oxidized stachyose - a high molecular 
weight protein -was used by Olsson [1976]. This compound has been shown to be 
too large to penetrate cell membranes. Intracoronary infusion of this linked adenosine 
compound elicited dose-dependent coronary vasodilation [Olsson 1976]. In the 
isolated perfused heart, Schrader [1977] reported that a protein-AMP-conjugate which 
is produced by coupling adenosine with 5'-AMP via phosphoamide linkages to a 
large molecular weight protein, demonstrated the same potent coronary vasodilation 
reaction as adenosine and AMP. Both experiments indicate that the adenosine 
receptor is most likely to be located at the surface of the vascular smooth muscle cells. 
Establishing the location of the adenosine receptor has not answered ihe 
question "How does adenosine actually trigger the vasodilation action?" Two 
mechanisms have been proposed, in one smooth muscle cyclic 3',5'-AMP (cAMP) 
is increased and in the other the inward c~cium current during the action potential in 
vascular smooth muscle is inhibited [Berne, 1979; Feigl, 1983]. In Berne's 
laboratory, effects of adenosine on calcium influx [Harder, 1979; Herlihy, 1976] have 
been studied in isolated large and small coronary arteries. It has been shown that 
adenosine abolished the action potentials in vascular smooth muscle and this action 
could be rapidly recovered totally or partially by addition of adenosine deaminase ,or 
excess calcium, but there was no direct measurement of calcium flux after adenosine 
administration. This finding is in agreement with Schnaar and Sparks, [1972], who 
observed adenosine-elicited relaxation of dog coronary arteries contracted with 35rnM 
K + and suggested that adenosine acted by decreasing the membrane permeability to 
Ca2+. However, Verhaeghe's [1977] experimental result was not consistent with 
those of Schnaar and Sparks as he found that adenosine inhibited the noradrenaline 
contraction of canine saphenous vein equilibrated in Ca2+_free solutions. It is still 
unknown how adenosine inhibits the calcium uptake in vascular smooth muscle cells -
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by its effect on adenosine receptors or by other mechanisms which change membrane 
conditions. Based on the observations: 
• Adenosine increased cyclic AMP levels of guinea pig cerebral cortex 
slices [Sattin, 1970]; 
• Exogenous adenosine produced coronary dilation and an increase in cyclic 
AMP release [Huynh-Thu, 1978] and 
• A good correlation was shown between cyclic AMP concentration and 
adenosine relaxation of isolated coronary vascular strips [Kukovetz, 
1978], 
it was proposed that adenosine induces coronary vasodilation by increasing vascular 
smooth muscle cyclic 3',5'-AMP concentration [Berne, 1979; Feigl, 1983]. 
However those observations require a very high adenosine concentration - about 100 
times higher than in physiological coronary vasodilation. 10-4M adenosine failed to 
produce augmentation of cAMP [Herlihy, 1976]. Vehaeghe [1977] also observed no 
change in the cAMP con~ent when the canine saphenous vein was exposed t~ 
adenosine. After inhibiting the enzyme phosphosdiesterase which degrades cAMP, 
-the adenosine relaxing effect was enhanced on isolated coronary vascular strips 
[Napoli, 1980]. Therefore, it would be unlikely for adenosine-elicited vasodilation to 
be due to increments in intracellular cAMP. Unfortunately these findings were not 
sufficient to decide whether the adenosine-induced potentiating of the stimulated 
adenylate cyclase was produced by an interaction with the binding of the hormones to 
their respective receptor sites, or by an interference with the catalytic unit _of the 
enzyme. 
Raberger and co-workers [1970] investigated the effects of intracoronary 
adenosine infusion on myocardial metabolism. This results revealed an increase in 
myocardial glucose uptake, myocardial lipolysis and lactate and hydrogen ion release. 
They was concluded that adenosine infusion produces coronary vasodilation via 
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acidosis and increased carbon dioxide production, both contributing to adenosine 
metabolic effects enhancing glycolysis. Further studies to test this hypothesis· 
demonstrated that [Raberger, 1971]: 
• exogenous adenosine became a more potent coronary vasodilator in the 
acidosis and hypercapnia environment and 
• adenosine stimulated increased glucose uptake was secondary to increased 
coronary blood flow instead of an insulin-like action. 
Other studies showed that the increase of carbon dioxide after adenosine 
vasodilation was due to a flow-dependent washout in isolated cat hearts [Tumheim, 
1976]. In another set of experiments, adenosine infusion and acidosis were found to 
relax vascular smooth muscle by a different mechanism [Tumheim 1977]. This did 
not support Raberger's hypothesis. 
3.3.2.4 Adenosine Inhibitors 
It is important to study inhibitory agents for adenosine in order to understand 
biological ph~nomena or to assess their physiological significance. Two groups of 
chemicals have been found to be effective. blocking agents: xanthine derivatives and 
adenosine deaminase. 
1.Xanthine Derivatives 
Theophylline and aminophylli1'.le are the most common xanthine derivatives 
used for studing coronary vasoregulation. Aminophylline is a more soluble form of 
theophylline and contains ethylene diamine. 
In anaesthetized animal preparations, aminophylline elicited coronary 
vasodilation when administered either intravenously [Gilbert, 1929; Oei, 1977] or 
directly into coronary beds [Boyer, 1941; Melville, 1950]. However, in intact and 
conscious dogs, intravenously injected aminophylline produced coronary constriction 
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even though there were corresponding increases in myocardial contractivity and 
arterial pressure which were expected to result in metabolically mediated coronary 
vasodilation [Rutherford, 1981]. This vasoconstriction was inhibited by c:x-adrenergic 
blockade, indicating that this effect may be sympathetically mediated. In summary, a 
different effect of aminophylline appears in anaesthetized animals on the one hand and 
in intact animals and humans on the other. How this occurs remains a question. 
Some workers demonstrated positive inotropic effects of aminophylline in isolated 
hearts [Massingham, 1972; Verna, 1976] and increased cardiac rates [Rutherford, 
1981]. These effects were produced at high dosages which make it more difficult to 
adjust for this drug's effect on vascular smooth muscle. 
Afonso and co-workers [1970b] demonstrated that aminophylline blocked 
50-75% of the coronary vasodilating effects produced by exogenous adenosine 
administration intravenously or into the coronary artery. The result was consistent 
with other work which showed that pretreatment with aminophylline or theophylline 
antagonized the coronary vasodilating effects of injected' adenosine in intact hearts 
[Schiltz, 1977; Gross, 1976; Biinger, 1975; Merrill, 1978] and in isolated coronary 
arteries [Jones, 1981]. This inhibition was not complete. 
Recently, it has been reported that 8-phenyltheophylline (8-PT), a xanthine 
analogue, is the most potent available adenosine antagonist while having relatively low 
activity as an inhibitor of calcium-dependent phosphodiesterase. This independent 
activity will cause the increases in heart rate, cardiac contractility and MVO 2 [Smellie, 
1979]. Griffith and co-workers [1981] showed that 8-PT was 100 times as effective 
as_ aminophylline as an adenosine antagonist in isolated vascular ring segments of 
rabbit basilar arteries. Bache et al [1988] showed that 8-PT elicited 95±1.2% 
inhibition of the excess flow volume in response to 20µg adenosine intracoronary 
infusion, while adenosine deaminase only produced- 73±11 % inhibition, without 
causing significant alterations of cardiac activity. Thus 8-PT is the most potent 
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known adenosine competitive inhibitor and its adenosine antagonistic activity is 
relatively selective. This will make it the preferred P1-purinoceptor antagonist to 
theophylline or aminophylline. 
It has been suggested that this adenosine inhibitory action of xanthine 
derivatives might occur at the coronary vascular smooth muscle or at the myocardial 
level [Afonso,1970a]. Dutta and co-workers [1979] found that methylxanthines 
compete with adenosine for adenosine binding sites in cardiac microsomal 
preparations. The antagonism of the inhibitory responses to adenosine by xanthine 
derivatives such as 8-PT, theophylline _and aminophyline was reversed by washing 
[Griffith, 1981]. When theophylline was linked to stachyose molecules, It was still 
active in blocking exogenous adenosine effects. This indicates that theophylline acts 
on receptors on the surf ace of vascular smooth muscle, but does not establish that 
theophylline blocks the vasodilatory action of adenosine by competing for a common 
receptor [Olsson, 1976]. 
2.Adenosine Deaminase 
Adenosine deaminase is an enzyme which catalyzes the rapid degradation of 
adenosine to inosine. Intracoronary infusion of adenosine deaminase has been used to 
test the adenosine hypothesis in various conditions such as changing coronary 
perfusion pressure [Dole, 1985], treadmill exercise in conscious dogs [Bache, 1988], 
and coronary occlusions [Saito, 1981]. By detecting 1311-labeled adenosine deaminase 
in cardiac lymph nodes, the presence of the enzyme in interstitial fluid was confirmed 
[Saito, 1981; Dole, 1985]. During the enzyme intracoronary infusion, Dole et al 
demonstrated that the average value of lymph 131J-adenosine deaminase activity was 
3.2±0.4 µ/ml which was believed to be able to degrade 29µM adenosine in the 
interstitial spaces [Dole, 1985]. This indicates that there was more than enough 
adenosine deaminase penetrating into the interstitium because there was no evidence 
that cardiac interstitial adenosine concentration ever attained the 29µM level. The 
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enzyme was also efficacious because it inhibited 73±11 % of coronary vasodilator 
response to exogenous adenosine [Bache, 1988]. In summary, exogenous adenosine 
deaminase can be used as an endogenous adenosine blocking agent to study the 
adenosine hypothesis. 
3 . 3 . 3 Adenosine and Cardiac Activity 
3. 3. 3 .1 Adenosine and Vascular Basal Tone 
Multiple agents maintain basal vascular tone. To verify the hypothesis that 
adenosine is responsible for the physiological regulation of CBF, many investigators 
have tried to test whether there is a continuous release of adenosine under normal 
conditions from myocardial cells into interstitial fluid, and whether lowering the 
concentration would decrease CBF unless some other mechanism has compensated 
this decreased flow due to less adenosine [Rubio, 1969; Gewirtz, 1986; Kroll, 1985; 
Richman, 1964]. Richman [1964] used 8-azaguanine which is considered as an 
adenosine deaminase inhibitor in a Langendoff-perfused rabbit heart. No adenosine 
was detected in the venous perfusate under normal oxygenation with or without 
adenosine deaminase inhibitor. However, adenosine was found in the hypoxic heart 
with the inhibitor, but not without the inhibitor, indicating under severe hypoxia 
adenosine was released by myocardial cells into the interstitium. The same result was 
found by Katori [1966] in guinea pig and cat hearts. However, adenosine was first 
found in the pericardia} fluid of presumably well-oxygenated dog hearts, suggesting a 
release of adenosine by the heart under normal 'resting' conditions [Rubio, 1969]. It 
was also found that artificial hypoxia increased the adenosine concentration 
significantly compared with the well-oxygenated heart. It was concluded that 
adenosine concentration in the interstitial space regulates CBF to maintain the oxygen 
balance in the myocardium [Rubio, 1969]. Adenosine was also assayed from 
'normal' hearts in pericardia! perfusate from both open chest [Miller, 1979] and closed 
chest dogs [Watkinson, 1979]. 
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Saito et al [1981] did not observe a change of CBF during adenosine 
deaminase infusion under _resting conditions, concluding that the nucleoside may not 
function in a similar capacity under basal, steady-state conditions. Using closed chest, 
sedated domestic swine, Gewirtz and co-workers [1986] set up a more careful 
experiment in which adenosine deaminase was infused into the coronary circulation at 
a dose sufficient to deaminate several times more than the maximal myocardial output 
of adenosine after having verified that the enzyme penetrates into the interstitial fluid. 
They failed to demonstrate a decline in regional myocardial flow in each layer in 
response to adenosine deaminase infusion, but they did observe a significant reduction 
versus control in the distal-to-circumflex flow ratio for epicardial and transmural 
layers. The results suggest that adenosine only plays a modest role in maintaining 
coronary arteriolar tone under steady-state conditions. 
After confirming that [Kroll, 1985]: 
a) the deposited adenosine deaminase was siefficient to deaminate adenosine 
by showing that the vasodilation induced by adenosine infusion was 
inhibited in the adenosine deaminase - treated area versus the control 
region; 
b) the inhibition of adenosine vasodilation was fully recovered with EHNA 
(an inhibitor of adenosine deaminase ) , indicating that the inhibition effect 
was contributed to the enzymatic action of adenosine deaminase; and 
c) aden_osine deaminase had a significant effect on interstitial adenosine by 
showing that deaminase activity was found in cardiac lymph, suggesting 
its penetration into the interstitial space. 
Kroll and Feigl demonstrated that simultaneous CBF measured with radioactive 
microspheres was not different in a region treated with adenosine deaminase from a 
region without adenosine deaminase. Based on this evidence, they concluded that 
adenosine is normally below the vasoactive threshold and is not an important regulator 
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for CBF under unstressed ·conditions. It seems generally agreed that adenosine does 
not contribute to maintenance of coronary vasomotor tone in basal condition. 
3. 3. 3. 2 Adenosine and Increased Cardiac Work 
Exercise makes CB F increase. If adenosine is responsible for this 
physiological change, it would be expected that the adenosine concentration in 
' ' interstitial fluid would increase during exercise. High correlations between the 
adenosine concentration in pericardia! perfusate, which was recognised as reflecting 
the extracellular fluid adenosine concentration, and MV02 as well as coronary 
vascular resistance were observed during stellate ganglion stimulation in anaesthetized 
dogs [Watkinson, 1976; Miller, 1979], atrial pacing in anaesthetized dogs [Knabb, 
1983; Saito, 1980; Randall, 1985], aortic constriction [Saito, 1980; Mckenzie, 1980], 
isoproterenol infusion [McKenzie, 1980], intracoronary norepinephrine [Manfredi, 
1982; Jone, 1982] and during treadmill exercise in conscious dogs [Watkinson, 1977; 
McKenzie, 1982; Ely, 1983]. Watkinson et al [1979] measured the pericardia! fluid 
adenosine concentratiop in four dogs. Adenosine concentration increased from an 
average value of 95.5±7.6pmol/ml at rest to 263±19.lpmol/ml at a heart rate of 
204±bpm. In isolated saline perfused guinea pig hearts, a correlation between CBF 
and tissue adenosine production was demonstrated under the influence of several 
positive and negative inot.ropic agents [Degenring, 1976]. It was also found an 
increase in cardiac lymph adenosine concentration - another index of the extracellular 
fluid adenosine concentration - in response to an increase in cardiac work [McKenzie, 
1983]. This was supported by Foley [1978], who observed that pericardia! fluid 
adenosine levels rose with aortic constriction in rats. CBF was not measured. Saito 
[1980] has suggested that adenosine is a single vasoactive metabolite which is 
predominantly responsible for the coronary functional hyperemia based on the 
observation of the consistent parallelism between CBF and MVO 2 under a variety of 
conditions in which cardiac performance was changed in either direction. Manfredi 
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and Sparks [1982] reported that vasodilation produced by intracoronary infusion of 
norepinepherine instead of atrial pacing was accompanied by an increased adenosine 
release by the heart. The bulk of the data has shown a significant correlation between 
endogenous adenosine concentration and CBF. 
By using positive inotropic agents such as histomine, nor-adrenaline (NA) and 
adrenaline (A) to stimulate isolated, saline perfused guinea pig hearts, adenosine 
release by these hearts was correlated with MV02 and presumably CBF. CS oxygen 
content decreased wit~ stimulation. However the change of heart rate ( chronotropic 
agent) by itself has no effect on adenosine release [Wiedmeier, 1977]. Similar results 
were reported by Saito et al [1980]. It was concluded that oxygen may be a potent 
stimulus for adenosine production. In other words, increased cardiac work produces 
hypoxia respectively which triggers adenosine to be released into the interstitial space 
to dilate arteries. However, McKenzie and co-workers [1982] demonstrated that 
when four factors indicated no myocardial hypoxia (low myocardial lactate content, 
continued lactate uptake, lack of changes in the lactate-pyruvate ratio, and stable CS 
oxygen tension), significant correlations (r=0.74-0.83) amongst myocardial adenosine 
content, CS adenosine concentration, and coronary resistance were obtained using 
conscious treadmill exerCising dogs. They suggest that adenosine is responsible for 
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increased CBF during increased metabolic activity, but hypoxia is not the stimulus for 
adenosine production in treadmill exercise. 
More recently interest has been directed toward the role of adenosine in 
coronary vasodilation during exercise by using an adenosine blocker, either adenosine 
deaminase by intracoronary infusion or a potent adenosine competitive inhibitor used 
systemically. Randall and Jones [1985] showed aminophylline intravenous injection 
attenuated the increase in CBF (p<0.05) and enhanced the increase in myocardial 
oxygen extraction (p<0.05) when increasing cardiac rates by pacing. This supports 
adenosine's role in coronary active hyperemia induced by an increase in heart rates. 
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However both theophylline [McKenzie, 1987] and aminophylline [Jones, 1982] failed 
to alter the increase of CBF by isoproterenol administration [McKenzie, 1987] or 
intracoronary infusion of norepinephrine [Jones, 1982]. The reason for the very 
discrepant result shown between these two groups of investigators, ie an increase of 
adenosine concentration -was obtained after aminophylline administration by 
McKenzie, but not by Jones after theophylline infusion, is not clear. McKenzie 
[1987] proposed that adenosine blockade elicited an increase of myocardial adenosine 
production which may just compensate the competitive inhibition produced by the 
blockade. Unfortunately, these investigators did not measure coronary sinus p02, 
pC02, and pH in order to test whether other putative vasodilators were involved in 
this reaction. After being sure that both adenosine deaminase and 8-PT produced 
inhibitio_n of coronary vasodilation in response to exogenous adenosine, Bache [1988] 
found: a) neither adenosine deaminase nor 8-PT significantly altered coronary 
vascular resistance and myocardial oxygen extraction; b) neither of them affected 
CBF, coronary vascular resistance during exercise and the relationship between 
MV02 CBF; c) neither of them decrease coronary venous oxygen tension during 
exercise. These data suggested that adenosine does not play an important role in 
coronary vasodilation during exercise. It is possible that those previous results imply 
that adenosine is an important factor for coronary functional hyperemia when oxygen 
demand is increased by a chronotropic stimulus (eg increasing heart rate) and is not an 
important regulator when oxygen demand is increased by an inotropic stimulus (eg 
isopreterenol, norepinepherine, or systemic exercise), even though these stimuli also 
have a small chronotropic effect. However, those data without using adenosine 
blockade showed the opposite result. Current conflicting data provide no answer to 
this question. 
In summary, the coronary vasodilation in response to exogenous adenosine 
can be nearly completely blocked by an adenosine antagonist (theophylline, 
aminophylline or 8-phenyltheophylline), but the vasodilation in response to proposed 
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endogenous adenos~ne was not or very little affected by those inhibitors during 
increased cardiac work. Thus, whether aden_osine is a mediator responsible for 
metabolic vasodilation is still an enigma. 
3. 3. 4 Adenosine and Other Vasoregulatory Situations 
Even though this thesis is mainly concerned with active hyperemia in coronary 
, circulation, I will discuss briefly other vasoregulatory situations relating to local 
control of coronary flow. 
3. 3. 4 .1 Adenosine and Reactive Hyperemia 
Reactive hyperemia is the excessively increased flow volume after the release 
of an arterial occlusion. If adenosine is an essential endogenous _vasoregulatory 
mediator following the occlusion of the coronary artery, the adenosine concentration 
should reach a certain level which can be responsible for the increase of CBF, and the 
time course of adenosine production and its levels should be similar to that of the 
response of reactive hyperemia [Feigl, 1983; Olsson, 1975; Belloni, 1979]. 
Adenosine appears in CS blood during reactive hyperemia in quantities relating 
to the duration of the occlusion interval [Rubio, 1969]. In dog hearts, Olsson et al 
detected a marked increase in myocardial tissue levels of adenosine, doubling after 
5secs [Olsson, 1970] and 5-6 fold after 15secs [Olsson, 1978] of coronary artery 
occlusion. During the reactive hyperemic response after coronary occlusion, 
myocardial adenosine concentrations dropped exponentially in concordance with the 
flow rate to the control value [Olssop., 1978]. In the isolated guinea pig heart the 
release of 14C-adenosine increased and closely paralleled the changes in coronary 
resistance during reactive hyperemia [Schrader, 1977]. In all cases preocclusion 
values for the release of labeled adenosine were reached when coronary flow returned 
to control values after coronary occlusion. This supports the adenosine hypothesis. 
However, the relationship between coronary flow and myocardial adenosine 
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concentration was not consistent with the relationship between coronary flow and 
coronary plasma adenosine levels during intracoronary infusion of adenosine [Olsson, 
1978]. 
Coronary occlusion for very short durations such as one heart beat or even a 
fraction of diastole, induced no detectable change on myocardial metabolism, but it 
still elicited a hyperemic response [Bi.kens, 1974; Giles, 1977; Schwartz, 1982]. 
Giles interpreted this as myogenic in origin because he believed the period of 
occlusion was too short to provoke the release of metabolites; in contrast, Shwartz 
favoured a metabolic mechanism. The key argument is how rapidly coronary 
occlusion induces the hypoxic stimulus to produce vasoactive metabolites. If 
myoglobin is completely saturated, the oxygen reserve could support cardiac activity 
for about 6 seconds in the conscious dog [Olsson, 1964]. It has been observed that 
cardiac muscle adenosine levels are already substantially increased following 5secs of · 
coronary occlusion [Olsson, 1970], but it still unknown when adenosine is elevated. 
By using an intracoronary infusion of adenosine deaminase to destroy 
adenosine in the cardiac interstitium, the hyperemic response to coronary occlusion 
was reduced, but not completely abolished [Saito, 1981]. Doubling the rate of 
adenosine deaminase did not further reduce the intensity of reactive hyperemia. 
However, we still cannot exclude the possibility that either the adenosine concentration 
or the adenosine induced vasoactivity was enhanced due to adenosine deaminase 
administration. These results showed that both theophylline and adenosine deaminase 
demonstrated the same extent of inhibitory effect in reactive hyperemic response -
about 35% reduction. Saito [1981] suggested that adenosine contributes ~5% 
responsibility for this response. 
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3. 3. 4. 2 Adenosine and Autoregulation 
The argument for adenosine to be the metabolite responsible for ~oronary 
autoregulation is that the change of perfusion pressure would result in change of 
adenosine production. ie increased perfusion pressure induces decreased adenosine 
release which reduces flow rate under that pressure so that the flow is reasonably 
constant and vice versa. There have been only three studies addressing adenosine's 
role in coronary autoregulation [Schrader, 1977; Dole, 1985; Hanley, 1986]. 
In the isolated guinea pig hearts, a decrease in perfusion pressure in steps from 
60-20cmH20 which was believed to be the autoregulatory range results in a 
progressive increase in the rate of adenosine release and in the perfusate concentration 
of adenosine. The change of adenosine concentration closely paralleled the change of 
coronary resistance [Schrader, 1977]. This finding supports adenosine involvement 
in the adjustment of CBF during autoregulation. However, by means of an epicardial 
well technique, Hanley and co-workers [1986] observed that cardiac interstitial 
adenosine concentration remained constant during autoregulation although there was a 
significant difference in coronary resistance, and the coronary bed still autoregulated 
normally when interstitial adenosine was reduced to levels close to zero by adenosine 
deaminase infusion in blood perfused dogs in vivo. It was concluded that adenosine 
is not an essential mediator in coronary autoregulation unless the change of adenosine 
was beyond the sensitivity of the method of detection [Hanley, 1986]. A similar 
conclusion was made by Dole et al [1985] because adenosine deaminase did not alter 
the time course for coronary pressure-flow relationship either within the 
autoregulatory range or beyond it. The diametrically conclusions of Schrader and 
others remain unresolved. As Schrader [1977] has pointed out, a correlation between 
I 
adenosine and autoregulation can only suggest, but can not prove, that adenosine is 
the fundamental determinant of changes in coronary resistance during autoregulation. 
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3.3.S Conclusion 
Although there is much impressive data to support an important role for 
adenosine in local control of CBF, the adenosine hypothesis remains a hypothesis. 
Whether the measured adenosine during various cardiac activities is causally related to 
CBF or just coincidentally related, in other words adenosine is only one form of 
waste from metabolism, can not be decided with current evidence. Current data 
appear to suggest that negative data are more convincing than positive ones. It is 
conceivable that adenosine is not responsible for coronary basal tone, but it can not be 
excluded as the agent for coronary regulation during exercise. However, a 
quantitative study of the role of adenosine in reactive hyperemia suggests that 
adenosine is responsible for a portion of reactive hyperemia. If adenosine is involved 
in coronary vasoregulation, there are still not sufficient data to determine by what 
mechanism adenosine triggers vasodilation and whether adenosine is the final agent _ 
for regulation of vascular resistance is still unclear. 
3. 4 OTHER PUTATIVE V ASODILATORS 
3. 4 .1 Carbon Dioxide and Hydrogen 
A close correlation between cardiac carbon dioxide level and CBF was first 
demonstrated by Barcroft and Dixon [1907] in the isolated canine heart-lung 
preparation. It has been repeatedly observed that hypercapnia by inhalation of carbon 
dioxide gas increases CBF using different experimental preparations [Gremels, 1926; 
Raberger, 1975; Neill, 1975] and different flow measurements. During constant-flow 
-
perfusion, hypercapnia elicited decreased coronary resistance [Case, 1976; Clancy, 
1975; Daugherty, 1967]. It has also been demonstrated that hypocapnia caused by 
hyperventilation decreased CBF [Kittle, 1965; Alexander, 1976]. During coi:istant 
flow perfusion in coronary circulation hypocapnia increased coronary resistance 
[Case, 1976; Daugherty, 1967]. However, in other work hypercapnia failed to 
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induce CBF increases [Kosche, 1971]. The majority of reports states that carbon 
dioxide is a coronary vasodilator. One group of investigators has gone so far as to 
suggest that myocardial pC02 is the primary agent controlling coronary flow [Case, 
1976]. Those conflicting reports were partially due to differences in the animal 
preparation and durations of change in pC02 when cardiac hemodynamics were 
measured [Feigl, 1983]. 
The aerobic metabolism of myocardial cells generates carbon dioxide 
continuously as the result of complete oxidative reactions of the substrates. The 
amount of cai produced by the myocardium is in proportion to MV02 determined by 
the respiratory quotient. C02 is carried in the blood in three forms (as dissolved, 
bicarbonate and carbamino compounds) and is mainly excreted by the lungs and 
kidneys. C02 plays an important role in maintaining body pH. It has been well 
established that C02 and acidosis cause a direct myocardial depressant effect on 
isolated papillary muscles [Gonzalez, 1971; Mattiazzi, 1977] and isolated perfused 
hearts [Williamson, 1975]. In the myocardium, C02 has no ~fficulty reaching the 
coronary resistance vessels due to its high diffusibility. 
Severinghaus et al [1967] found that arterial pC02 rather than tissue or venous 
pC02 correlated with cerebral vascular resistance. Based on the observation that when 
C02 was blown directly over exposed brain cortex, cerebral vasodilation occurs 
[Meyer, 1964], it was suggested that C02 acts directly on the smooth muscle cells of 
arteriolar and arte:i:ial vessel walls. This direct relaxing effect on vascular smooth 
muscle was also shown by others [McLellan, 197 4; Radawski, 1972]. After 
administration of atropine and propranolol or bretylium, the effect of hypercapnia on 
myocardial blood flow was not altered even though the calculated MV02 was reduced 
and the aortic pressure and heart rate were unchanged. Apparently the flow in this 
situation was over-perfused as far as oxygen demand was concerned. This suggests 
that elevated pC02 has a direct vasodilating effect on the myocardial circulation instead 
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of through changes in cardiac work or through the release of autonomic transmitters 
[Ledingham, 1970]. Unfortunately, those workers did not measure the antagonizing 
effect of b~ocking agents. However, in Kontos and co-~orkers' [1977] studies, they 
demonstrated that the effect of C02 on cerebral blood flow was mediated by local 
alteration of H+ concentration. During hypercapnia there is a significant rise in blood 
epinephrine, norepinephrine, and 17-0H corticosteroids in normal humans [Sechzer, 
1960], and increased rate of catecholamine synthesis in rats [Nahas, 1968]. With 
stabilized MVO 2 and an adrenergic beta-receptor blockade, sotalol (in sufficient doses 
to block the effects of 5µg of adrenaline), hypercapnia (arterial pC02=85 mmHg) by 
C02 inspiration failed to increase CBF significantly compared with the effect of 
hypercapnia in the absence of beta-blockade, but elevated CS p02 [Van den Bos, 
1979]. It was concluded that high arterial C02 causes coronary vasodilation through 
an adrenergic effect instead of through the direct effect of carbon dioxide. 
Rooke and Sparks [1980] examined whether arterial C02 mediates a significant 
fraction of the steady state in CBF while varying MV02 with catecholamine 
infusions, ie how C02 influences the relationship between CBF and MV02 during 
increased cardiac activity. An increased arterial pC02 systemically produced a small 
increase in CBF independent of MV02. This vasodilating .effect was much smaller 
than the augmentation in flow elicited by increasing MVO 2. Thus, the vasodilator 
potency of C02 is very low. They concluded that arteriolar wall pC02 is not a major 
cause of functional hyperemia and suggested that the phenomenon of pC02 increases 
causing an increase in cardiac venous p02 at any value of MV02 was due to -Bohr 
shift. 
As arterial carbon dioxide increases, corresponding decreases in pH (Bohr's 
I • 
effect) was expected. In determining whether the effect of C02 on CBF is due to the 
change of pH, Kittle et al { 1965] demonstrated that increased arterial C02 still 
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augmented CBF under constant arterial pH, controlled by the intravenous infusion of 
0.9N trishydroxymethylaminomethane. 
In summary, many studies have shown that hypercapnia increases and 
hypocapnia decreases CBF when arterial pC02 was the independent variable. If the 
hypothesis that C02 is a vasodilator responsible for coronary metabolic vasodilation is 
correct, one would expect that the change of myocardial carbon dioxide in either 
direction will elicit concomitant changes in CBF when. other metabolic related 
substances are constant. Unfortunately, under normal conditions it is not possible to 
separate the effect of C02 and MV02 on coronary circulation, because any change in 
MV02 will be matched by corresponding change in C02 production under a stable 
respiratory quotient. In other word, with current techniques it is almost not possible 
- to study the effect of carbon dioxide without changing other metabolic parameters. 
Whether the changes in CBF after the alteration of C02 are caused by the change in 
pH alone or by the combination of other changes of vasoactive substances, or by the 
combination of increased pC02 and elevated catechplamines, needs further 
investigation. There is no evidence for the relationship between the CBF and the 
concentration of myocardial endogenous C02. There is also not sufficient evidence to 
show how C02 might alter the contractile state of vasculai: smooth muscle. 
3.4.2 EDRF 
Furchgott and Zawadzki [1980] were the first to discover that the vasal 
relaxation induced by acetylcholine (Ach) and other agonists of muscarinic receptors 
in isolated rabbit aorta or other arteries was dependent on the presence of endothelium 
and this endothelium-dependent relaxation by Ach results from the release of a 
non-prostanoid diffusible relaxing factor, called endothelium-derived r~laxing factor 
(EDRF) [Furchgott, 1983]. It is generally agreed that EDRF is a potent vasodilator 
s~bstance released by the endothelium [Furchgott, 1980; 1983; Vanhoutte, 1986]. 
Evidence came from experiments wi~ isolated arteries [Busse, 1985; Furchgott, 1983; 
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Peach, 1985], large conduit arteries in vivo [Angus, 1983; Pohl, 1986] and resistance-
sized vessels in intact rabbit hin.dlimbs [Pohl, 1987]. 
EDRF half-life values of about 6seconds were reported from a perfusion 
bioassay system independently for EDRF released from rabbit thoracic aorta by Ach 
[Griffith, 1984],' for EDRF released from cultured bovine aortic endothelial cells by 
bradykinin [Cocks, 1985] and for EDRF released from canine femoral arteries by 
Ach [Rubanyi, 1985]. However, others reported that the half-lives were 25seconds 
in rabbit aorta and 50seconds in canine femoral arteries [Forstermann, 1986]. This 
discrepancy was explained by the finding that superoxide dismutase (SOD) marke~y 
stabilized EDRF- released by Ach [Rubanyi, 1986] and by brady~nin [Gryglewski, 
1986], indicating that superoxide anions (Of) can inactivate EDRF. Thus, different 
preparations and laboratories would give different 0 2- levels. After a.number of 
vasodilators were discovered to be endothelium-dependent relaxing agents (eg 
A23187, ATP, and substance P), it was suggested that extracellular calcium ions 
play an important role in the release of EDRF [Furchgott, 1981; Singer, 1982; Long, 
1985]. At an EDRF symposium in 1986, Furchgott proposed that EDRF is the free 
radical nitric oxide (NO) based on his findings that the characteristics of NO-induced 
relaxation are similar to those of EDRF-induced relaxation [Furchgott, 1988]. Palmer 
[1987] successfully showed that the amounts of NO released by bradykinin from 
cultured porcine endothelial cells were sufficient to account for the biological activity 
of the EDRF. 
Based on the findings that nitrovasodilators activate soluble guanylate cyclase 
of vascular smooth muscle via nitric oxide, and that guanylate cyclase might cause an 
increase of cyclic GMP [Gruetter, 1979], the direct activation of guanylate cyclase by 
EDRF was also reported [Forstermann, 1986]. It was speculated that cyclic GMP 
has a causal role in the endothelium-dependent relaxation. Good correlation was 
repeatedly shown between the increase in cyclic GMP and the degree of relaxation 
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[Furchgott, 1984; Rapoport, 1983]. Later, little evidence was found that the relaxing 
agents by EDRF also dilate resistance vessels in a similar manner on the rings of very 
small arteries [Furchgott, 1987] and on perfused vascular beds [Pohl, 1987]. 
Many conditions and agents were found to inhibit endothelium-dependent 
relaxation by Ach in rabbit and dog arteries such as anoxia, quinacrine, 
eicosatetraynoic acid (ET YA), nordihydroguaiaretic acid (ND GA), 
p-bromophenacylbromide (BPB), Methylene blue and Hemoglobin [Furchgott, 
1989]. Some act on the endothelial cells to interfere with the production of EDRF. 
Some were found to interact with EDRF itself [Griffith, 1984]. Methylene blue 
elicits the increase in cyclic GMP related to relaxation [Holzmann, 1982]. The 
inhibition effect of Hb is very much the same except that its inhibitory action can be 
reversed by washout from the arterial preparation [Martin, 1985; 1986]. 
Relaxation of an artery with endothelium-free bioassay preparation was 
produced by the effluents from the artery with endothelium and this relaxation can be 
blocked by EDRF inhibitors. This suggests that the basal release of EDRF [Griffith, 
1984; Rubanyi, 1985] may be in part responsible for the development of vascular 
basal tone. Some EDRF blockers inhibit endothelium-dependent relaxation of rabbit 
aorta by inhibiting mitochondrial electron transport or by uncoupling oxidative 
phosphorylation. This interfered with the synthesis and release of EDRF [Griffith, 
1986]. These data suggest that production of EDRF is dependent on· mitochondrial 
ATP synthesis in endothelial cells. Therefore, the change of metabolic states, such as 
exercise or hypoxia, could cause the alteration of endothelium states. Studies done on 
perfused peripheral arteries showed that vascular smooth muscle relaxation due to 
intravascular hypoxia relied on the presence of endothelial cel,ls and it was suggested 
that prostacyclin produced by endothelium may be involved in this dilation [Busse, 
1983]. Following the observations that severe hypoxia elicited vasoconstriction in 
isolated coronary arteries [Borda, 1980; Rubanyi, 1985; 1986] and prostacyclin is a 
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vasodilator released by endothelium [Moncada, 1989], Wadsworth and co-workers 
[1990] attempted to investigate whether this hypoxia-induced constriction was caused 
by the decrease of prostacyclin in the isolated coronary artery .. They found that 
hypoxia (p02 = 8mmHg) induces a sustained contraction with the presence of 
endothelium and a small relaxation with the absence of endothelium. By using various 
receptor antagonists and enzyme inhibitiors they also concluded that this reaction 
involved multiple mechanisms which could comprise the reduced but not abolished 
synthesis of prostacyclin, the release of vasoconstrictors, the release of vasodilators 
and EDRF. Moderate hypoxia produces the vasodilator from endothelium in isolated 
rat tail and canine femoral arteries [Busse, 1983] and in isolated cerebral arteries 
[Pearce, 1990]. However, severe hypoxia induces both contracting and relaxing 
factors from the vascular endothelium [Pearce, 1990; Wadsworth, 1990]. These 
conflicting results are believed to be due to the suppression of cyclooxygenase activity 
when p02 values are lower than 10-15mmHg [Lands, 1978; Needleman, 1975]. 
In summary, EDRF is a very powerful and short-lived vasodilator of large 
and small arteries and veins. Although nitric oxide appears to be the major EDRF, it 
can not explain all endothelium-dependent responses of isolated arteries. _Since 
intracoronary infusion of low doses of Ach produced coronary vasodilation and an 
increase in coronary sinus oxygen tension without a change in cardiac contractivity or 
myocardial oxygen consumption, Feigl [1990] suggested EDRF can be an 
independent vasodilator. However, the current view on EDRF is still confusing. 
The physiological role of EDRF is not determined yet. It is still uncertain what 
physiological signals trigger the release of EDRF. There is a lack of evidence to 
show that EDRF constitutes an initial or secondary event in metabolic vasodilation. 
3.4.3 Potassium 
A few observations have coupled K+ to the cardiac effort which links with 
metabolic vasoregulation. lntracoronary infusion of small doses of K+ causes 
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coronary vasodilation in the isolated beating heart [Bunger, 1976] and in the isolated 
coronary arteries [Norton, 1972; Gellai, 1974]. Probably the most convincing data 
defining the role of K+ was presented by Murray and co-workers [1979]. In 
open-chest dogs under constant - flow preparation, they compared the time courses of 
changes in coronary resistance and coronary venous K+ concentration following a step 
heart rate increase. The interstitial K + concentration calculated by their earlier method 
[Murray, 1978] reached the level sufficient to account for about half of the initial 
vasodilation. However, the result did not support a role for K+ in maintenance of 
coronary vasodilation because in 6 out of 9 dogs venous K+ rose and then fell while 
coronary circulation was still similar in magnitude to the dilating state. The coronary 
vasodilatory effect of K+ was inhibited, but not abolished by ouabain [Bunger, 1976; 
Murray, 1978]. they suggested that Na+-K+-ATPase may be the K+ receptor. 
In summary, K+ may play a small role in initial vasodilation due to increased 
heart rate. Under normal physiological conditions the importance of K+ in maintaining 
vascular basal tone and in both triggering and supporting metabolic vasodilation is not 
yet determined. 
3.5 INTERACTION OF METABOLIC VASODILATORS 
With current technology, it is extremely difficult to set up an experimental 
preparation in which the independent variables do not trigger changes in the other 
variables which also influence vascular resistance. Thus, to understand the inter-
relation and inter-reaction amongst those putative metabolic vasodilators becomes very 
important. Only those interactions related to my experimental work are reviewed here. 
Since adenosine is the most controversial putative vasodilator and the 
conclusions about the role of adenosine have included to two extremes, is or not, 
much effort has been put into reviewing the interaction between adenosine and other 
vasodilators. Three questions arise: 
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a) Are they interacting, and if so, how? 
b) Does adenosine act as a transmitter signalling the changes of other 
metabolic factors? In other words, do other putative candidates regulate the 
coronary bed resistance through adenosine production, and the change of 
adenosine controls the vascular smooth muscle tone? 
c) Is adenosine only an intermediate metabolite? Does it affect vascular 
smooth muscle tone directly or only induce some changes of vascular tone 
which in turn finally cause an adjustment of coronary blood flow? 
3.5.1 C02 and 02 
In Ledingham and co-workers' [1970] study, hypercapnia consistently caused 
a decrease of MV02. It was considered as an effect separate from the vasodilator 
action on coronary vessels. Two reasons have been suggested for this: a) a reflexion 
of the general decrease in total body oxygen consumption and b) decreased myocardial 
contractility due to diminished pH which was caused by increased C02. However, 
during increased cardiac activity the phenomenon, of pC02 causing an increase in ·-
cardiac venous p02 at any value of MV02, was suggested to be due to Bohr shift 
because there was very little effect of C02 on CBF [Rooke, 1980]. 
3.5.2 C02 and Prostaglandins 
To determine whether the vasodilating effect of C02 is mediated by 
prostaglandins, Rooke and Sparks [1980] applied indomethacin in doses sufficient to 
block the coronary vasodilator effect of arachidonic acid injection [Harlan, 1978]. 
Indomethacin did not change the relationship between pC02 and coronary oxygen 
delivery. Prostaglandins did not appear to mediate either the coronary vasodilation 
associated with increased systemic pC02. 
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3.5.3 Adenosine and Oxygen 
Berne [1963; 1964] has ,shown that anoxia and severe hypoxia result in the 
appearance of inosine and hypoxanthine in the cardiac perfusate. It was suggested that 
adenosine acts as a transmitter signalling the oxygen tension at a critical site in the 
myocardial cell to adjust the vascular muscle tone. When employing an inhibitor of 
adenosine deaminase, 8-azaguanine, adenosine was detected in the perfusate of 
isolated cat and guinea pig hearts in quantities proportional to the increase in coronary 
flow due to graded hypoxia [Berne, 1964; Katori, 1966]. Stronger evidence was 
provided by Schrader et al [1977] that both perfusate adenosine and 14C-adenosine 
are quantitatively increased subject to different degrees of hypoxia. However 
coronary vasodilation induced by hypoxia was not altered by intravenous 
aminophylline injection. In these experiments the coronary artery was not maximally 
dilated, tested by exogenous adenosine infusion during hypoxia. The result does not 
support the hypothesis that adenosine is responsible for vasodilation during hypoxia 
[Afonso, 1972]. To study the interaction between the effects of oxygen and adenosine 
on helical coronary arterial strips contractile tension induced by acetylcholine, Gellai 
[1973] observed that adenosine-induced relaxation is augmented in inverse'proportion 
to tissue bath p02, and in the absence of adenosine in the tissue bath the change of 
p02 has no effect on the contractile tension of the strip. This result led them to 
propose that p02 plays a direct role in regulating coronary vascular tone with the 
presence of adenosine which may have a constant level in vivo. 
3. 5. 4 Adenosine and C02 and pH 
Based on the findings that the intracoronary infusion of adenosine on dogs led 
to an increase in glucose uptake, to the appearance of myocardial. lipolysis and to a 
release of H+ ions and total C02 from the heart, Raberger [1970] proposed that 
adenqsine leads to a metabolic acidosis and via changes in the myocardial pC02 to 
coronary vasodilation. To test this hypothesis, the effects of an intracoronary 
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application of adenosine on CBF were investigated over a wide range of arterial pH 
and pC02 and at different degrees of extra- and intra-cellular buffer capacities 
[Raberger, 1971]. The results show a significant dependence of the coronary 
vasodilatory action of adenosine on the arterial pH when concomitant changes in 
extracellular buffer capacity and changes in arterial pC02 lead to a reciprocal change in 
intracellular pH and coronary vascular conductance. However this does not exclude 
the possibility that both adenosine and pH or C02 have a separate effect on vascular 
smooth muscle. 
3. S. S Adenosine and Prostaglandins 
Since Minkes et al [1973] observed that the adenosine nucleotides ATP and 
ADP are potent releasers of a prostaglandin-like material from the rabbit heart, 
prostaglandins, the adenine nucleotides and their derivatives may interact in the 
regulation of CBF [Alexander, 1975] as.far as the vasoactive effect of adenosine and 
prostaglandins is concerned. However, the use of indomethacin failed to alter the 
exogenous adenosine dose-response curte in heart-lung preparation [Alexander, 
1975]. 
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CHAPTER 4 
METHODS 
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4.1 MATERIALS AND INSTRUMENTS 
4 .1.1 Experimental Animals 
Sheep bred on the University of Tasmania's experimental farm with the 
following general characteristics were used: 
Species: 
Sex: 
Weight: 
Age: 
Polworth(ram)-Comeback (ewe) cross 
both 
23-35Kg 
6-9 months 
4 .1. 2 Experimental Instruments and Their Calibrations 
4 .1. 2 .1 Blood Pressure Measurements 
Statham P 23ID pressure transducers (Statham Laboratory Inc.) were used for 
blood pressure measurements with size 7 catheters. The system used to obtain 
measurements is shown in Figure 4.1: 
Blood Pressure 
Measurement 
Pressure transducer 
Blood Pressure 
Recording 
--- Catheter 
artery, vein, 
or 
cardiac cavity 
Fig. 4 .1 : Diagrammatic representation for blood pressure measurements 
The pressure sensing element in the transducers is a semi-conductor strain-
gauge, which linearly converts pressure to voltage over a restricted range. A check 
that all the transducers used had a linear pressure-voltage relationship in the pressure 
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· range 0 - 180mmHg is included in Appendix A. Only those transducers showing a 
linear calibration (~0.99) in the pressure range 0-180mmHg were used in this work. 
7F catheters with side holes were used. The level of transducer was kept to the 
tip of the catheter as close to the centre of the right atrium as possible. However, in 
practice, it is not possible to get an absolute zero value. As far as my research is 
concerned, the difference of data is more important than the absolute value among 
pressure, flow and oxygen saturation. Thus, a small shift of zero baseline will not 
affect the analysis of the data as long as the instrument is correctly calibrated. It is 
essential when using these transducers to keep the cardiac catheter free of thromboses. 
High doses of heparin (initial dose 500µ/Kg, I.A., then about 250 µ/Kg, I.A. every 
1-2 hours) were used to ensure there was no clotting during experiments. 
4.1.2.2 Blood Flow Measurements 
Various sizes of NARCO electromagnetic flowmeters were used for coronary 
blood flow and pulmonary artery flow measurements. The system is illustrated in 
Figure 4.2: 
Blood Flow 
Meas rement 
Blood Flow 
Recording 
~--flowmeter probe 
cannulation 
--- flowmeter probe 
....__ _ electromagnetic flowmeter 
Fig. 4. 2: Diagram for blood flow measurements 
The principle for electromagnetic flowmeters is based on the Faraday effect 
[Woodcock, 1975]: when a magnetic field is applied at right angles to the direction of 
motion of a conducting field, a potential difference is set up at right angles to both the 
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flow direction and the magnetic field. To reduce experimental artifacts such as that 
due to polarization of the sensing electrodes, and to improve the signal-noise ratio, the 
NARCO flowmeters use an alternating magnetic field. The flowmeters used have 
linear calibration curves passing through zero and equal sensitivities with forward and 
backward flow. 
I relied on the calibration supplied by the manufacturer with each probe. The 
internal calibration system of the flowmeter was used to calibrate the data acquisition 
system. Before each experiment, the flowmeter probes were cleaned thoroughly and 
soaked in saline for at least 20 mins. The flowmeter was calibrated according to the 
manufacturer's instructions and the offset carefully minimized according to calibration 
factors supplied for each probe before cannulating the probes on vessels. After 
cannulation, the vessel was repeatedly occluded to determine the zero flow. The 
surroundings of the flowmeter probe are kept as dry as possible to avoid pick up of 
spurious signals by the system. After finishing an experiment, the calibration was 
carefully performed again to assure the validity of the previous calibration. 
4.1.2.3 Metabolic States Measurements 
A fibre optic .technique is used to continuously measure coronary sinus 02 
saturation (S02). An OXIMETRIX Oximetry System (Abbott Laboratories, 
U.S.A.) was loaned by the Intens~ve Care Unit of Royal Hobart Hospital. The 
system contains three components: a fibre-optic catheter, optical module and 
computer. The optical module receives reflected ligh~ signals, converts them to 
electrical signals and amplifies them for transmission to the computer which computes 
S02 values. 
An ABL3 Acid-Base Laboratory was used for pH and blood gas analysis. 
Blood samples were drawn into iced heparinized plastic syringes. Blood was kept in 
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ice immediately after withdrawing. Measurements were earned out on the ABL3 
previously calibrated with known gas mixtures. 
4. 1. 2. 4 Data Recording · 
Analog signals fronf the pressure transducers, flow meters and oxygen 
analyzer were amplified with an 8-channel polygraph (Grass Co.) and plotted on 
conventional chart paper during experiments. 
In the early experiments, a 7-channel analog tape recorder (Racal Recorders 
Ltd, Store 7 DS) was used to record all the data, which was later digitized for 
computer analysis. The relationship of input to output in the tape recorder was 
carefully checked for all 7 channels to ensure that it was linear to within the resolution 
of the analogue-to-digital converter (about 1 part in 500) (See appendix B). 
In later experiments, signals from the polygraph amplifier were directly 
digitized during experiments with an analogue-to-digital interface (NB-DMA-8, NI-
488 for Macintosh- series number 3643 and Lab View software: National Instruments) 
in a Macintosh II computer (Apple Corporation). 
4 .1. 2. 5 Computer Analysis 
Data from the analogue tape recorder were digitized with an 8-channel 10-bit 
analogue-to.:digital converter (Central Science Laboratories, University of Tasmania) 
and transferred to a PD_Pll computer (Digital Equipment Corporation) running the 
Unix Operating System via a DMA board. Calibration factors were derived from 
digitized data obtained while calibrating the transducers. These factors were applied to 
the raw digitized data before further processing. 
In later experiments, data digitized directly on the Macintosh II using the 
LabView software were transferred to a SUN workstation where they were 
decoded, calibrations were applied and then processed. 
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The polygraph amplifiers are configured as low frequency pass amplifiers with 
an adjustable high frequency cut-off point usually set at 30Hz. When digitizing, data 
were sampled at lOms intervals, providing approximately 3x over-sampling. 
A variety of programs were written on the PDPll and Sun Unix systems to 
process the data, fit parameters and display results as follow: 
decal 
mndst 
decodes the binary data collected by the Lab View system and 
calibrates it on the Sun Unix systems. 
Uses left ventricle pressure to separate each beat into systolic and 
diastolic phases, the mean diastolic and systolic data (including 
flow, pressure, coronary resistance and cardiac work) is then 
calculated on a beat by beat basis. 
xu4 finds the offset point of stimulus of aortic constriction, where 
proximal aortic pressure has come back to control value, for 
further decay calibration. 
expfit 
congrad 
finds the highest value of mean coronary blood flow or lowest 
value of coronary resistance due to hypoxia for further analysisl. 
uses Powell's conjugate gradient minimisation technique [Press, 
1988] to determine the best values of a, b, k to fit a curve "y = b 
I 
+a e-ki". , 
4 .1. 2. 6 Statistical Analyses 
Some statistical calculations were carried out on the Macintosh: 
Excel was used to store blood gas analysis data and half lives 
and calculate the mean, standard deviation (SD), 
standard error of mean (SEM), and slope in linear 
regression and other calculations. 
<'J 
lexpfit was originally used for quickly determining approximate decay times by linearizing data, but the 
congrad programme provided better results with noisy data. 
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StatView 
Criket Graph 
was used to do two-tailed pair student's t tests and 
calculate the mean and SEM. 
was used to graph the data for presentation and compare 
two groups of data by using linear regression. 
4.1.3 Drugs and Chemicals 
T bi 41 D d h . al fi th' . a e . rugs an c ermc s or 1s mvesttgation . . 
Name Supplier Use 
Pentobarbitone Sanofi induction and continuous anaesthesia 
Sodium Bicarbonate R.H.H. Pharmacy intravenous infusion when needed to correct 
metabolic acidosis due to anaesthesia 
1) slow drip into jugular vein to compensate 
Physiological Saline R.H.H. Pharmacy the loss of body liquid during experiments 
2) flushing all the lines to prevent coagulation 
of blood in catheters 
3) some drug or chemical solutions 
4) soak flowmeter nrobes for calibration 
systemically for sheep to avoid blood 
Heparin R.H.H. Pharmacy coairulation 
Ethanol and Sodium Sigma dissolving 8-phenyltheophylline 
Hvdroxide 
Phentolamine R.H.H. Pharmacy blocking adrenergic a.-receotor (lmg/Kg, I.V.) 
Prooranolol Sigma blocking B-receptor (2m!!IK!!, I.V.) 
8-phenyltheophyline Sigma adenosine competitive antagonist (7.5mg/Kg, 
I.V.) 
adenosine Sigma; check the blocking effect of 
8-ohenvltheoohvlline 
nonadrenaline Si!!ma; check the blockinl! effect of ohentolamine 
adrenalin Si!!ma; check the blockinl! effect of a.. B blockers 
isoprenaline Sigma; check the blocking effect of oropranolol 
4. 2 ·EXPERIMENTAL METHODS 
4. 2 .1 Animal Preparation and Experimental Setup 
Sheep were studied in an acute, open-chest preparation. They were 
anaesthetized with pentobarbitone (35mg/kg I.V. bolus). Anaesthesia was maintained 
with continuous intravenous pentobarbitone injection (4mg/k:g/hour) through a jugular 
vein catheter. The animals were artificially ventilated (3.5L/min) by a positive 
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pressure respirator via a cuffed tracheal tube and a non-rebreathing system. Inspired 
air was supplemented with oxygen so that arterial oxygen tension remained between 
100 and 150mmHg. Tidal volume and respiratory rate were constant during each 
experiment. Carbon dioxide tension was kept at 30±5mmHg. Arterial pH was 
maintained at 7.45±0.05 by a supplement of sodium bicarbonate through intravenous 
infusion when needed, although the efficiency of this manoeuvre was not determined. 
The heart was exposed through a left lateral thoracotomy by removing the 
fourth left rib. The pericardium was incised and the heart was suspended in a 
pericardia! cradle. The pulmonary artery and coronary circumflex artery were 
carefully separated for electromagnetic flowmeter probe cannulation. The proximal 
aorta was dissected for aortic band cannulation which will be fully described in the 
next section). Sheep were instrumented as indicated in Table 4.2. 
T bi 4 2 E d h. ( £ d 'l) a e . xpenmenta mstruments an t err purpose see text or etru . . 
PRESSURE INTRUMENTS 
Aorta #7 fluid filled catheter 
Left Ventricle #7 fluid filled catheter 
Coronarv Sinus #7 fluid filled catheter 
Carotid Arterv Arterial introducer (for aortic catheter) 
Venous anv catheter as deliverv lines 
-
FLOW 
Pulmonary 16 NARCO RT 500 
Coronary circumflex 2 - 3.5mm NARCO RT 500 
OXIMETER 
Coronarv Sinus #7 fluid filled fibre optic catheter 
CARDIAC 02 USAGE 
Proximal Aorta Same catheter as for PRESSURE 
Coronarv Sinus Same catheter as for S02 
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Proximal aortic pressure was measured with a Statham P 23ID transducer via a 
7F catheter side hole through an introducer in the left carotid artery. Left ventricular 
pressure was measured with a pressure transducer via a 7F catheter through the left 
ventricular wall. The hemiazygous vein was isolated (the anatomy of sheep is 
included at appendix C). A 1F catheter (or a fibre-optic catheter) was inserted into the 
coronary sinus through the hemiazygous vein which was then occluded beyond the 
insertion site, so that coronary sinus pressure could be recorded by using a pressure 
transducer and coronary sinus blood could be taken at the same time as the proximal 
aortic sample for hemoglobin and blood gas analysis. 16mm and 2-3.5mm 
electromagnetic flowmeter probes were placed separately on the pulmonary artery and 
the coronary circumflex artery. Coronary sinus 02 saturation was also continuously 
detected by a fibre optic catheter. The instrumented sheep heart is shown in Figure 
4.3. All animals were anticoagulated with heparin sodium and kept warm by using an 
electrical heater during experiments. After completion of the studies, the sheep were 
killed with a lethal dose of sodium pentobartital. The position of the coronary sinus 
cannula tip was determined by postmortem and ranged from 3-4cm from the coronary 
sinus ostium. 
4.2.2 Stimulus 
Pressure rise and hypoxia were the interventions chosen for this study. 
Aortic band cannulation 
A length of fibreglass measuring tape and a plastic tube were used to make an 
aortic band which was cannulated on the proximal aorta as shown in Figure 4.4. This 
measurable band enabled the aortic cross-sectional area to be decreased by a 
measurable amount for each experimental run. 
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Fig 4.3: Diagrammatic representation of the instrumented sheep heart 
(1. Right Ventricle; 2. Left Ventricle; 3. Left Atrium; 4. Apex; 5 Aorta; 6. Pulmonary Artery; 7. 
Longitudinal Groove; 8. Left Anterior Descendants; 9. Great Vein; 10. Circumflex Artery; 
11.Intermediate Groove; 12. Hemiazygos Vein; 13. Descending Aorta; 14. Left Carotid Artery; 15. 
Catheter; 16. Aortic Band; 17. Plastic Tube; 18. Catheter; 19. Occluder to block the venous blood 
from the the lung; 20. Coronary Sinus; 21. Pulmonary Flowmeter Probe; 22. Circumflex 
Flowmeter Probe; 23. Cathether in L V). 
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Low oxygen percentage mixed gas 
Three types of mixed gas were used to systemically decrease oxygen supply: 
Type I: 
Type II: 
Type III: 
pure nitrogen 
5% of oxygen + 95% of nitrogen 
5% of oxygen + 5% of carbon dioxide + 90% of nitrogen 
I 
I 
I 
I 
I 
A 
,. ... 
Aortic band 
Plastic tube 
Aortic band 
Proximal aorta 
Fig. 4. 4: Diagrammatic representation of the aortic band. (see text for explanation) 
4.2.3 Outline of Research Protocol 
After a sheep was set up as described in 4.2.1 and control data ~ere obtained, 
the interventions were applied. Hemodynamic variables were continuously monitored 
before each intervention to ensure that steady-state resting conditions had been 
achieved. When the animals had achieved steady-state hemodynamic conditions, both 
aortic and coronary sinus (CS) blood samples (l .Oml each) were taken anaerobically _ 
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for measurement of hemoglobin, pH, pC02, pOz, S02, and Na+ and K+. Samples 
were also withdrawn at intervals through experiments for blood gas and electrolytic 
balance measurements. Blood flow, pressure and CSS02 were measured 
continuously through the control period, the period of intervention and the recovery 
period as shown in Figure 4.5. At least 20 heart beats of control data were collected 
and the whole period of recovery from offset to steady-state was taken. 
on off 
t during t 
.. 
~--"!"!"""-- (intervention) •----------before after 
• • (control) (recovery) 
data collection 
~--------------------~ 
Fig. 4. 5 : Diagram for illustration of the period of data collection 
Data were recorded both on chart paper by the polygraph for quick checking 
during experiments and by analog tape recorder for further analysis on computer. 
Some experiments were digitized on a Mac II by Lab View system in the operating 
theatre. There were at least three runs for the same intervention. For instance, I 
recorded at least three runs increasing proximal aortic pressure by 20% lasting 2mins. 
Runs at different pressure increases and different dura,tions were performed in a 
random order. 
Using. paper chart-recording data as reference, data were digitized1 frqm the 
analog tape recorder using the data acquisition programme decal and stored on the 
computer. Using the computer, continuous coronary resistance, cardiac work and the 
half life of decay of response due to ifltervention were calculated 
1The data were digitized at lOms sampling intervals in all cases. 
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The same protocol was carried out for each sheep before and after adenosine, 
a and f3 receptor inhibitions. Each group of experiments used at least 6 sheep. 
4.3 DATA ANALYSIS 
4. 3 .1 Data Rejected (Experimental Criteria) 
a) During the experiment, a 2-3second coronary artery occlusion was 
performed to ensure that the coronary circumflex flowmeter baseline had remained 
stable. Data were rejected if zero flow measurement was shifted more than 5% of the 
normal flow value. Otherwise, if the flowmeter showed a constant zero-flow offset, it 
would be extracted during analysis. 
b) Noisy data were rejected. 
c) Data were rejected if During steady-state conditions the pH lay outside the 
range 7.35 - 7.45 to ensure all the experimental runs started from a common baseline, 
except the experiments discu~sed in chapter 6. 
d) If the aortic pressure in the resting period changed more than 20% except 
when using a and f3 blockers, data were rejected. 
e) If any of the hemodynamic variables failed to achieved a new steady-state 
baseline, data were discarded. 
4. 3. 2 Calculation of Derived Parameters 
4.3.2.1 Calculation of Coronary Resistance, Cardiac Work and MV02 
After experimental data had been collected, digitized, calibrated and stored in 
the computer, coronary resistance (er) and cardiac work (cw) for each sample were 
calculated using equations 4.1 and 4.2. 
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where: 
where: 
CR= 
p LVP+ CSP 
aop- 2 
CQ 
CR - coronary resistance; 
Paop - proximal aortic pressure; 
L VP - left ventricu.lar pressure; 
CSP - coronary sinus pressure; and 
CQ - coronary flow. 
w P - the rate of potential work; 
P - pressure of proximal aorta; and 
(4.1) 
(4.2) 
F - flow rate of cardiac output (mean pulmonary artery 
flow). 
Myocardial oxygen consumption (MV0 2) was calculated by equation 4.3 
using the data both from computer and blood gases measurements. 
where: 
CBF - coronary blood flow; 
A-artery; 
V -venous; 
(4.3) 
(A-V) 02 content - arteriovenous oxygen content 
difference. 
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4. 3. 2. 2 Calculation of Half Life 
A representation of a typical experimental trace is shown in Figure 4.6. 
off 
before 
I 
during t after (intervention) 
(control) (recovery) I 
coronary resistance 
·- - - - -
.... 
A G H 
c D 
Fig. 4. 6 : Diagram for illustration of half life calculation 
where A-Bis the control baseline, Bis the intervention starting point, C is the point 
·where er stabilizes after intervention, C-D is the stable period of er during 
intervention, E is the point intervention ceases , E-F is the period of recovery of the 
er, G is the point er returns to a stable value, G-H is a stable er. If we can assume 
first-order decay kinetics, then we expect that the curve E-F -G-H will have the 
equation: 
R(t) = Rb + Ro e-kt (4.4) 
where R(t) is the effect of the response at time t after point E, Ro is a constant which 
represents the response caused by the intervention in the period C-D, Rb is the 
baseline response (represented by the section G-H), k (s-1) is the rate constant for the 
decay of the response. 
The half-life of the response, 1:!, is defined as the time for the response to decay 
2 
to half its original value (relative to the baseline value Rb), ie at l!. 
2 
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Values of k were found by fittingl Equation 4.4 to the curve marked E-F-G-H2. 
Then half life: 
(4.5) 
4.3.3 Analysis Protocol 
After er and cw were calculated and exponential decay curves fitted to the 
decay portions of the data to derive b. values, the following analyses were performed: 
2 
a) Calculated b. values were compared with different degrees and durations of 
2 
aortic constrictions. The degree of aortic stenosis was measured by the 
change of proximal systolic pressure (refer to chapter 5). 
b) Correlations between er and metabolic parameters during systemic hypoxia 
were studied (refer to chapter 6). 
c) The mean diastolic coronary flow and coronary resistance were separately 
compared with the coronary sinus oxygen saturation in either increased 
cardiac work or decreased systemic oxygen supply (refer to chapter 7). 
d) 
e) 
4.3.4 
The b. of the vasodilating effect of intracoronary adenosine infusion was 
2 
determined at several dose levels with different sheep (refer to chapter 8). 
The procedure described above was repeated after using adenosine, a and 
/3 blockers (refer to chapters 6, 7, 8, 9). 
Statistical Analysis 
The instrument and computer calibrations have been fully explained in section 
4.1.2. 
1 Due to the noisy experimental data, I used Powell's conjugate gradient minimisation technique to fit all 
three parameters Rb, Ra, k simultaneously. A least-squares criterion-minimum CE <Xiobservcd - Xi calculated )2) 
was used to select values Rb, Ra and k for best fit. 
2Examples of the data fitting technique are found in a later section - actual protocols for different aims 
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Mean, standard deviations and standard errors were applied for data analysis. 
The standard errors of mean(SEM) presente& in the figures and tables represent the 
variability between animals [degree of freedom (d.f.) = n -1, for n animals]. 
In some experiments, it was necessary to determine whether two slopes were 
significantly different. The two slopes (S1, S2) from separate linear regression fits 
were compared for parallelism [Kleinbaum, 1988]; three alternative hypotheses can be 
found: 
S1 -::1: S2 
The test statistic for evaluating parallelism is then given by: 
where: 
,,.... 
T= 81 -S2 
SD (S1-S2) (4.6) 
S 1 =least-squares estimate of the slope S1 using the ni observations 
S 2 = least-squares estimate of the slope S2 using the nz observations 
S D (S1-S2) = estimate of the standard deviation of the estimated 
difference between slopes ((Sl-S2)) 
where S D (Si-Sz) is equal to the square root of the following variance: 
SD~ " -S2 j 1 +--1--] 
Sl-SZ- P,Y,1 (nl-l)S~l (n2-l)S~2 (4.7) 
where 
2 2 
2 (nl-2)Sytx1 +(n2-2)Sy;x2 
S P,Y/X nl + n2 - 4 (4.8) 
where 
2 
S Y/Xl =residual mean-square error for the groupl data 
2 
S Y/X2 =residual mean-square error for the group2 data 
2 
S x1 = variance of the X's for the group 1 data 
2 
S x2 = variance of the X's for the group2 data 
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The test statistic given by 4.6 will be distributed as a Student's t with ni+ nz-4 
degrees of freedom when the hypotheses is true. The following critical regions are for 
different hypotheses and significance level a: 
T :2: t nl+n2-4, 1-a. 
T ~ t nl+n2-4, 1-a. 
IT I :2: t nl+n2-4, t-a./2 
4 .4 ACTUAL PROTOCOLS 
4. 4 .1 Actual Protocol for Chapter Five 
4.4.1.1 Aims 
for S1 > S2 
for S1 < S2 
for S1 '# S2 
The aim of these experiments was to investigate whether common mechanisms 
exist in coronary vasoregulation due to exercise. ~e time course, of decay (t.) of both 
coronary resistance and diastolic coronary blood flow was determined in response to -
the different degrees and durations of left ventricular afterload before and after a, f3 
and adenosine receptor inhibitions. 
4.4.1.2 Method 
The sheep experimental setup was fully described in section 4.2. 13 (out of 
. 17) successful animal experiments were used as a control group in which no inhibitors 
were added. Similar measurements were obtained from 7 (out of 10) sheep before and 
after adenosine, a and f3 receptor inhibitions. Other animals died unexpectedly or had 
various problems with instruments during experiments. The experiments are 
summarized in Table 4.3. 
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Table 4.3: Number of sheep for chapter 5 experimental work 
inhibition (group2) 
control 
(groupl) 
adenosine adenosine+a.-, 
control ~-adrenergic 
inhibition inhibitions 
No. of sheep 17 10 10 10 
successful 13 7 7 5 experiments 
Group 1 
This is a pure control group. After the sheep had been set up and all recording 
instruments connected, it was allowed to rest for 30 minutes. Hemodynamic variables 
were continuously monitored and arterial blood-gas analysis was performed during 
this period to ensure that steady-state resting ~onditions had been achieved. After 
obtaining resting hemodynami~ measurements, proximal aortic systolic pressure was 
increased by approximately 15%, 30% and 45% for the different durations: 30-, 60-, 
90- and 120-seconds. The interventions were applied in random order and each 
intervention was repeated at least 3 times for every sheep. An interval of at least 
lOminutes was allowed between runs, so that after each run, the sheep were given 
sufficient time to rest until the hemodynamic variables recovered to stable valuesl. 
Group2 
This group consisted of 7 successful experiments for both control and 
adenosine inhibition, 5 successful experiments for fully blocked study including both 
adenosine, a.- and J3-receptor inhibitions. Sheep were instrumented with 
1 It is almost impossible for all the hemodynamic variables to recover completely to the original steady-
state resting conditions in my preparation, thus, new steady-state resting conditions were required. 
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intracoronary cannulationl for intracoronary adenosine injection in additions to the 
basic setup described in section 4.2. When the animals had achieved steady-state 
hemodynamic and arterial base-acid balance conditions, a similar protocol to that used 
for groupl, but the intervention times were all 120seconds. Thereafter, the 
dose-response curve of intracoronary bolus administration of adenosine2 was 
determined before and after intravenous administration of 8-phenyltheophylline 
(8-PT: 7.5mg/kg)3 to ensure the proper blocking effect had been achieved. 8-PT 
was injected slowly due to the high concentration of ethanol and sodium hydroxide in 
the solution. Generally 45minutes4 were required for 8-PT to produce more than 
80% blocking effect in sheep. Immediately thereafter, the aortic pressure increase 
protocol was repeated in random order. Finally, adenosine dose-response curves 
were observed. Following the intravenous injections ofphentolamine (lmg/kg)5 and 
propranolol (2mg/kg)6 as a.- and f3-adrenergic receptor blockers, the aortic pressure 
increase protocol was repeated again. Due to the vasoregulatory effect of both a.- and 
f3-blockers, the hemodynamic variables showed a new baseline which demonstrated 
low heart rate, low pressure and low cardiac contractility. However, as long as .a 
steady-state had been achieved, the above protocol was repeated. 
lThis will be fully described in section 4.4.4. 
2Refer to later section 4.4.4. 
38-PT was dissolved in the solution (3 part absolute ethanol + 1 part lM NaOH by volume) to make a 
concentration of 50mg/rnl for intravenous administration. 
4Maximal blocking effect of 8-PT was invariably observed within 45mins. 
5 The original commercial saturation (lOmg/rnl) was used. 
6 Diluted with isotonic saline to a concentration of 5mg/ml for intravenous administration. 
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4. 4 .1. 3 Data Analysis 
Following tJie experimental criteria set in section 4.3.1 and after ensuring there 
were no distortions of computerised data, data were selected for further analysis. 
Three degrees of proximal aortic constriction were carried out for the varying 
durations. Figure 4.7 demonstrated the proximal aortic pressure changes caused by 
the different degrees of constriction. Equations 4.1 and 4.2 were used to estimate er 
and cw (the only contributor to the change of cw was the change of proximal aortic 
systolic pressure because the cardiac output, mean pulmonary artery blood flow, was 
not changed). Figure 4.8(Aa,b,c) show the measured and computed hemodynamic 
variables in response to the aortic constriction stimulus. The calculated mean diastolic 
and systolic data1 were plotted against tiple beat by beat on Figure 4.8(B) from the data 
of Figure 4.8(A). The onset and offset of CBF and er due to the inteiventions can be 
seen. The following abbreviations are used: 
cqd mean diastolic coronary blood flow 
cqm mean coronary blood flow 
er mean diastolic coronary resistance 
s.aop systolic proximal aortic pressure 
cw mean calculated cardiac work 
LVDP left ventricular end diastolic pressure 
d.aop diastolic proximal aortic pressure 
pqm pulmonary artery mean flow 
In this case, the aortic constriction induced a 43% increase in aortic pressure and lasted 
120 seconds. Data were collected for 210 seconds, which included the data before 
inteivention, during, and after inteivention2. Figure 4.8 also demonstrates there are 
no obvious changes in cardiac output (pqm), L VDP and d.aop during inteivention. 
lUsing programme mndst (sec section 4.1.2.5). 
2same symbols were used as Figu~e 4.6. 
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Fig. 4.7: The changes of proxima1 aonic pressure due to a gradual aortic constriction 
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Fig. 4.8(Aa): Hemodynamic variables before, during and ~after aortic constriction. (cq - coronary blood flow; cqm - mean coronary blood flow; er - calculated coronary 
resistance). continued on next page. 
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Fig. 4.8(Ab): Hemodynamic variables before, during and af1er aortic constriction. (cw - calculated cardiac work; LVP - left ventricular pressure; aop - proximal aortic 
pressure). continued on next page. 
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Fig. 4.8(Ac): Hemodynamic variables before, during and afler aortic constriction. (pq - pulmonary artery flow; esp - coronary sinus pressure; pqm - mean pulmonary 
artery blood now). 
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Fig. 4.8(B): Mean diastolic and systolic hemodynamic continuous changes before, during and 
after aortic constrictions. (see text for details) 
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In Figure 4.8(B), cqm and cqd increases and er decreases following the 
cardiac work increases induced by proximal aortic constriction. This figure shows the 
response immediately after intervention, then CBF and er stabilizing until the 
intervention is withdrawn. Immediately thereafter, CBF and er return toward the 
baseline before, intervention. This is called the off set response or decay in response to 
the withdrawal of the intervention. Due to the many factors which might affect the 
onset data, only offset responses were analysed. The programme xu41 was used to 
select the offset response starting point E in Figure 4.8(B). E-F-G-H represents the 
decay of the response after the withdrawal of intervention. This section of the 
response was fitted to an exponential decayz and half lives were obtained. Figure 4.9, 
4.10 and 4.11 represent the curve fitting for the control, adenosine blocking, and 
adenosine, a, ~ receptor blocking data. 
Linear regressions were calculated for the calculated decays against the degree 
and duration of aortic constrictions. The relationships between the li and the 
2 
percentage change of cqm, cqd and er were also determined. Peak change of the 
cqm, cqd and er was read directly by computer programme and was expressed as a 
percentage of control. Statistical analysis is the same as described in section 4.3.4. 
' 4. 4. 2 Actual Protocol for Chapter Six 
4.4.2.1 Aims 
The aim of this group of experiments was to study the relationship between 
coronary resistance and metabolic parameters in response to the different degrees of 
systemic hypoxia before and after a, ~ and adenosine receptor inhibitions. 
1 Refer to section 4.1. 
2Using programme congrad and equations4.4 and 4.5 (refer to section 4.1.2.5 and 4.3.2.2 
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Fig.4.9: 
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eqm (original) 
eqm (fitted) 
...................... ~...---....r..~ ....:-:':":: ...~ ... :7.": ••••
30 40 50 
time (sec) 
er (original) 
er (fitted) 
eqd (original) 
eqd (fitted) 
60 70 
Exponential curve fitting of decay in cqm,cr and d.cq in control data of group 2. cqm 
- mean coronary blood flow; er - diastolic mean calculated coronary resistance; cqd -
diastolic mean coronary blood flow. h(cqm) = 5.12; ti(cr) = 5.33;, ti(cqd) = 5.06 
2 2 2 
(data from experiment 90.10.8, increase of proximal aortic pressure is 28%; ~ncrease 
of calculated cardiac work is 30%; duration of intervention is 120 sees. 128 data 
points) 
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Fig.4.10: 
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Exponential curve fitting for cqm, er and cqd after adenosine blockade. cqm, mean 
coronary blood flow; er, diastolic mean calculated coronary resistance; cqd, diastolic 
mean coronary blood flow. t!.(cqm) = 4.93; h(cr) = 3~85; h(cqd) = 4.03. (Data 
2 2 2 
from experiment 90.9.25, increase of proximal aortic pressure is 46%; increase of 
calculated cardiac work is 44%; duration of intervention is 120 seconds. 137 data 
points) 
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Exponential curve fitting after adenosine, a and ~ receptors blockage. cqm - mean 
coronary blood flow; er - diastolic mean calculated coronary resistance; cqd -
diastolic mean coronary blood flow. For these data, l!.(cqm) = 5.96; l!.(cr) = 5.49; l!. 
2 2 2 
(cqd) = 3.68. (data from experiment 90.11.12, increase of proximal aortic pressure is 
50%; increase of calculated cardiac work is 37%; duration of intervention is 120 
sees. 97 data points) 
89 
4.4.2.2 Methods 
Table 4.4 shows number of sheep for different parts of the experiment. 
Table 4.4: Number of sheep used in experimental work described in this chapter 
I 
inhibition (group2) 
control 
(groupl) 
adenosine adenosine+a-, 
control ~-adrenergic 
inhibition inhibitions 
No. of sheep 10 8 8 8 
successful 
experiments 8 6 6 ·5 
Group 1 
This was a control group in which no blockers were used. It consisted of 10 
sheep. 8 animals were successful and two died. A similar protocol to that used for 
chapter 5 was performed except hypoxia was the intervention. Each gas mixture was 
used for ventilation for different durations causing different degrees of systemic 
hypoxia. Experimental runs were randomized and each set required at least 3 runs per 
sheep. An interval of at least 20 minutes was allowed for animal to recover completely 
between runs, which means all the hemodynamic variables and blood gas analysis had 
reached· a stable value. 
Group2 
There were 6 successful experiments in this group. Sheep were instrumented 
with intracoronary cannulation for intracoronary adenosine injection in addition to the 
basic setup as group 1 for determination of the 8-PT blocking effect. Similar 
procedures were carried out as described for group2 of chapter 5 except systemic 
hypoxia was a stimulus. 
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4. 4. 2. 3 Data Analysis 
Figure 4.12 shows the hemodynamic variables in response to hypoxia on the 
chart - recording. Figure 4.13(B) demonstrates the mean diastolic and systolic data1 
from digitized and calibrated data shown in Figure 4.13(A~,b~c) on a beat by 'beat 
basis. The onset and off set of CBF and er due to systemic hypoxia can be seen. In 
Figure 4.132, systemic hypoxia was caused by inspiring type I gases and lasted 
120seconds. This caused ~he proximal aortic pOz to reach 35.9mmHg and S02 
74.6%, 490seconds of data (992beats) were digitized. It included the data before 
intervention A-B, during intervention D-E (120secs) and after intervention E-E'-F-
G-H. MV02 was calculated by averaging cqm (A-B) and picking up highest value 
(I) by programme exp/it and using equation 4.3, then both baseline MV02 and 
hypoxia MV02 were obtained. 
Because there were concomitant changes including pressure, flow and 
metabolic parameters due to systemic hypoxia, it was prohibited to study the decay of 
the response after the withdrawal of intervention. The analysis has directed to study 
the relationships amongst the coronary resistance, metabolic parameters and MV02 
before and after adenosine, a, J3 receptor blockades. 
1Calculated by mndst. 
2same symbols and abbreviations were used as in Figures 4.6, 4.7 and 4.8. 
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Fig. 4.12: The changes of hemodynamic variables due to sysLemic hypoxia in chan-recording 
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Fig. 4.13(Aa): Hemodynamic variables before, during and after sysLemic hypoxia. (cq - coronary blood flow; cqm - mean coronary blood flow; er - calculated 
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4. 4. 3 Actual Protocol for Chapter Seven 
4.4.3.1 Aims 
The aim of this experiments was to study the relationship between the coronary 
sinus (CS) 02 content (S02) and both the increased cardiac work and systemic 
hypoxia and to determine which feedback control system, the 'open-loop' or 'close-
loop', operates in coronary circulation. In other words, I wanted to investigate 
whether metabolic vasodilation exists solely for supplying blood for the oxygen needs 
of the heart during increased cardiac work and systemic hypoxia. 
4.4.3.2 Methods 
The same experimental sheep and setup as in chapter 5 and chapter 6 were used 
for this investigation. An OXIMETRIX fibre optic catheter was inserted into CS for 
continuous measurement of CS S02. Blood samples were taken from both proximal 
aorta and CS simultaneously for p02 and other blood gases and acid-base balance 
assessment. In this group, seven sheep were used. 
4. 4. 3. 3 Data Analysis 
Data analysis followed the procedures described in sections 4.3.3 and 4.3.4. 
4. 4. 4 Actual Method for Chapter Eight 
4.4.4.1 Aims 
The aim of this final group experiments was to determine the dose-response 
curve of intracoronary infusion of adenosine and the decay (t:i) of CBF and er in 
2 
response to intracoronary exogenous adenosine infusion. 8-PT blocking effect of 
exogenous adenosine is also observed. 
97 
4.4.4.2 Methods 
Apart from the basic setup described previously, polyethylene tubingl (OD: 
0.6lmm; ID: 0.28mn; PE: 10) was inserted into the coronary circumflex artery as 
coronary cannulation before the flowmeter probe for intracoronary infusion (see 
Figure 4.14). 10 sheep were included in this experiment. The response of CBF to 
..... r:---- -- lml Syringe 
Polyethylene Tubing 
Clrcumnex Artery 
LAD 
Fig. 4.14: Diagrammatic representation of the intracoronary cannulation 
intracoronary bolus administration of adenosine in constant volume doses containing 
of 0, 2, 5, 10, 20, 50, 100 and 200µg were observed. In each case, the adenosine 
was dissolved in 0.25 ml of normal saline. Between each dose, the sheep were 
allowed to recover fully. 
Figure 4.15 illustrates the response of cqm, cqd, er, s.aop, L VDP and 
d.aop to exogenous adenosine (lOµg). The highest value (point I) was picked up by 
lsupplied by Dural Plastics and Engineering, Dural, N.S.W., 2158, Australia 
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the programme expfit, and the E' point also determined. Thereafter, the data pieces 
in the region E'-F-G-H were used by the programme congrad for exponential 
curve fitting. The values obtained are shown in Figure 4.16. 
After giving 8-PT adenosine dose-response curves were obtained to determine 
the blocking effect. Half lives of exogenous adenosine after blockade were also 
calculated by the same procedure. 
4. 4. 4. 3 Data Analysis 
The procedures already described in sections 4.3.3 and 4.3.4 were used. 
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4. 5 DISCUSSION OF TECHNIQUES 
4. 5 .1 Discussion of Experimental Methods 
4 . 5 .1.1 Sheep as the Experimental Animal 
As far as fundamental physiological mechanisms are concerned, if differences 
between human and higher mammals exist, they often seem to be of a more 
quantitative than qualitative nature. Therefore, it is reasonable to use the acute sheep 
model. The sheep, because of its coronary venous system anatomy, is a suitable 
model for this work. However, this work will need to be repeated in another animal 
model. 
4. 5 .1. 2 Intervention - stenosis 
The aortic band enables us to force the sheep heart to a high performance state 
by suddenly constricting the aorta. If the sheep was well prepared and all the 
parameters were stable, it was found that this method only increased systolic pressure 
(afterload on the heart), whereas the proximal aortic diastolic pressure remained the 
same, indicating that this intervention does not change the coronary driving pressure 
since the coronary artery flow is mainly determined by diastolic pressure, [Katz, 
1988]. In addition, this method enabled the aortic cross-sectional area to be changed 
in the desired range. Again, if the sheep's condition was good, it was possible to get 
a repeatable alteration of aortic pressure by constricting to the same aortic cross-
sectional area. 
Braunwald [1958] demonstrated that aortic constriction increased MV02, but 
reduced (A-V) 02. However,.Blumenthal and co-workers [1962] found that aortic 
stenosis distal to the coronary ostia lowered (A-V) 02 but stenosis proximal to the 
ostia raised myocardial oxygen extraction. This was further supported by Saito and 
his colleagues [1982], who showed that constriction of the descending thoracic aorta 
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increased MV02, but reduced myocardial oxygen extraction in open-chest dog hearts. 
This reduction in (A-V) 02 was abolished by atropine or vagotomy. In the current 
work, an aortic band was placed proximal to the coronary ostia, it suggested there 
was no parasympathetic coronary vasodilation involved as far as the (A-V)02 was 
concerned. This led to an experimental design without using any parasympathetic 
blocking interferences. 
The change of aortic pressure may affect the left ventricular pressure. Left 
ventricular diastolic pressure influences on the diastolic coronary pressure-flow 
relationship have been reported [Aversano, 1984]. In addition, aortic stenosis elicits a 
similar increase in left ventricular systolic pressure which will compresses 
intramyocarc:J,ial vessels and result in a retrograde pressure wave [Spaan, ,1985], 
increasing coronary resistance and decreasing mean CBF [Sabiston, 1957]. 
However, with the servo-controlled coronary arterial pressure system, systolic 
contraction did not significantly impede diastolic CBF at heart rates up to 
160beats/min by comparing flow during diastole with flow during a prolonged 
asystole [Katz, 1988]. This confirmed that diastolic CBF is not influenced by systole 
under normal circumstances. However, if the left ventricular diastolic pressure is not 
changed, which is the case in this work, diastolic intramyocardial vascular waterfall 
may be absent although conclusive proof for the presence or absence of 
intramyocardial waterfall phenomena is not yet available. Therefore, diastolic CBF 
was separated for data analysis to exclude the influence of ventricular systolic pressure 
on the mean CBF in this work. 
Gregg [1963] found the perfusion pressure for coronary arteries to be sirnjlar 
to aortic ones and that left CBF was predominant in diastole in dogs. A close linear 
relationship between pressure and flow was demonstrated by Bellamy [1978] during 
diastole. It is logical to believe that coronary perfusion pressure is similar to aortic 
diastolic pressure. Thus, it is important to exclude the effect of aortic constriction on 
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the diastolic aortic pressure. Therefore the criterion, aortic diastolic pressure does not 
change significantly in response to aortic constriction, was used for data selection. 
This matches most of my experiments, which may be because diastolic pressure was 
mainly determined by the peripheral circulation. The data in Figure 4.8 demonstrate 
that there was no significant effect of aortic constriction on diastolic aortic pressure. 
In addition, careful examinations of all hemodynamic variables and some 
indices of myocardial metabolism (table5.l) ensured that heart rate and diastolic left 
ventricular pressure did not contribute to the change of cardiac work. Since there was 
also no alteration of pulmonary artery flow, it is reasonable to use the increase of 
aortic pressure as an estimate of increased cardiac work. 
In summary, the proximal aortic constriction 1 did not cause the significant 
changes in diastolic proximal aortic pressure, diastolic left ventricular pressure, heart 
rate, cardiac output. However, the formula used to calculate the coronary resistance 
can also minimize those pressure effects. It is reasonable to use this stimulus to study 
the decay of the local coronary vasoregulation in response to the increased cardiac 
work. 
4. 5 .1. 3 Intervention - systemic hypoxia 
Three types of gas mixtures were used to produce systemic hypoxia artificially 
on the sheep. If the sheep condition was stable, repeatable systemic hypoxia could be 
induced by adjusting the gas supply. 
4. 5 .1. 4, The Selections of Adenosine, a- and ~-Receptor Blockades 
So far, many agents have been found to have blocking action on the adenosine 
induced vasodilation such as dipyridamole, aminophylline, theophylline and adenosine 
lThis stimulus was applied for no more than 3 minutes. 
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deaminasel. However, the competitive inhibition of adenosine by methylxanthine was 
incomplete, for instance, 10-6 M adenosine which is a concentration that p~oduced 
85% of maximal coronary dilation can only be inhi_bited by 20% by 5.5*1Q-5M 
theophylline [Bunger, 1975; Merrill, 1978]. 8-phenyltheophylline (8-PT) was found 
to be the most poterit available adenosine antagonist with relatively low activity of 
phosphodiesterase inhibition [Smellie, 1979]. Thus, 8-PT was chosen as adenosine 
inhibitor in this investigation. The effectiveness of adenosine blockade was showed 
by the comparison of the effect of adenosine vasodilation during intracoronary bolus 
adenosine injection before and after systemic administration of 8-PT. 
Phentolamine and propranolol are the classic a- and J3-blocking agents. Both 
phentolamine and propranolol are able to produce an almost instant effect on the 
vasoregulatory system. The effectiveness of a- and J3-receptor blockades was 
I 
demonstrated by the absence of tachycardia and vasodilation when injecting 
nor-adrenaline (lOµg, bolus), adrenaline (lOµg. bolus) and isoprenaline (lOµg, 
bolus) into the left ventricle. 
4 .5 .2 Discussion of Derived Parameters' Calculations 
4. 5. 2 .1 Calculation of Coronary Resistance 
Ohm's law for electricity defines resistance, R, as the the ratio of voltage drop, 
E, to current flow, I, so that E =I* R. Similarly, in fluid mechanics, the analogous 
hydraulic resistance or the resistance across a vascular bed, R, is usually calculated 
from the pressure drop across the bed divided by flow through it. Thus: 
Pi - Po = Pdriving = R * Q 
as illustrated in Figure 4.17 
1 Refer to chapter 3. 
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Fig. 4.17: Diagrammatic representation of resistance qtlculation 
Calculation of absolute coronary vascular resistance needs the effective 
downstream pressure representing the height of the "vascular waterfall" [Bellamy, 
1978; Permitt, 1963] when the downstream pressure is higher than the external 
pressure of the vessels. This is not a measurable quantity in our experimental setup. 
Due to multiple factors involved in determining coronary resistance apart from 
vascular tone, perfusion pressure and blood viscosity, more complex influences arise 
from the h~terogeneity of behaviour in different layers of the left-ventricular wall and 
the alteration of the regional blood distributions. As Hoffman [1990] pointed out, it is 
not possible to calculate accurate coronary resistance (er) when you_can not set up 
steady states for various parameters. 
Even so, this work still attempts to calculate er by using the formula proposed 
by Kilpatrick [1989] in our laboratory, as shown in equation 4.1. This formula is 
based on the assumption that there is a linear gradient of resistance across the 
myocardial wall and a linear distribution of coronary arterioles throughout the 
myocardial wall. As is well known [Berne, 1979], myocardial perfusion is mainly 
determined by perfusion pressure and er. IT we can calculate er which is still believed 
to be determined by metabolic factors, we may be able to exclude the perfusion 
pressure effect on coronary circulation. Thus resistance can be shown 
diagrammatically in Figure 4.18. If we assume the material across left ventricular wall 
is uniform, the left ventricular pressure (LVP) and coronary sinus pressure (esp) 
both tend to collapse the coronary vessels, and the effect of these two pressures on the 
coronary resistance should be linear across the ventricular wall. In the centre of the 
ventricular wall, this pressure is equal to the mean of L VP and esp. During systole, 
L VP is much greater than esp and esp will have no effect on coronary resistance 
vessels due to the waterfall effect. Also during systole, distribution of coronary flow 
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across left ventricular wall is very uneven [Downey, 197 4]. During diastole, 
however, the distribution of CBF has been shown to be usually very uniform across 
left ventricular 
cavity 
Fig. 4.18: 
coronary 
__ ...._ resistance 
vessels 
Coronary resistance of the whole system 
the ventricular wall in the normal beating heart in anaesthetized dogs [Becker, 1973; 
Buckberg, 1975; Downey, 1974; Hoffman, 1990]. Therefore, although the 
assumption that there is a linear distribution of coronary arterioles across myocardial 
wall is not strictly anatomically accurate, for diastolic coronary flow the errors may be 
assumed negligible. Thus formula 4.1 is reasonable for the estimation of er during 
diastole. er for this work was calculated by using formula 4.1 in programme mndst 
on each digitizing sample. The diastolic er were averaged, beat by beat, to minimize 
the effects of systolic compression on the calculated coronary resistance [Denison, 
1956]. 
4. 5. 2. 2 Calculation of Cardiac Work 
The energy needed for cardiac work performance mainly comes from aerobic 
chemical metabolism, ie substrata are combined with oxygen to form water, carbon 
dioxide and energy [Elzinga, 1983; Berne, 1981]. The whole cardiac energy 
requirement can be divided into two parts, internal work and external work. The 
former may be defined as the work for metabolic processes which produces heat 
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inside the heart and is difficult to calculate because both the substrata used by the ·heart 
to liberate energy, and the precise value of energy equivalent of the substrata burnt by 
the heart, remain unknown. In contrast, external work can be calculated without any 
significant assumptions about energy equivalent and substrata. This work is the 
energy needed for ejecting blood into the aorta from the left ventricle and we can 
directly measure the amount of blood ejected by the left ventricle and the pressure at 
which this ejection occurs. There are two components for the external work 
performed by left ventricle: kinetic work to accele:r;ate the blood a certain velocity 
and potential work to restore the energy. In the normal beating heart, during 
diastole most of the energy is potential - storing energy for the ventricle ejection and 
during systole most of the energy is transformed from potential to kinetic. The kinetic 
work can be calculated from the equation [McDonald, 1974]: 
1 F3 
wk = -p-
2 A2 
where wk is kinetic power, p, the density of blood, F, volume flow and A, the 
internal cross-sectional area of the aorta. The potentfal work can be calculated by 
equation 4.2 [Milnor, 1966]. 
Thus, if the cardiac output is constant during the intervention which we apply 
to the heart, it is reasonable to only use potential power (equation 4.2) to estimate the 
work done by the heart. This is the case in this investigation. An aortic band was 
used to increase cardiac work, which is pressure work. Even though the aortic band 
decreases the cross-sectional area of the aorta, the change is small. As I consider the 
' 
amount of kinetic power out of the total cardiac work is negligible, equation 4.2 is 
reasonable for measuring cardiac work. Because the cardiac output is constant during 
increased cardiac work by aortic constrictions, it is reasonable to only use the proximal 
aortic pressure as an estimate of cardiac work. 
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The left ventricular pressure-volume area (PV A) concepts can further prove an 
obvious increase in cardiac work during increased proximal aortic pressure by using 
aortic band. During its cycle, the heart traces the loop a-b-c-d-d-e-a shown in 
Figure 4.19 - produced when instantaneous ventricular pressure is plotted against 
instantaneous ventricular volume. 
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Fig.4.19: Schematic illustration of pressure-volume area (PVA), containing two 
components-external mechanical work and potential energy. (modified from Suga 
[19_79, 1980, 1982], see text for explanations) 
The significance of this loop has been well-documented by Suga and Sagawa 
[Khalatbeigui, 1979; Suga, 1980; 1982]. a-h is the end diastolic pressure-volume 
relation curve and a-g is the end systolic pressure-volume line. The loop b-c-d-e-b 
represents four phases in the cardiac cycle: 
isovolumetric relaxation phase 
rapidfilling phase 
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e-b line 
b-c line 
isovolwnetric contraction phase 
ejection phase 
c-d line 
d-e curve 
As Suga et al point out, PV A in a normal pumping cycle consists of two 
areas: one is the rectangular area (loop b-c-d-e-b) which represents the external 
mechanical work and the other is the triangular area (loop a-b-e-a) and which 
represents the potential energy. The whole area represents the total mechanical energy 
generated by each cardiac cycle and has been used as the index of myocardial oxygen 
consumption. The product of flow and pressure (equation 4.2) integrate over a cycle 
produces the external stroke work which is the area in the loop b-c-d-e-b. 
As the proximal aortic pressure was increased by the aortic band, the changes 
in the PV A shown in Figure 4.18 would occur: 
• Increasing left ventricular pressure without changing ventricular volume 
gives the loop b'-c-d'-e'-b'. The external work increase is dependent on 
the difference between the e'-f-d-d'-e' area and the e-b-b'-f-e area. 
Overall, the PVA is increased. 
• Increasing left ventricular pressure associated with a decrease of left 
ventricular output, causes the ventricular volume to increase ( c shifts to 
c'). In this situation, external work is the loop b'-c'-d"-e'-b'. Both 
external and internal work increase. ~VA (loop a-c'-d"-e'-a) increases 
as well. 
• Increasing the afterload of the left ventricle, the heart may increase its 
contractility in order to maintain the original cardiac output. This will 
induce a shift of a-f line to a-i, sp that the loop b-c-d"'-e"-b 
represents the external mechanical work. Overall, the PVA (loop a-c-
d'"-e "-a) increases. 
Overall, increasing the proximal aortic pressure does increase cardiac work, 
however, it may not always increase external work. Equation 4.2 may not accurately 
represent the working output of the heart. It can only be used as an estimate. 
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4. 5. 2. 3 Calculation of Myocardial Oxygen Consumption 
The volume of oxygen consumed by the heart is determined by the cardiac 
activity and performance. A TP is the principle source of chemical energy in the heart 
under aerobic conditions. MV0 2 is closely coupled with the utilization of ATP. 
Even though the cardiac venous blood oxygen saturation is normally low compared to 
other systemic venous blood, the myocardium can still extract more oxygen from the 
coronary system under certain conditions. 
Due to the difficulty of making direct measurements of MVO 2 in the 
closed-chest animal, 25 different indexes of MV0 2 have been proposed over the past 
70 years based on the assumption that total mechanical work done by the ventricle 
correlates closely with MV02 [Baller, 1979]. The relationship between calculated 
MVO 2 index and exact MVO 2 index has been compared in the isolated heart with a 
high correlation being repeatedly observed from many hearts over a wide range_ of 
MV0 2 values [Baller, 1979, 1981; Suga, 1987; Rooke, 1982]. A considerable 
variation of interrelationship has also been shown amongst hearts [Burkhoff, 1987; 
Schipke, 1990; Suga, 1987]. This variation is attributed to such factors as biological 
variation, the difference of metabolic substrata utilization, and a varied proportion of 
ATP sources. The relationship between three well-accepted indices of MV02' PV A 
[pressure-volume area, Suga, 1987], PWI [pressure-work index; Rooke, 1982] and 
Et [total energy requirement; Bretschneider, 1972], and the actual MV0 2 was found 
to alter with changes in afterload condition and contractile state [Schipke, 1990]. 
These authors concluded that each index had shortcomings in being able to predict 
MV0 2 accurately over a wide range ofhemodynamic conditions. 
Fortunately, the special hemiazygos vein system in the sheep enables us to 
measure CS oxygen content directly (see appendix C). Therefore, we simultaneously 
withdrew blood samples from the proximal aorta and the coronary sinus for 
measurements of oxygen saturation and haemoglobin as well as blood gases and pH. 
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Blood oxygen content was calculated using oxygen 1.34mVg Hb when fully saturated 
plus dissolved oxygen 0.003 lmVmmHg p02 per lOOmls of bloodl as followed: 
02 content= 1.34 [Hb] x S02(%) x 1/100 + 0.0031 p02 (4.9) 
where [Hb] is haemoglobin concentration (g/dl) of the sample, S02 is oxygen 
saturation(%) and p02 is oxygen pressure in Torr. Both were measured by ABL3 
Acid-Base Laboratory. Thus ventricular MV02 will be calculated from the product of 
CBF and arteriovenous oxygen content difference as equation ( 4.3). It is necessary 
to point out that the coronary sinus only drains most of the circumflex inflow. 
However equation 4.3 is reasonable for estimating MV02. 
4. 5. 2. 4 Significance of the Half Life of Response 
It has been observed [Feigl, 1983] that a change in demand of the heart for 
oxygen will induce alteration of coronary circulation. The two interventions I applied 
to the sheep both cause a change of cardiac metabolic state, which elicits the 
vasoregulation of CBF. Let us assume that there is one substance X or a group of 
substances acting as one which is responsible for this vasoregulation. Then applying 
the intervention to sheep would cause the production and accumulation of this 
substance X. As the concentration of substance X increases_ in the interstitium, it 
induces vasodilation in the coronary circulation which causes the fall of coronary 
resistance in the arterial system. As soon as the intervention ceases and myocardial 
cell is back to normal condition, the concentration of substance X declines and the 
change of coronary vasodilation would recoyer to basal condition. This thesis 
primarily investigates the decay response of coronary circulation after interventions. 
1These figures were obtained on dogs. It may not be the same for the sheep as the sheep has two types of 
hemoglobin, whose structure can be q~ite different from that in dogs. ' 
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If a substance X is responsible for coronary vasoregulation during these 
interventions, then when the intervention stops X can either 
(a) decay by itself - because it is inherently unstable; or 
(b) decay in a reaction with a scavenger. 
In case (a), we have true first order kinetics [Mayer, 1980]: 
where [X] is the concentration of X. The solution is the familiar exponential decay: 
[X] = [X]0 e -kt 
where [X]o is the concentration of X when the intervention ceases. 
In case (b), we have a reaction: 
X + S-> X' + S' 
where S is the scavenger and X' and S' are the products of the reaction of X and S. 
We now have second order kinetics: 
a(Xl= k[X][S] 
dt 
where [S] is the concentration of the scavenger. Since the concentration of X will be 
very low and the scavenger is likely to be present in much larger concentrations (S 
could even be water), it is very likely that 
[SJ » [X] 
so that [S] will remain essentially constant during the decay of [X]. thus we can 
substitute a new constant: 
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k' = k [SJ 
and obtain pseudo-first-order kinetics. 
In this thesis, I have reported k or k' as the half-life, 1:! - the time for any 
2 
concentration of X to decay to half its original value: 
In conventional kinetic studies, it is assumed that the active component, X, 
will eventually decay completely, ie 
[X]00 = 0 
However, if X is also the primary agent for basal vascular tone, its concentration 
cannot decay completely. In addition to the scavenging of X by S, there must be 
continuous production of X from some source, thus we have: 
a[XJ = k" - k' [XJ 
at 
In the absence of the intervention, we have the equilibrium situation: 
and 
Integrating (4.10): 
Evaluating the integrals: 
a[x] = o 
at 
k" = k' [X]9 
t 1-~,ln(k"-k'[X])lo = t~ 
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(4.10) 
(4.11) 
Expanding: . ~· {- ln(k" - k'[X]) + ln(k"-k'[XJo)) = t 
For convenience, put 
Rearranging: 
a =(k"- k1X]o) 
In( k" - k'[XJ ) = -k' t 
a 
Taking the exponential of both sides: 
and rearranging: 
k" - klX] = 9 -k't 
a 
-k'I 
k" - k'[X] = a e 
[X] = ~· ( k" - ae -k't) 
Thus [X] will still show an exponential decay with the same decay constant, k'. 
Thus, if substance X is a single chemical, whi~h decays with first- oi pseudo-
first-order kinetics, and the response induced by increased afterload is caused by this 
single agent, the measured tJ. should be constant regardless of the degree and duration 
2 
of increased afterload. 
Furthermore, if neural control and humoral control is also involved in this 
coronary vasoregulation, four possibilities could occur after using blockers if the 
blocking effect is complete: 
• Both the vasodilating response and tJ. after different interventions could 
2 
remain the same, suggesting that the vasoregulation is caused by a single 
mechanism and is not related to neural and hwnoral control. 
• The response remains the same, but tJ. changes to another relatively stable 
2 
value. This means that there is direct neural and/or humoral control of 
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production of substance X. However, the body can now compensate 
through other chemicals when that basic route is blocked in order to keep 
blood supply to the coronary circulation. 
• The LI.stays the same, but the response changes. This can be explained if 
2 
neural and humoral controls are only indirectly involved in the release of 
substance X. The blockers ofthf!Se agents only.change the concentration 
of substance X. 
• Both the 1:! and response are changed relatively to a new stable value. In 
2 
this case, humoral and neural controls are likely to be directly involved in 
the normal vasoregulation under those interventions. 
Thus, if coinplete blocking agents can be selected for sympathetic, 
parasympathetic and humoral (adenosine and EDRF) control, it is possible to search 
for the mechanism for the vasoregulation under these interventions from the changes 
of the response and half life. In addition, it is possible to identify substance X by 
testing the half lives of thos_e ·chemicals proposed to be responsible for coronary 
vasoregulation one by one. 
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CHAPTER 5 
RESULT 1 - DECAY OF CORONARY 
VASODILATION IN RESPONSE TO 
INCREASED CARDIAC WORK 
117 
5.1 RESULTS 
5 .1.1 Hemodynamic Assessment of Increased Cardiac Work 
Table 5.1 gives the ranges of heart rate, systolic and diastolic aortic pressure, 
left ventricular diastolic pressure, mean pulmonary blood flow, blood acid-base 
balance and electrolyte analysis on samples withdrawn from both proximal aorta and 
coronary sinus in response to 25-44% increase in proximal systolic aortic pressure for 
a 120 second period. Because the experiments were performed in the open-chest 
whole sheep, baseline hemodynamic variables differed from sheep to sheep. There 
was no significant difference between heart rates, diastolic aortic pressure and diastolic 
left ventricular pressure. A statistical difference between control and stimulus was 
found in the pH of proximal aortic blood, but not in the coronary sinus blood. 
Significant differences in pC02 were found in the coronary sinus, but not in the 
artery. The range of differences were small. The changes ofp02 and S02 were much 
more complicated than Table 5.1 shows. These differences would be discussed in 
chapter 7. In the control group, I have randomly selected three sheep to study the 
sequence of response throughout a whole experiment lasting 3-4hours. The sheep 
showed similar magnitude responses as time passed. This suggests that the responses 
of sheep to interventions were not related to the sequence of interventions applied. 
In summary, the stimulus applied for this study did not produce significant 
changes in heart rate, diastolic aortic pressure and cardiac output. Thus, in this 
chapter, I use the changed systolic pressure to express the change of cardiac workl. 
1 Refer to section 4.5 .1.2. 
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Table 5.1: Hemodynamic Variables and Indexes of Myocardial Metabolism 
during increased cardiac work 
AorUc Constrlcdon 
(changes of range) 
Control 
on PVlluc off Pvaluc 
Heart rate (bcals/min) (DF=12) 104.6±2.6 103.24±2.6 n.s. 104.0t3.1 n.s. 
Systolic aortic prcssum myondilfcrcnt~gn>cmc:<mtrimm 
Diastolic aortic prcllSllM (DF=l 1) 80.7±3.0 79.9±3.S D.S. 79.7±A.07 n.s. 
Diastolic L. V. prc11S11M (DF=ll) 10.S±0.8 11.Clt0.7 D.S. 10.0±0.9 n.s. 
pqm(DF=ll) 0.9±0.0S 0.9±0.07 D.S. 0.9±0.06 n.s. 
pH(DF=21) Aor!a 7.48±002 1A9±0.02 <O.OS 7.47±0.02 n.s. 
c.s. 7Al±0.02 7A2±0.02 D.S. 7.42±0.02 n.s. 
pC02(DF=21) Amla 32.S±l.3 32.S±l.6 D.S. 32.8±1.S n.s. 
c.s. 38.6±1A 39A±l.6 <O.OS 40.0±1.7 n.s 
p02(DF=21) Aor!a 102.11±6.97 111.4±7.0 <O.OS 115.4±16.3 n.s. 
c.s. 262±1.09 27.5±1.07 n.s. 24.S±0.95 <O.OS 
HC03 (DF=21) Aor!a 30.S±0.74 31.1±0 87 <0.01 30.8±0.85 n.s. 
c.s. 32.2±0.58 33.7±0.75 <0.Dl , 34.1±0.8 D.S. 
TC02 (DF=21) Aor!a 31.1±0.79 31.7±0.95 <DOS 31.S±0.88 n.s. 
c.s. 33.1±0.63 34.6±0.78 <0.01 35.0±084 D.S. 
S02(DF=21) Aor!a 95.8±1.07 96.9±1.03 <OOS 96.78±0.96 n.s. 
c.s. S8.0t3.03 59.9±3.16 n.s. 54.8±3.14 <O.OS 
K+(n=3) Am1a 2.S 2.SS 2.6 
c.s. 2.7 2.S 2.S 
Na+(n=i3) Aorta 139 136 141 
c.s. 144 143 140 
control - control data before aortic constriction; on - data at 2minutes after aortic constriction 
off - data at 30 seconds after aortic constriction; 
P value - two tailed probability of difference of paired data between control to on and on to off: 
P<0.05 - statistically significant difference; n.s. - not statistically significant; 
DF- degree of freedom (n-1); 
Aorta - sample from proximal aorta; CS - sample from coronary sinus; 
All data are expressed as MEAN±SEM. 
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5. l ."2 Half-Life and Degree and Duration of Increased Cardiac Work 
Before any Antagonists 
Figures 5.1 and 5.2 show the changes of coronary resistance and mean 
diastolic coronary blood flow in response to different degrees of increased cardiac 
work in one experiment (5.1) and to the different periods of increased cardiac work 
(5.2). Figure 5.1 demonstrated that the more severe the increased aortic pressure is, 
the more CBF and,cr change. Their good correlation from a single sheep experiment 
was shown in Figure 5.3. However, the CBF and er did not change further 
following the longer period of the increased aortic pressure (Figure 5.2). 
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Fig.5.1: Mean diastolic coronary blood flow and coronary resistance in response to different 
degrees of aortic constriction with the same duration (60secs). (.1p - percentage 
change of systolic aortic pressure; cqd - diastolic coronary blood flow; er - diastolic 
coronary resistance). 
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Mean diastolic coronary blood flow and coronary resistance in response to 90, 60, 45 
and 30 seconds of aortic constriction with same degree. (.1.p - percentage change of 
systolic aortic pressure; cqd - diastolic coronary blood flow; er - diastolic coronary 
resistance). 
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The relationship between the calculated decay (half life) and the degree and 
period of change of percentage of systolic aortic pressure, which indicated the 
increased cardiac work, is shown in Figure 5.4. The half life is independent of the 
duration and degree of increased cardiac work. Figure 5.5 shows plots of the half life 
of the recovery of mean coronary blood flow, calculated diastolic mean coronary 
resistance and mean diastolic coronary blood flow versus percentage increase in aortic 
pressure. Half lives of cqm, er and cqd were below ?seconds despite the large 
variation in aortic pressure. Similarly, the decay of three parameters (cqm, er, cqd) 
versus the duration of increased' aortic pressure was plotted in Figure 5.6. The values 
of these half lives were also below ?seconds. Finally, Figure 5.7 summarizes the 
average half lives in 12 sheepl in response to both different degree and duration of 
aortic constriction. Values are expressed as mean±SEM (seconds). The decay of 
the responses from 12 sheep are: 
t!. (cqm) = 4.67±0.17 (seconds) 
2 
t!. (er)= 4.73±0.20 (seconds) 
2 
t!. (d.cq) = 4.63±0.26 (seconds) 
2 
lane sheep with only 4 values was deleted from the results, leaving res~lts from 12 sheep. 
124 
20 
20 
• 
• 
• 
• 
60 
time (seconds) 
A- stcpl: t.p = 11.36% ± 0.28 (mean± SBM) 
• 
• + 
• 
• I 
• 
60 
time (seconds) 
100 
100 
+ 
• 
.t. 
• 
.t 
• . : 
2-1-.--=' ............................ ._ .......... _,.. .......... __, 
20 60 
time (seconds) 
B- stcp2: t.p= Zl.7%±2.17 (mcan±SEM) 
• cqm 
+ er 
.t. cqd 
100 
C - stcp3: lip = 47 .4% ± 4.08 (mean± SEM) 
8 
10 
0 
• 
• 
.t. 
Fig. 5.4: 
.t. 
+ 
• 
.A. 
• 
• 
• 41. 
30 
.. 
.A. 
t.p (% of control) 
D-Duralion=30sccs 
• 
• 
•.a. I 
• 
40 
t.p (% of control) 
F - Dunwon = 60 sees 
.... 
• 
• 
50 
80 
6 
ll 
c 
8. 
~ • 
0 4 " ! 
.. 
.A. 
• 
• 
• 
.t. 
2...p ............... .,_ .......... __,,.... .......... -... .......... ~ 
10 
• 
0 
30 
t.p (% of control) 
E - Duration= 45 sees 
•• 
• 
.t. 
30 
t.p (% of control) 
• 
• 
G - Duratim = 90 sees 
50 
• 
• 
60 
Relationship between decay of cqm, er and eqd and different degrees and durations 
of increased proximal aortic pressure from one sheep experiment. (.l\p - percentage 
of control in proximal aortic systolic pressure; eqm - mean coronary blood flow; 
er - diastolic mean calculated coronary resistance; eqd - diastolic mean coronary 
blood flow). See text for explanation. 
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Decay of cqm (mean coronary blood flow), er (mean diastolic calculated coronary 
resistance) and cqd (mean diastolic coronary blood flow) in response to different 
degree and duration of aortic constriction in 12 sheep. Values are mean±SEM. 
'all' summarizes the data from 12 sheep. 
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5.1.3 Half-Life and Increased Cardiac Work After Using Adenosine, 
a and p Receptor Inhibitions 
Each sheep in this group was subjected to various degrees of aortic constriction 
for a single duration (120 seconds). The relationships between the changes of cqm, 
er and cqd and percentage change from control in proximal aortic pressure are ~hown 
in Figure 5.8 for each experimental state (control, adenosine blockade and adenosine, 
a-, P-receptors blockade). There was a slight increas-e of slope in the relationship 
between response and pressure after using 8-PT and more increase after using 
phentolamine and propranolol. The slopes are shown in Table 5.21. 
Table 5.2: Slopes of the relationship between coronary blood flow and coronary 
resistance before and after inhibitions 
Control & ADO blockade Control & ADO, A and 8 blockade ADO blockade & ADO, A and 8 blockades 
Acqm Acr Acqd Acqm Acr Acqd Acqm Acr Acqd 
Slope! 0.90 0.52 0.70 0.90 0.52 0.70 1.03 0.66 0.92 
Slope2 1.03 0.66 0.93 1.73 1.07 1.26 1.73 1.07 1.26 
Tvalue 
-0572 -0.758 -1.456 -3.212 -3.189 -2835 -2.024 -2231 -1.267 
DF (nl +n2-4) 83 83 83 73 73 73 54 54 54 
Student'st 1.990 1.990 1.990 2.648 2648 2.648 2009 2.009 2009 
P value 005 0.05 0.05 0.01 0.01 0.01 0.05 0.05 0.05 
Conclusion n.s. n.s. n.s. s s s s 
Control - before inhibition; ADO - adenosine; n.s. - no significant difference; s - significant 
difference. 
1 Refer to section 4.3.4 for statistical method. 
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Fig. 5.8: Relationship between the change of cqm, er and cqd and the percentage changes of 
proximal systolic aortic pressure due to aortic constriction for a duration of 120 seconds 
before and after adenosine, a- and 8-receptors inhibition. (Data are expressed as 
percentage of control from 7 sheep, each sheep included three types of experiment -
control; adenosine blockade; and adenosine + adrenergic receptors blockade; t-significant 
association p<0.01). 
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Table 5.3 summarizes the results of experiments measuring the half-lives in 
response to increased cardiac work before and after using 8-PT, phentolamine and -
propranolol in seven sheep. 
Table S.3: Mean half lives of decay before and after adenosine, a and 13-receptors blockade 
Control Aller ADO Inhibition After ADO, :lh and .8 blockades 
Sheep 
cqm er cqd eqm er cqd cqm er cqd 
1' 7.90 5.36 5.93 7.11 5.51 7.69 
2 4.69 5.39 4.42 3.11 6.12 3.47 4.S3 4.32 4.93 
3 4.28 4.13 5.66 480 3.35 4.76 5.90 5.24 4.10 
4 4.86 4.62 4.49 4.40 4.78 4.65 7.21 3.99 3.86 
5 5.50 5.49 4.71 5.65 4.14 4.36 4.22 5.91 5.01 
6 5.05 3.99 4.31 4.6S 6.32 5.24 3.26 3.99 5.70 
7 6.13 4.56 4.30 7.00 3.S6 4.70 
Mean 529 4.75 4.S5 5.25 5.04 5.06 5.14 4.66 4.75 
SEM 0.33 025 0.41 0.39 0.46 0.67 o.so 0.39 0.41 
cqm - mean coronary resistance; er - mean diastolic calculated coronary resistance; cqd - mean 
diastolic coronary blood flow; ADO - adenosine 
Under control conditions, the decays of response following the withdrawal of various 
degrees of increased cardiac work for 120 seconds were: 
cqm 5.3±0.3 seconds; 
er 4. 7±0.2 seconds; 
cqd 4.8±0.4 seconds. 
Neither 8-PT nor phentolamine nor propranolol alter the decay of recovery in 
response to the withdrawal of stimulus as shown in Figure 5.9. 
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cqm er cqd 
• Control 
E2J After adenosine inhibition by 8-phenyltheophylline 
0 After both adenosine and A-, B-receptors inhibition by phentolamine and propranolol 
Fig 5.9: Mean decay (seconds) of cqm, er and cqd before and after adenosine, a- and~­
receptor inhibitions. No significantly different from control was showed by paired t 
- test for both adenosine inhibition and adenosine, a-, ~- receptor inhibitions. 
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5.2 DISCUSSION 
As the proximal aorta constricts, consequently increasing the afterload of left 
ventricle, the myocardial cells suddenly need to do more work to overcome the 
resistance. This increase of cardiac activity requires more energy which mainly comes 
from the blood supply. The way to meet this requirement is either to extract more 
nutrients from each ml of blood in the coronary circulation or to increase coronary 
blood flow. Since the coronary reserve is relatively small compared with that of other 
circulations, the coronary blood flow usually increases. The mechanism for this has 
not been ascertained. 
The present results demonstrate that the degree of aortic. stenosis is directly 
proportional to the cardiac work as long as the myocardium is not depletedl due to 
"over-load". So, the more severe the aortic constriction, the stronger cardiac activity 
is. The increased cardiac work will increase production of metabolite(s). Similarly, 
the longer the period of aortic constriction, the more sustained situation myocytes are 
in before the myocytes are exhausted. If this is true, it should cause more 
accumulation of metabolite(s), consequently a gradual increase ih coronary blood flow 
and decrease in coronary resistance should be seen. In fact, I did not observe this: 
once the coronary resistance was stabilized after intervention, it tended to stay stable 
until the stimulus was withdrawn. If the metabolite(s) produced are responsible for 
the decrease of coronary resistance or increase of coronary blood flow and is 
substance X, when the stimulus stops, X can either decay by itse~f or decay in a 
reaction with a scavenger. Figure 5.5 and 5.6 shows the distribution of half lives 
against either degree or duration of stenosis. The degree and the duration does not 
affect the decay of the response as shown in figure 5.4. There is no correlation 
1 Myocardial depletion will affect the myocardial constriction and may be shown as an increase in left 
ventricular end diastolic pressure. This was not observed in this study. 
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between the decay of response, in coronary blood flow, diastolic coronary blood flow 
and coronary resistance, and either the degree or the duration of the aortic constriction 
stimulus. In addition, a longer period of the intervention does not cause further 
change in coronary resistance. These results suggest that substance X is a single 
chemical with a short half life. 
Despite the substantial evidence that adenosine is not responsible for the 
maintenance of coronary basal vasomotor tone, adenosine is still supposed by ~any 
laboratories to play an important role in coronary vasodilation in response to increased 
cardiac activity under the normal physiological conditionsl. The present investigation 
was undertaken to determine whether the antagonism of adenosine on the coronary 
resistance vessels would impair the coronary vasodilation which occurs during 
increased cardiac work. The use of adenosine blockade changed augmentation of the 
responses shown by the slope in the relationship between coronary resistance and 
coronary blood flow and increased cardiac work, but this slight increase of slope was 
not statistically significant (Table 5.2). Thus, adenosine receptor blockade with 
8-phenyltheophylline did not interfere with the relationship between the coronary 
resistance and cardiac work. This result is consistent with recent findings by Bache 
and co-workers[l988], who found that neither adenosine deaminase nor 
8-phenyltheophylline changed the increase in coronary blood flow or the decrease in 
coronary venous oxygen tension that occurred during treadmill exercise in conscious 
dogs. Before concluding whether adenosine is a mediating factor for vasodilation 
during increased cardiac work, two points need to be considered: 
a) Since 8-PT is a competitive adenosine receptor blocker and there is a very 
rich resource for adenosine production in the heart, it is possible for the 
system to generate more adenosine to compete the receptqrs with 8-PT. 
In that case, it seems rational to expect the decay of the response after fhe 
lRefer to section 3.3.3. 
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withdrawal of aortic constriction to stay the same after using an adenosine 
blocker and close to the decay of the response due to exogenous adenosine 
administration, assuming that extravascularly released adenosine and 
intravascularly administered adeno~ine have similar physiological effects. 
The half life of exogenous adenosine will be discussed in chapter 8; 
b) Adenosine is a mediator. When the system is subject to adenosine 
blockade, it may be able to trigger another mechanism or release another 
metabolite to provide compensating response. If this were the case, the 
change of decay from the control should be observed after adenosine 
inhibition, and the half life of control should be very close to the decay of 
exogenous adenosine. No such alteration was found. 
These two possibilities would keep the relationship between the corop.ary 
resistance and cardiac work constant after adenosine inhibition. However, the 
observation that no significant difference was found between the half lives before and 
after adenosine inhibition (Table 5.3) suggests that substance X is a single metabolite, 
unless the compensatory metabolite after blockade has a similar half life to the control 
one. It is very likely the same metabolite was responsible for the reaction of both 
control and adenosine blockade groups. The question of whether it is adenosine will 
be examined by looking at the half life of exogenous adenosine. 
For a better understanding of the response to increased cardiac work, it is 
important to clarify the involvement of sympathetic and parasympathetic systems in the 
changes of CBF and coronary vascular resistance. It has been well documented that . 
the coronary vasculature is innervated by both the sympathetic and parasympathetic 
division of the autonomic nervous system [Berne, 1979; Feigl, 1983]. The data in 
Figure 5.8 and Table 5.2 show a significant increase of slope in the relationship 
between the change of reaction in cqm, er and cqd and the change of aortic pressure 
after the sheep were blocked with 8-PT, phentolamine and propranolol. · This 
indicates that the coronary circulation would dilate more in response to the same 
degree of cardiac work with a.- and ~-adrenergic blockade than without them. This 
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suggests that coronary ex-receptor vasoconstriction must be dominant in coronary 
vasoregulation due to increased cardiac work caused by increase of the afterload on the 
left ventricle. When sheep were under complete blockade of ex- and J3-receptors, there 
was no significant change of half lives from control. This suggests that the release of 
substance X is not controlled by neurogenic stimulation. 
As the proximal aortic constrictions were performed, carotid sinus hypotension 
might occur. It was found that carotid sinus hypotension results in no change 
[DiSalvo, 1971] or decrease [Mohrman, 1978; Powell, 1979] in coronary res~stance. 
With a beta-blocker (propranolol: lmg/kg) and bilateral vagotomy, carotid shms 
hypotension resulted in sympathetic coronary vasoconstriction in closed-chest dogs-
with controlled aortic pressure and myocardial oxygen metabolism [Powell, 1979]. 
This indicated that an ex-receptor coronary vasoconstriction from the carotid sinus 
reflex is independent of aortic perfusion pressure, myocardial metabolism and 
autoregulation. Another possibility is that the reduction of carotid sinus pressure 
could reach 50-60mmHg when aortic stenosis was applied with ex and J3 blockers. It 
was observed that a carotid sinus pressure below 50-60mmHg caused an activation of 
chemoreceptor fibres which produces reflex vagal parasympathetic coronary 
vasodilation [Vatner, 1975] in conscious dogs. This was found to be due to 
pulmonary hyperinflation when chemoreceptors were stimulated with nicotine. This 
would not be the case in anaesthetised animals with controlled ventilation. The use of 
propranolol in this study prevented an autonomic change in heart rate and contractility. 
This is not perfect prevention, further work should be carried out by using atropine 
and propranolol together to prevent parasympathetic effects. 
In summary, the use of adenosine and ex, J3 receptor blockers did not 
sign_ificantly interfere with the decay of the response and only changed augmentation 
of the vasodilation. This further supports the proposal that substance X is a single 
metabolite. 
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5.3 CONCLUSION 
The recovery of coronary resistance to normal after the change of the afterload 
I 
of left ventricle has a constant short half life of 4. 7±0.2 seconds. The half life is not 
related to either the degree or the duration of increased work. a, 13 and adenosine 
inhibitors do not alter this half life. Coronary a-adrenergic vasoconstriction is 
dominant in the neurogenic control of coronary circulation in response to the increase 
of afterload of left ventricle. 
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CHAPTER 6 
RESULT 2 - RELATIONSHIPS BETWEEN 
CORONARY RESISTANCE AND METABOLIC 
PARAMETERS 
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6.1 RESULTS 
During the analysis of the experimental results, it was found that many_ 
parameters, such as pH, pC02, p02 and S02, had changed following the recovery 
in coronary blood flow and coronary resistance after the withdrawal of systemic 
hypoxia. Therefore, the meaningful study of decay of the response was totally 
prohibited. Thus, I have directed the investigation to analysis of the correlation 
between coronary resistance and other parameters. 
6 .1.1 · Hemodynamic Variables and Assessment of Systemic Hypoxia 
There was no detectable deterioration of myocardium during either the 
normoxic oxygen supply or the low oxygen gas supply. In the uncontrolled 
experimental model, systemic hypoxia caused by different types of mixed gases was 
studied. Two typical phenomena were observed and are shown in Figure 6.1 and 
Figure 6.2. The following abbreviations are used: 
cqm 
er 
pqm 
HR 
s.aop 
d.aop 
s.LVP 
LVDP 
pH(A) 
pC02(A) 
p02(A) 
S02(A) 
pH(V) 
pC02(V) 
p02(V) 
S02(V) 
mean coronary blood flow (mls/min) 
mean calculated diastolic coronary resistance (mmHg min/ml) 
mean pulmonary blood flow (litres/min) 
heart rates {beats/min) 
systolic proximal aortic pressure (mmHg) 
diastolic proximal aortic pressure (mmHg) 
systolic left ventricular pressure (mmHg) 
diastolic left ventricular pressure (mmHg) 
pH - arterial blood from proximal aorta 
pC02 - arterial blood from proximal aorta (mmHg) 
p02 - arterial blood from proximal aorta (mmHg) 
% oxygen saturation of arterial blood from proximal aorta 
pH - venous blood from coronary sinus 
pC02 - venous blood from coronary sinus (mmHg) 
p02 - venous blood from coronary sinus (mmHg) 
% oxygen saturation of venous blood from coronary sinus 
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Fig. 6.1: One type of change in hemodynamic variables and assessments due to hypoxia. (Data 
from experiment 90.10.16, type III intervention for 150 seconds, see text for details). 
The broken lines in aop and er were caused by sampling. 
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In Figure 6.1, 11 blood samples were taken: sample 1 - baseline before 
intervention; 2 - 60secs after low oxygen supply; 3 - 90secs after intervention; 4 -
120secs after intervention; S - 150secs after intervention (at this point intervention 
was withdrawn); 6 - 30secs after withdrawal; 7 - 90secs after withdrawal; 8 -
120secs afterwards; 9 - 150secs afterwards; 10 - 180 sees afterwards; 11- after all 
the hemodynamic variables recovered to the stable state. 
The response to the applied intervention (systemic hypoxia) included: 
• eqm increased and er decreased. This response lasted more than 30secs 
after the withdrawal of intervention before returning toward the control 
values. 
• cardiac output, represented by pqm, increased and HR also increased. 
• both aortic pressure and left ventricular pressure continuously decreased 
initially, then increased before the intervention was withdrawn and stayed 
nearly stable while eqm and er recovered toward the baseline. 
• L VDP. increased while s.L VP and aop decreased. 
• pH in both artery and vein decreased with hypoxia and then gradually 
recovered toward the baseline. There is some delay of response in pH 
after withdrawal of intervention. 
• pC02 in both artery and vein continuously increased, until 120secs after 
the withdrawal of the intervention before recovering toward the baseline. 
• pOz and S02 in both arterial and venous blood were shifted consistently, 
especially in venous. They decreased initially and remained low for at 
least another 30 sees after the withdrawal of intervention and then 
gradually recovered to the control values. 
In Figure 6.2, 8 blood samples were taken: 1 - control values; 2 - 60secs 
after intervention; 3 - 90secs after stimulus; 4 - 120secs after stimulus (at this point, 
the intervention was withdrawn); S - 30secs after withdrawal; 6 - 60secs after 
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withdrawal; 7 - 90secs afterwards; 8 - 120secs afterwards. The differences of 
reaction from Figure 6.1 to 6.2 are: 
• The pressures in s.aop, d.aop, s.LVP and L VDP continuously 
increased even after the withdrawal of stimulus, then decreased toward the 
baseline before the measured lowest p02 was reached. 
• pH increased first, then deceased; pC02 decreased, then increased. 
There were 7 sheep using mixed gases (type IIJI) as stimulus, 3 used type I 
and II as stimulus. Those using type III all showed the first type of response to 
hypoxia as Figure 6.1. However, other sheep using type I and II all demonstrated the 
reaction as shown in Figure 6.2. 
6 .1. 2 The Correlation between Coronary Resistance and Parameters 
before and after Adenosine Inhibition 
Following the results shown in Figure 6.1 and 6.2, the correlations between 
the coronary resistance (er) and various properties (pH, pC02, pOz, S02) of both 
proximal aortic blood and coronary sinus and myocardial oxygen consumption 
(MV0 2) in 8 sheep before and after adenosine inhibition2were determined by fitting 
the equation: 
er= a +bx 
(where x is the other parameter). The complete data sets are set out in appendix D. 
Table 6.1 summarizes the values, n (sample size), a (intercept), b (gradient) and r 
(correlation coefficient), amongst all the variables in 8 sheep. Sheep 3 and 7 used type 
I and II as intervention, others used type III. The statistical significance was also 
'A ·t.1:-
1Gas mixtures are listed in section 4.4.2. 
2Adenosine blocking effect by 8-phenyltheophylline will be shown in chapter 8. 
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determined from the value of rand n [Hoel, 1976]. The results in Table 6.1 may be 
summarized as follows: 
• There was a poor relationship between er and pH(A), except in sheep 4 
and 6 in which there was a positive slope. There were three negative and 
five positive slope in all. 
• There was a poor relationship between er and pC02(A). 
• Good correlations (statistical significance: p=:;;:0.05) were found between er 
and oxygen (p02; S02) from both artery and vein in all sheep. 
• The relationship between er and venous pH and pC02 varied from sheep 
to sheep with no consistent response. 
• Statistically meaningful correlation was found between er and pC02(V) 
in 2 sheep in which one showed a negative slope and the other one a 
positive slope. 
After adenosine blockade: 
• There was a poor correlation between er and pH(A). 
• Poor correlation was obtained between er and pC02(A). 
• There was a good correlation between er and p02(A). 2 out of 7 were 
statistically significant. 
• Very good correlations (statistically significant) were found between er 
and S02(A) in all sheep. The relationship was improved from control. 
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Table 6.1: Linear regression analysis between er and other parameter amongst 8 sheep 
Condition Sheep No. 
Parameter Results 
2 3 4 5 6 7 8 
Control 11 8 7 10 7 8 12 7 
Artery pH (A) a -148.9 -53.4 9.26 -868 -73.1 -67.6 63.5 11 8 
b 20.27 73 -1.12 11.6 9 61 9.07 -8.19 -140 
r 0.31 035 0.01 0.68* 0.73 094t 022 0001 
pCOZ(A) II 5.25 3.9 1.56 2.79 3.92 3.42 -2.50 974 
b -0.15 -0.02 -0.02 -0.10 -0.14 -0.11 0.14 
-026 
r 0.32 0.51 0.10 0.54 0.64 0.88t 018 0.88± 
p02 (A) a -0.08 0.39 0.54 0.46 0.39 0.32 0.29 
-001 
b 0.02 0.02 0.09 0.09 0.01 009 001 005 
r 065* 0.73* 0.74 057 0.64 0.73* 0.71t 095t 
S02 (A) a -2.1 022 046 -019 -1.48 -1.65 -0.62 014 
b 004 0.01 0.06 0.01 0.03 0.03 002 002 
r 0.77t 0.81* 0.60* 0.59 0.81* 0.60 0.65* 0.98t 
Venous pH (V) a -53.3 -24.7 5233 -149.7 -135.4 -100.7 91.6 -3863 
b 7.42 347 -6.94 20.0 18.0 13.5 -11.9 522 
r 0.03 0.03 0.72 071* 0.98t 0.72* 0.63* 0.23 
pC02(V) a 
-0.21 3.12 -0.77 4.41 4.27 4.62 -3.19 486 
b 005 -004 004 -0.15 -013 -0.14 0.14 
-922 
r 0.02 0.07 0.70 0.34 0.88t 0.66 059* 0.01 
p02 (V) a -0.99 -0.02 0.46 0.39 -1.03 0.11 -0.06 009 
b 01 0.07 002 002 0.11 0.03 005 0 JI 
r 0.73t 0.84* 0.57 0.34 0.84* 0.27 0.66* 0.84t 
S02(V) a -0.25 0.41 0.58 0.47 -0.31 0.04 0.17 0 68 
b 004 003 0.008 001 003 0.02 002 005 
r 072* 086* 0.61* 045 0 89t 041 0.60* 0 85t 
MV02 a 2.62 1.44 1.41 1.98 1.88 2.22 1.72 
-086 
b -0.05 -0.01 -0.03 
-002 -0.07 -0.06 -0.03 
-002 
r 0.68* 0.19 0.55 092t 0.49 076* 0.59* 071* 
After ADO inhibition 
Artery n 6 6 10 8 7 7 8 
pH(A) a 
-75 2 -29 07 81.27 -62.8 -140.8 -47 9 14.4 
b 10.3 3.96 -10.88 854 18.9 6.43 -1 79 
r 0.62 0.65 0.51 0.35 0.85* 0.56 0.06 
pC02(A) a 2.59 1.85 0.03 2.95 4.03 2.77 -0.03 
b -0.07 -0.04 002 -009 -0.10 -0.09 0.03 
r 0.82* 065 0.02 0.38 0 84* 0.61 0.08 
pOZCAl a -004 0.81 043 0.69 -0.01 0.66 0.32 
b 001 002 0.04 001 003 0.06 001 
r 0.89* 0.57 0.56 0.67 0.9lt 053 0.66 
S02(A) a -054 -0.08 -0.56 
-0.13 -1.44 -2.65 -0.91 
b 0.01 0.02 0.01 002 0.04 0.04 002 
r 0.82* 0.79* 0.96t 0.96t 0.76* 
MV02 a 1.16 1.31 110 24 1 31 2.23 0.79 
b -0.02 -0.02 -0.02 -0.003 -002 -0.07 004 
r 0.73 0.20 0.83* 0.82* 0.20 0.90t 0.14 
n - number of data points; a - intercept; b - slope; r - correlation coefficient; * - significantly 
associated (p s; 0.05); t - significantly associated (p s; 0.01). ADO - adenosine 
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Figure 6.3 exhibits the correlation between percentage change of coronary 
resistance and percentage change of proximal aortic oxygen saturation in 8 sheep 
before and after adenosine inhibition by 8-phenyltheophylline. Other parameters did. 
not show a statistically meaningful correlation. 
The slopes from data A and B in Figure 6.3 were compared by calculating the 
statistic calculated T which is distributed as a Student's t with da.ta A size + da.ta B size 
- 4 degree of freedom1• However, in this case, 
From student's t table: 
Slope in graph B = + 1.57 
Slope in graph A = + 0.93 
T = 3.107 
t = 2.617, when df = 120, p = 99.5% 
so T > t, 
and there is less than 0.5% possibility for slope A and slope B to be the same, ie slope 
B is significantly steeper than slope A. 
In summary, there is a linear relationship between coronary resistance and 
pOz, S02 which is better and 'steeper after adenosine blockade, ie after adenosine 
blockade, a change of oxygen concentration in the artery causes a relatively larger 
change of coronary resistance than before. 
1 Refer to section 4.3.4. 
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Fig. 6.3: The correlation between the percentage change of coronary resistance (Acr) and the 
percentage change of arterial oxygen saturation (AS02(A)) before (A) and after (B) 
adenosine inhibition. (70 and 52 data points from 8 sheep, t -statistically significantly 
associated, p :5: 0.01) 
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6.2 DISCUSSION 
In the current study, the calculated coronary resistance (er) was employed to 
investigate the effect of systemic hypoxia on coronary vasodilation before and after 8-
pheny ltheophy lline. Systemic hypoxia has been observed to augment cardiac 
sympathetic nerve activity in the canine myocardium [Feigl, 1983]. This response 
was also shown in my preparation (Figure 6.1 and 6.2). The hypoxia causes an 
increase of the aortic pressure and an increased perfusion pressure for coronary 
circulation. So, using er rather than coronary blood flow (CBF) in the analysis can 
minimize this effect. 
The difference between Figure 6.1 and 6.2 may be caused by the different 
mixed gases used as intervention because there is an extra 5% C02 in the gases for the 
Figure 6.1 experiments. This extra C02 has a direct negative inotropic effect on the 
heart [Williamson, 1975], which causes an initial decrease in proximal aortic pressure 
and left ventricular pressure until the sympathetic effect overcomes it. Thus, gas type 
I and II shows a greater sympatho-adrenergic response than type ID. 
In the study of correlation between er and the other parameters, 2 out of 8 
sheep between er and pH in arterial blood sh,owed significant association. In both 
cases, pH > 7 .5: Thus the systemic hypoxia only decreased the severity of alkalosis 
which may be caused by over-ventilation (both showed low arterial pC02), and did 
not cause acidosis. However, the rest showed acidosis caused by hypoxia and did not 
show significant association with er. Thus, the 2 correlations observed should not 
lead to the conclusion that arterial acidosis plays a role in this hypoxia induced 
vasodilation. 
Scheuer [1968] used hyperventilation and bicarbonate infusion to increase pH 
(7.35 -> 7 .87) under nearly constant arterial pC02: this did not induce significant 
changes in CBF and MV0 2• However, they did not calculate the er. In my study, 
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although in 4 sheep, er correlated with pH in coronary sinus (CS) blood, two of 
these sheep were the same sheep which showed the correlation between er and 
pH(A). The other two showed negative slopes. If the values of acid-base and blood 
gases in CS indicate the value in myocardium, my results do not support the 
hypothesis that the severity of acidosis in the myocardium has an effect on the 
determination of er. 
The present results do not completely exclude pH as an agent in coronary 
vasodilation, because the stimuli did not cause pH to fall below 7.2. At this pH 
value, other workers discovered that has an independent effect on coronary 
vasculature resistance in isolated rabbit hearts [Clancy, 1975] and in closed-chest 
anaesthetized dogs [Tarnow, 1975]. However, this does not support pH as playing a 
role in hypoxia induced physiological vasoregulation of CBF. 
pC02(A) showed correlation with er in 2 sheep - neither of which had a 
correlation with pH(A). Neither case used type I or II gases as the intervention which 
elicits a greater sympathetic response. This result is consistent with previous findings 
- increased pC02 is associated with CBF in some experiments-but not in others. 
Van den Bos and co-workers [1979] studied the effect of high pC02 on CBF by 
using adrenergic ~-receptor blockade to stabilize MV0 2 and found no change in CBF 
when pC02(A) was doubled. They concluded that the coronary vasodilation 
observed during hypercapnia was due to an adrenergic effect and not to a direct effect 
of C02. If their conclusion is true, those sheep (sheep 3 and 7) showing a greater 
sympatho-adrenergic response to extra 5% C02 in mixed gases should exhibit the 
better correlation with er than others. However this was not the case. The current 
approach could not determine the role of arterial pC02 in coronary regulation. The 
C02 production in myocardium, represented by pC02(CS), was independent of er in 
most sheep. However, the effect of myocardial C02 on vascular smooth muscle could 
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not be excluded because the effect may be masked by other concomitant changes 
which cause more dominant changes in er. 
Both p02(A) and S02(A) showed a good correlation with er in all the sheep. 
This makes it impossible to reject the association between arterial oxygen and er in 
response to systemic hypoxia although other factors also varied under this condition. 
By what mechanism is arterial oxygen related to er? In section 3.2, it was noted that 
systemic hypoxia undoubtedly caused the increase in cardiac sympathetic nerve 
activity, in the current preparation shown by the increase of heart rate, cardiac outp-ut 
and aortic pressure . a 1-adrenergic coronary vasoconstriction appeared to be 
dominant in the neural control of CBF during hypoxia [Grice, 1987]. This would 
lead us to suppose the vasodilation observed in this study was purely due to local 
regulation. Since p02 in CS did not fall below 8mmHg, which is the critical value 
for mitochondria [Berne, 1980], it is unlikely this vasodilation was caused by direct 
effect of oxygen on resistance vessel tonel. Amongst all the putative candidates found 
to be responsible for hypoxia induced coronary vasoregulation at one time or another, 
adenosine appears to have most support altho~gh there is no direct evidence for this. 
If adenosine plays an important role in hypoxic vasodilation, it is logical to expect that 
after using a potent adenosine blocker (8-phenyltheophylline) [Smellie, 1979; Griffith, 
1981] there would be a poorer correlation between arterial oxygen and er and the 
change of arterial oxygen should elicit less change ~n er. However, my data show the 
opposite result. It suggests that adenosine does not play an important role in hypoxia 
induced-vasoregulation. This conclusion is not consistent with recent work done in 
' Merrill's laboratory, where they show both adenosine deami~ase and 
8-Phenyltheophylline attenuated canine coronary vasodilation during systemic hypoxia 
1 Refer to section 3.2.3. 
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[Wei, 1988; 1989]. Their results may be influenced by their non-physiological 
approach in which they used a controlled-flow system for investigation. 
Because the open-chest hemodynamic uncontrolled sheep was used as an 
experimental model, baseline hemodynamic variables would be different from sheep to 
sheep, and systemic hypoxia undoubtedly would influence neural control, which 
would cause changes in heart rate, cardiac output and aortic pressure. All the 
parameters including pH, pC02, p02, S02 and MV02 are varied together during 
systemic hypoxia. All this complicated the interpretation of the response of coronary 
blood flow and coronary resistance to systemic hypoxia. 
6.3 CONCLUSION 
The current study is not conclusive in determining which of the putative 
vasodilators have an effect on the coronary vasodilation due to systemic hypoxia 
because of the concomitant changes in other variables during intervention. However, 
it shows that arterial oxygen is strongly correlated with coronary vascular resistance. 
I~ also suggests that adenosine is unlikely to act as the transmitter between myocardial 
hypoxia and coronary vascular smooth muscle relaxation. 
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CHAPTER 7 
RESULT 3 - CONTINUOUS MEASUREMENTS 
OF CORONARY SINUS OXYGEN 
SATURATION DURING INCREASED 
CARDIAC WORK AND SYSTEMIC HYPOXIA 
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7.1 RESULTS 
7 .1.1 Change in S02 from Coronary Sinus due to Increased Cardiac 
Work 
Figure 7 .1 shows a typical set of traces from the polygraph including S02 
from OXIMETER. 
There was no consistency in the response of S02 during increased cardiac 
work. This result was surprising in view of our anticipation of increased work 
causing an increase of oxygen uptake. There were three types of change in coronary 
sinus S02 in response to increased cardiac work caused by increased proximal aortic 
pressure in this study. They were: 
a) Increase in S02 (Figure 7 .2) 
b) Decrease in S02 (Figure 7.3) 
c) Nearly stable S02 (Figure 7.4) 
Figure 7.2 shows that S02(CS)1 increased from 68% to 73% as'the aortic 
constriction was applied, fluctuated above the control value during intervention and 
returned to the baseline after the stimulus was withdrawn. In another sheep (Figilre 
7.3), a decrease of S02(CS), from 65% to 60%, was observed in response to aortic 
constriction. However, in another trial (Figure 7.4) ~a nearly stable S02(CS) (±1 % ) 
was demonstrated. In these three figures, other hemodynamic variables showed 
, - similar responses to those I discussed in chapter 5. 
1Abbreviations are listed in glossary. 
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Fig. 7.1: The changes ofhemodynamic variables and S02 (CS) due to aortic constriction 
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Table 7.1 summarized the change of S02 (CS) in response to increased 
cardiac work by employing proximal aortic constriction from seven sheep. Coronary 
sinus oxygen saturation varied significantly both above and below resting states 
during intervention. 
Table 7.1: Summary of changes of S02(CS) in response to increased cardiac work 
Sheep Total Experimental Runs 
S02 (CS) In Response to Aortic Constriction 
No. of Increase No. of Decrease No. of no Change (S 1 % ) 
1 (20.3.90) 5 2 2 
2 (27.3.90) 7 4 2 
3 (7.3.90) 8 4 2 2 
4 (28.290) 6 4 
5 (salmon) 21 4 14 3 
6 (3.4.90) 7 5 0 2 
7 (29.6 90) 15 7 6 2 
SUM 69 Z1 29 13 
Increase - nwnber of runs in which S02 increased during aortic constriction; 
Decrease - nwnber of runs in which S02 decreased during aortic constriction; 
no change - nwnber of runs in which the change of S02 was less than 1 % during aortic constriction. 
Because the Oximeter machine, used for continuously measuring S02, became 
unservicable, I could not investigate this further eg to study the change under 
a-adrenergic blockade. 
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7 .1. 2 Change in S02 from Coronary Sinus due to Systemic Hypoxia 
Continuous measurement of S02 (CS) was also compared with the changes 
of hemodynamic variables before, during and after systemic hypqxia shown in Figure 
7.5. S02 (CS) declined immediately after mixed gases (Type ill) were applied, er 
also started to decrease, but eqm did not increase until S02(CS) fell below 68%. 
The most striking results were: 
• eqm returned to the control value much earlier than both S02(CS) (when 
S02 was only about 54%) and er. 
• When _S02 had changed direction toward the baseline (point L), er 
continue to decrease and eqm continue to increase for about 10 seconds, 
then returned toward the baseline. There was a lag (about 10 seconds) in 
the response of er and eqm to the change of S02. 
Data in Figure 7.5 (1000 heart beats) were used for linear regression analysis between 
eqm/er and S02(CS). Excellent correlation (r = 0.91) was found between 
S02(CS) and er, which was much more closely associated than S02 (CS) and eqm 
(Figure 7.6). In Figure 7.7, the data from Figure 7.6 has been re-plotted in order to 
distinguish the two stages - oxygen decreasing and oxygen recovery. A "hysteresis" 
or a "lag" reaction of eqm and er can be seen. 
However, the data in Figure 7 .8 from the same animal did not show the same 
lag response of er following change of S02, although good correlations remained 
between eqm, er and S02 (Figure 7.9). Figure 7.10 shows two stages - oxygen 
decreasing and recovery - of response shown in figure 7 .9. In another sheep 
(hypoxia experiment), 4 out of 7 (associated with good condition of sheep) hypoxic 
runs showed the lag reaction in response to the change of S02 similar to that in 
Figures 7 .5 and 7.6. The ratio of coronary resistance to oxygen saturation in coronary 
sinus was plotted against time through the whole run before, during and after systemic 
hypoxia continuously on beat by beat basis in Figure4.ll. This shows the constant 
159 
ratio during the period of decreasing oxygen supply, a lag response in er when 
oxygen level had started to recover toward baseline and finally the ratio falling toward 
a new stable value. 
For the same reason, I was only able to use 3 sheep, of which 2 sheep have 2 
runs and 1 sheep has 7 runs, for systemic hypoxia experiments with continuous S02 
(CS) measurement. 
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7.2 DISCUSSION 
Aortic constriction causes the myocyte to do more work in order to overcome 
the extra resistance due to the augmentation of proximal aortic pressure and keep 
cardiac output constant for systemic circulation. As has been demonstrated in chapter 
5, this increase elicited an increase in coronary blood flow and decrease in coronary 
\ 
resistance. Since the bulky evidence suggested that coronary metabolic vasoregulation 
is closely linked to the oxygen usage by the myocardium [Feigl, 1983; Berne, 1979], 
one logical speculation is that the increased cardiac work induces the heart to consume 
more oxygen, which causes the fall of oxygen level in the intramyocardium. The 
myocytes may be able to detect this fall and release vasoactive substances to increase 
blood flow and allow the intramyocardial oxygen to recover. This theory is a "close-
loop" controlling mechanism and was supported by Berne's experiments [Berne, 
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1979] in which they found that CBF only increased if the venous oxygen content was 
below a critical level of 5.5ml/100rnl. 
Generally the coronary sinus oxygen value represents the myocardial oxygen 
level1. Although the oxygen levels in the myocardium and coronary sinus are not 
equal, it is reasonable to assume that a fall in coronary sinus S02 reflects a decrease in 
myocardial oxygen level. The coronary sinus S02 results from the drainage volume 
of oxygen level in myocardium. If the close-loop controlling system operates in 
coronary vasodilation due to the applied intervention, a fall of S02 (CS) initially and 
then recovery to the baseline would be expected during aortic constriction. However, 
my data, in which the coronary sinus oxygen saturation varied significantly both 
above and below control values during increased cardiac work while coronary 
resistance and coronary blood flow reacted to the change of cardiac work, did not 
support this hypothesis. It is more likely that harder-working myocytes released 
vasodilator(s) into the interstitium, regardless of the amount of oxygen in 
myocardium, in direct proportion to the work done by the heart, causing decreased 
coronary resistance and increased coronary blood flow. In most cases, the 
vasodilation appeared to be in excess of the Di requirement and caused increase of the 
S02(CS). Under the modulation of neural control of coronary circulation [Feigl, 
1983; Stone, 1983] during increased cardiac work, cx-adrenergic vasoconstriction2 
limited this over-reaction of metabolism to ensure adequate myocardial blood flow 
which caused the S02 (CS) to remain stable or to decrease. The decrease in coronary 
sinus oxygen level caused by cx-adrenergic vasoconstriction was also found by Feigl's 
group [1975]. In the vagotomized anaesthetized dog, with the stimulation of 
sympathetic nerve heart rate, blood pressure and CBF increased, and coronary sinus 
1 Refer to section 3.3.2. 
2rn neural control of coronary circulation, a.-adrenergic vasoconstriction was showed to be dominant during 
the increased cardiac work due to the aortic constriction. (see chapter 5) 
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p02 decreased from 19mmHg to 15mmHg. After J3-adrenergic blockade, the positive 
inotropic and chronotropic effects due to sympathetic stimulation were blunted, but the 
unmasked ex-receptor vasoconstriction result in a f~l of coronary sinus p02 from 
17mmHg to 1 lmmHg, which could be abolished by ex-receptor blockade. These data 
suggested that coronary sympathetic vasomotion is also involved in the regulation of 
myocardial oxygen tension. The results in this chapter suggest that the coronary 
metabolic vasoregulation functions like an "open-loop" controlling system during 
increased cardiac work. 
During systemic hypoxia, the coronary resistance decreased in a parallel with 
coronary sinus oxygen saturation, whereas coronary blood flow did not exactly follow 
the change in S02 (Figures 7.5 and 7.6). This suggests that the coronary vascular 
resistance is strongly associated with the changes of oxygen in myocardium. The lag 
response following the change of myocardial oxygen level invites speculation 
. regarding the role of oxygen delivery and metabolite(s) washout in the regulation of 
coronary blood flow. It could be explained in two ways: 
• Direct oxygen effect on the vasodilation 
Oxygen directly acts on the ~ascular smooth muscle causing the relaxationl. 
This induces parallel changes in myocardial oxygen level and coronary resistance. 
While myocardial oxygen level is being led toward the normal level by increased 
supply of oxygen, vascular smooth muscle has a "memory" relax further ("hysteresis" 
phenomenon), then realizes that it is too far from the current oxygen level and 
. over-corrects it - causing the ratio of cr/S02 during the period of oxygen decrease to 
be different from that during the period of decreased oxygen supply - gradually 
coronary resistance is parallel with oxygen level again as shown in Figure 7.11. With 
1 Refer to section 3.2.3. 
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hysteresis phenomenon, the more severe the change of coronary resistance due to 
hypoxia, the longer the lag period would be expected to be. The current data were not 
sufficient to clarify this. 
• Indirect oxygen effect on vasodilation 
Oxygen does not have a direct effect on the vascular smooth muscle. The 
lower level of myocardial oxygen causes the generation and release of vasoactive 
metabolite(s) from myocardium, in proportion to the degree of hypoxia, to dilate 
coronary vessels in order to supply enough oxygen for normal myocardial_function. 
When the myocardial oxygen level starts to recover toward the baseline, the 
metabolite( s) talce some time to metabolize causing the lag response. In this case, the 
coronary resistance should immediately follow the oxygen level in the parallel fashion 
after the lag period and this lag period should be related to the metabolism of the 
metabolite(s) responsible for the vasodilation during hypoxia. Due to the concomitant 
changes during systemic hypoxia, we could not determine whether coronary resistance 
parallels with oxygen level immediately after the lag period. The concomitant changes 
also complicate the study of the lag period in order to provide information about the 
metabolism of possible metabolite(s ). 
7.3 CONCLUSION 
The metabolic control of coronary blood flow in this model is not dependent on 
the metabolic status of muscle expressed by coronary sinus ~xygen levels. This 
suggests that an "open-loop" feedback system operates in coronary vasoregulation due 
to increased cardiac work. Coronary sinus oxygen saturation is very closely related to 
coronary resistance with hypoxia. This suggests either that oxygen is able to act on 
vascular smooth muscle directly or that low oxygen triggers. a release of very 
short-lived vasoactive agent(s) to induce vasodilation during hypoxia. 
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CHAPTER 8 
RESULT 4 - DECAY OF INTRACORONARY 
ADENOSINE ADMINISTRATION 
171 
8.1 RESULTS 
8 .1.1 Half-Life of Coronary Resistance and Coronary Flow to 
Exogenous Adenosine 
During resting conditions, intracoronary infusion of adenosine caused no 
significant change in heart rate, arterial pressure and cardiac output at low doses 
(~Oµg) as shown in Figure 8.11 and a significant decrease in arterial pressure at high 
doses (:=::50µg) as shown in Figure 8.2. 
The calculated half life of mean coronary blood flow (cqm), coronary 
resistance (er) and diastolic coronary blood flow (cqd) was independent of adenosine 
doses. The half lives are: 
t: (cqm) = 15.2±0.6 (seconds) 
2 
t: (er) = 26.6±1.2 (seconds) 
2 -
t: (cqd) = 18.6±0.7 (seconds) 
2 
8.1.2 Adenosine Dose Response Curve before and after 
8-phenyltheophylline 
The response (expressed as the percentage change of the control) to 
intracoronary adenosine infusion at different doses is shown in Table 8.1 and.Figure 
\ 
8.4 before and after intravenous 8-phenyltheophylline (8-PT: 7.5mg/Kg) 
administration. Under control conditions, adenosine infusion resulted in prompt 
dose-related increase of coronary blood flow and decrease of coronary resistance, with 
a more profound response when adenosine dose was below 20µg. 
lThe abbreviations are listed in glossary. 
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Fig. 8.1: The changes of hemodynamic variables to low doses of intracoronary adenosine 
infusion. (adenosine = 10µg/0.25ml) 
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Fig. 8.3: The decay (half lives) of cqm, er and cqd in response to different doses of intracoronary 
adenosine infusion from 9 sheep. 
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Table 8.1: Response of coronary blood flow and coronary resistance to intracoronary adenosine 
infusion in 9 sheep 
Control Aller 8-phenyltheophylllne 
Adenoslne No.of sample 
Dose (µg) Acqm (%) Acr (-%) Acq~ (%) Acqm(%) Acr (-%) Acqd(%) 
3 86.2±12.0 33.7±2.1 80.4±0.5 12.9* 7.69* 18.1 * 
2 7 136.4±44 43.3±2.0 112.3±4.0 22.8±4.3 8.57±2.7 46.9±9.3 
5 9 1728±5.23 60.7±2.3 146.6±5.5 32.4±1.5 18.0±2'.9 58.8±2.6 
10 9 199.3±4.20 721±2.3 180.1±7.1 64.4±4.2 24.4±3.6 104.5±9.3 
20 8 219.9±7.76 66.5±1.3 169.7±5.3 73.1±3.5 19.7±0.8 81.7±3.5 
50 7 250.3±7.55 75.5±0.5 209.1±7.3 149±3.6 27.5±2.3 130.8±5.2 
100 6 258.5±9.87 76.7±1.7 204.6±6.3 114.6±3.6 18.4±3.5 98.3±4.1 
200 4 281. 94±17 .5 75.6±0.9 215.4±7.2 133.8±6.0 28.6±2.6 113.8±5.4 
* - only two samples 
T bi 8 2 a e . enosme oc ng e ect 1v -P env1 eop1 iv ne . . Ad . bi ki ffi b 8 h Ith h lli 
variables adenosine doses (µg) 
1 2 5 10 20 50 100 200 
.l\cqm (%) 84 83 81 67 66 40 55 52 
.l\cr (%) 77 80 70 66 70 63 75 62 
.l\cqd (%) 77 58 59 41 51 37 51 47 
The blocking effect was expressed as percentage change of adenosine dose-response before and 
after 8-PI'. 
8-PT produced inhibition at all doses tested (Table 8.2; Figure 8.4). Table 
8.2 shows that at lower doses (adenosine ~ 5µg), 8-PT produced more significant 
adenosine inhibition. 
8.2 DISCUSSION 
Previously it has been reported (see section 3.3.2.4 - adenosine inhibitors) that 
8-phenyltheophylline is the most potent currently available adenosine blocker having 
the lowest cardiac effect produced by calcium-dependent phosphodiesterase inhibition. 
This blocking ability was confirmed in the present study, especially at low doses of 
intracoronary adenosine infusion. 8-phenyltheophylline produced more than 80% 
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inhibition of the excess coronary flow and decreased coronary resistance in response 
to 5 µg or less of adenosine. With this dose adenosine caused more changes (increase 
in coronary blood flow and decrease in coronary resistance) than the response caused 
by increased cardiac work described in chapter 5 and by systemic hypoxia as in 
chapter 6. Therefore, it seems reasonable to use 8-phenyltheophylline as the 
adenosine inhibitor to study the role adenosine plays in coronary vasoregulation due to 
aortic constriction and systemic hypoxia. The interesting result (Figure 8.4) was that 
after adenosine blockade, more adenosine (exceeding 20 µg) did not produce more 
change in the coronary blood flow and coronary resistance as one might expect with 
competitive inhibition. 
The half lives for the response to intracoronary adenosine were much longer 
than the response to aortic constriction observed in chapter 5. This does not support 
adenosine as playing a role in this vasodilation due to aortic constriction. However, if 
exogenous adenosine and endogenous adenosine have a different effect on vascular 
smooth muscle, eg they might combine with differential receptors on different sides 
of vessels, an endogenous adenosine effect on vasodilation due to increased cardiac 
work can not be excluded. It is likely, with the known high mobility of adenosine, 
that adenosine is able to interact with all receptors. Further work is needed to clarify 
this exception. 
8.3 CONCLUSION 
The half life of intracoronary adenosine is 26.6±1.2 seconds. It is much 
longer than the response caused by aortic constriction observed in chapter 5. It is 
unlikely that adenosine plays a role in the coronary vasodilation during increased 
cardiac work. 
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CHAPTER 9 
CONCLUSIONS AND RECOMMENDATIONS 
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9 .1 CONCLUSIONS 
The contributions of this investigation to understanding the local metabolic 
vasoregulation in response to the changes of cardiac work and oxygen supply have 
already been discussed in each separate study of this thesis, but will be reiterated here: 
• The constant and short decay of vasodilating response in response to the 
different degrees and durations of increased cardiac work is independent 
of ex-, f3-adrenergic receptor inhibitions. This suggests that common 
mechanisms exist in this vasoregulation, that the vasoactive metabolite(s) 
is very likely to be a single agent, and that the release of this vasodilator is 
not controlled by the neurogenic stimulation. 
• The decay of exogenous adenosine (intracoronary administration) is about 
26seconds, which is much longer than that of the vasoactive metabolite. 
This suggests that this vasodilator responsible for vasoregulation during 
increased cardiac work is not adenosine. 
• Coronary oxygen saturation - an index of the change of myocardial 
oxygen level - varied significantly both above and below control value 
(most of case showed an in~rease of the oxygen saturation) during 
increased cardiac work while coronary- resistance and coronary blood 
flow reacted to the change of cardiac work. This suggests that this 
metabolic vasodilati'on is in excess of the oxygen requirement, that the 
release of the vasodilator is related to the work done by the myocytes, not 
by the temporary oxygen deficiency of myocardium, and that the coronary 
metabolic vasoregulationfunctions like an "open-loop" controlling system 
during increased cardiac work. 
• Coronary cx-adrenergic vasoconstriction appears to be dominant in the 
neurogenic control of coronary system in response to increased cardiac 
work. This suggests that the neural control system acts like a 
"modulator" to adjust the metabolic vasodilation and to ensure adequate 
blood supply to the heart, although this modulation is not perfect even for 
the "healthy" individual. 
• Good correlation is found between coronary resistance and oxygen level 
in both artery and vein during systemic hypoxia. After using adenosine 
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inhibitor, the correlation is improved and the change of oxygen supply 
level causes more change in coronary resistance and coronary blood flow. 
This suggests that the metabolic vasoregulation during hypoxia is strongly 
related to the oxygen level and that adenosine is unlikely to act as a 
transmitter between myocardial hypoxia and coronary vasodilation. 
• There is a "lag" reaction of coronary blood flow and coronary resistance 
in response to the myocardial oxygen level, although the change of 
coronary flow and resistance follow very closely to the change of 
coronary sinus oxygen saturation. This suggests that either oxygen has a 
direct effect on vascular smooth muscle or the change of oxygen level 
causes the production ofvasodilator and this lag period.is related to the 
metabolism of this vasodilator. 
To examine the hypothesis that EDRF was involved in the coronary 
vasodilating mecI:ianism1, we attempted to use NOLA (nitro-L-arginine) to block 
EDRF. The outcome of these experiments was a prolonged hypertensive response to 
NOLA with no apparent recovery within the time of an acute experiment. In addition 
we found that acety lcholine produced a vasodilation after N 0 LA that could be 
distinguished from the normal response only by a slightly shorter duration. In 
conscious instrumented sheep, an intravenou~ bolus of 40mg/Kg NOLA resulted in a 
marked increase in systolic blood pressure which persisted for at least one hour but 
had returned to control by 24 hours. The blood pressure response to NOLA did not 
return to the initial response, until an interval of 8 days had elapsed between repeated 
boluses. Thereafter, the effect of NOLA on the coronary artery blood flow response 
to increased heart work by a proximal aortic band was investigated in the instrument~ 
open-chested anaesthetized sheep. We found, contrary to expectation, that NOLA 
produced a greater fall in coronary resistance in relation to pressure in the aorta that 
occurred without NOLA. NOLA appears to be a complicated compound. If NOLA 
does block EDRF in vivo (same as in vitro), one possible explanation for this finding 
lThis was not part of this thesis. 
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would be that EDRF is acting as an endogenous free radical scavenger for some other 
free radical species that mediates the increased coronary blood flow during increased 
heart work and therefore inactivates this radical [Vial, 1991]. 
9.2 RECOMMENDATIONS 
work: 
Based on the current findings of this thesis, several possibilities arise for future 
• Almost all anaesthetics are vasoactive. The study of decay of coronary 
resistance in response to increased cardiac work need to be repeated in 
other animal models and in conscious models under full neurogenic 
blockade. 
• The change of myocardial oxygen level in response to increased cardiac 
work need to be examined in conscious sheep under cx-adrenergic 
blockade. 
• The characteristics of endogenous adenosine need to be clarified - is it the 
same as exogenous adenosine? 
• Other putative vasodilator's decay (especially EDRF) need to be studied 
in order to search the final agent responsible for vasoregulation during 
increased cardiac work. 
• Using a coronary perfusion model (which allows coronary perfusing 
pressure be controlled and some metabolic parameters in reservoir blood 
be controlled in desirable level) the time course of coronary resistance in 
response to the different level of oxygen supply can be studied. Also 
under these conditions, the "lag" responsel of coronary blood flow to the 
change of oxygen supply can be confirmed and investigated precisely. 
• Further experiments with hypoxia and continuous coronary sinus oxygen 
measurements under various blockers are required. From my data there is 
1 Refer to chapter 7. 
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a suggestion that the "lag" in response of coronary resistance has a similar 
time course to that produced by increased work. 
• we have hypothesized this vasodilation could be due to a free radical (eg 
NO), but preliminary studies using NOLA are against this. Further 
studies using oxygen free radical scavengers such as SOD (superoxide 
dismutase) are required to rule out the presence of a dilating free radical 
based on oxygen which forms the common pathway for this vasodilating 
response. 
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APPENDIX A 
The Calibration for Pressure Transducers 
The following graphs demonstrate the pressure and output voltage relationship 
for three Statham P23ID pressure transducers which were used in the experimental 
work. In the pressure range 0 - 180mmHg, all the transducers showed a linear 
pressure-voltage relationship (R>0.99). 
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APPENDIX B 
Calibration for 7-channel analog tape recorder 
The following shows the input and output voltage relationship for the seven 
channes of the analog tape recorder. Almost perfect linearity was observed. 
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APPENDIX C 
Anatomy of the Coronary Circulation of the Sheep 
The sheep heart is located between the second and the fifth intercostal space. 
The blood supply to the heart is from the left and right coronary arteries. Principally, 
the left coronary artery supplies the left heart and the right coronary artery supplies 
right heart, but there is some overlap. As in Figure C.l, the left coronary artery arises 
at the root of the aorta behind the left aortic valve and passes back medial to the 
pulmonary artery. Near the origin of the left coronary artery it divides into left the 
anterior descendant (LAD) and the circumflex branch. The circumflex branch follows 
the coronary groove toe near the caudal border of the heart and ends close to the 
termination of the right coronary artery. LAD descends the left longitudinal groove. 
Another descending branch leaves close to the termination of the circumflex branch 
and is distributed over the caudal wall of the ventricle (during my work, I discovered 
the location of this branch varies from sheep to sheep). The right coronary artery 
arises behind the right aortic valve and passes along the right part of the coronary 
groove and passes down the right longitudinal groove of the heart. 
After passage through the capillary beds, most of the venous blood returns to 
the right atrium through the coronary sinus (CS). There are three major veins, the 
great, middle and small cardiac veins, in the coronary venous system. The great vein 
collects most of venous blood in the area supplied by the circumflex artery. It begins 
near the apex and accompanies the descending branch of the left coronary artery. At 
the coronary groove it turns along the left side around the caudal border of the heart 
where it joins with the vena hemiazygos and opens into the CS in the ~ght atrium. 
The middle vein collects most of venous blood in the area supplied by the right 
coronary artery. It opens independently into the right atrium immediately cranial to the 
CS. The small veins mainly collect venous blood from the right and left atrium. 
iv 
The important difference between sheep and human heart anatomy, is the 
Vena Hemiazygos system. It begins in the abdomen below the first lumbar 
vertebra and drains the venous blood from wall of the thorax on both left and right 
side. It passes through the diaphragm, dorsal to the aorta, and leaves parallel with the 
level of the hiatus aorticus, then turns ventrally and crosses thy aorta obliquely to reach 
the caudal border of the origin of the pulmonary artery. Here it turns caudo-ventrally 
across the left atrium, medial to the left phrenic nerve, to join with the great cardiac 
veins. Because of its special route, we can reach the coronary- sinus through the 
hemiazygos vein while it crosses the left atrium., 
4 
Fig. c .1 : Diagrammatic representation of the left side of the sheep heart. 
(see text for more details) 
(1. Right Ventricle; 2. Left ventricle; 3. Left Atrium; 4. Apex; 5 Aorta; 6. Pulmonary Artery; 7. 
Longitudinal groove; 8. Left Anterior Descendens; 9. Circumflex Artery; 10. Intermediate groove and 
descendens branch; 11.Hemiazygos vein ). 
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APPENDIX D 
The Regression Analysis for Chapter 6 
The following graphs demonstrate the relation between coronary resistance 
(er) and other parameters (pH, pC02, pOz, S02) from both arterial blood 
(ARTERY) and venous blood (VENOUS) and myocardial oxygen consumption -
' . 
MV02 ) for hypoxic experiments in chapter six. It consisted of 8 sheep. Each sheep 
was analysed separately before and. after adenosine (ADO) inhibition by 
8-phenyltheophylline. Data expressed as: 
y =a+ bx · 
where y represents er and x represents the other parameter. R"2 is the Correlation 
Coefficient. 
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5. Data from experiment 90.11.20 
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6. Data from experiment 90.10.9 
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7. Data from experiment 90.9.24 
A: ARTERY (control) 
2 2 
er + 
+ 
er 
+ 
+ 
+ • 
• 
• • + • • + 
y = 63.5 - 8.19x R112=0.22 y = - 2.50 + 0.14x R112=0.18 
0 0 
7.58 pH(A) 768 22 pC02(A) 
2 2 
er er 
+ • + • 
• + 
+ 
+ y = - 0.62 + 0.02x R112 = 0.65 + + 
• 
• 
+ 
+ • 
y = 0.29 + O.Olx R112=0.71 
0 0 
0 p02 (A) 100 2) 502 (A) 100 
B: VENOUS (control) 
2 2 
er er 
+ 
• 
+ 
+ • 
y = 91.6-11.9x y = - 3.19 + 0.14x R112=0.59 
0 0 
7.52 pH (V) 7.66 24 pC02 (V) 34 
2 2 
er , er 
• • 
• + 
• + 
y = - 0.06 + 0.05x R112=0.66 y = 0.17 + 0.02x R112=0.60 • 
• 
+ 
• • 
+ + 
• + 
+ + 
0 0 
0 p02 (V) 0 502 (V) BJ 
xix 
~( 
C: MV02 (control) 
2 
er 
• + 
+ 
+ y = 1.72 - 0.03x RA2 = 0.59 
+ 
+ 
• 
+ 
+ + + 
0 MV02 
D: ARTERY (ADO inhibition) 
600 
1~ 16 
er + 
+ 
y = 14.4 - l.79x RA2=0.06 + 
+ 
+ 
02 0.2 
7.4 pH (A) 7.6 
1.6 1.6 
y = 0.32 + O.Olx RA2 = 0.66 
+ 
02 0.2 
20 p02 (A) 120 
E: MV02 (ADO inhibition) 
1.6 
er + 
+ 
+ 
y=0.79 + 0.04x RA2=0.14 
+ 
+ 
0.2 
0 MV02 1200 
xx 
er + 
+ 
+ 
+ y = - 0.03 + 0.03x RA2=0.08 
+ 
24 pC02(A) 33 
er + 
+ 
y = - 0.91+0.02x RA2=0.76 + 
+ 
+ 
+ 
f£) 502 (A) 100 
7. Data from experiment 90.11.22 
A: ARTERY (control) 
2.0 2.0 
er • • er 
• • 
y = 11.8 - 1.40x R112=0.001 
• • 
• • 
• • 
• y = 9.74 - 0.26x R112 = 0.88 
• • 0.8 0.8 
7.43 pH(A) 7.48 2) pC02(A) ~ 
2.0 2.0 
er • er • 
• • 
• • 
• • 
y = - 0.01 + O.OSx R112=0.95 • y = 0.14 + 0.0~ R112=0.98 
• • 0.8 0.8 
10 p02 (A) 00 3'.l 502 (A) 9'.) 
B: VENOUS (control) 
2.0 2.0 
er • er • 
• y = - 386.3 + 52.2x 
y = 4.86 - 9.22x R112=0.0l 
• • 
• • 
• • 
• • 
• • 0.8 0.8 
7.420 pH (V) 7.442 37 pC02 (V) ~ 
2.0 2.0 
er • er • 
• • 
• • 
• • 
• y = 0.09 + O,.llx R112=0.88 • 
• • 
y = 0.68 + O.OSx R112 = 0.85 
• • 0.8 0.8 
6 p02 (V) 18 0 502 (V) 
xxi 
C: MV02 (control) 
2.0 
er + 
y = - 0.86 + 0.02x 
• 
• 
0.8 -+---""-----...... ---------. 
100 MV02 180 
xxii 
